{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"machine_shape":"hm"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"code","source":["import pandas as pd\n","import os\n","import kagglehub\n","import zipfile\n","import json\n","from collections import Counter\n","import matplotlib.pyplot as plt\n","from lxml import etree\n","import xml.etree.ElementTree as ET\n","\n"],"metadata":{"id":"vT5Dej-0eoKS","executionInfo":{"status":"ok","timestamp":1750520536127,"user_tz":240,"elapsed":590,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":1,"outputs":[]},{"cell_type":"code","source":[],"metadata":{"id":"PlcOYDsgZaAm"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["Drug A Features:\n","Drug class,\n","Mechanism/Target,\n","chemical structure/SMILE,\n","known individual side effects,\n","Administration method and Dosages\n","elimination pathway (kidneys or liver)\n","Drugbank: Route of Elimination\n","Drug B Features:\n","Same list as Drug A\n"],"metadata":{"id":"d9wTHHh1ZcKr"}},{"cell_type":"markdown","source":["## **Import Drug Bank**"],"metadata":{"id":"Looxdp_lcLh4"}},{"cell_type":"code","source":["from google.colab import drive\n","drive.mount('/content/drive/')\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"TBBagFJXOv9M","executionInfo":{"status":"ok","timestamp":1750520671241,"user_tz":240,"elapsed":24437,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"17d85941-1d07-42a2-d633-c8b499104ef4"},"execution_count":2,"outputs":[{"output_type":"stream","name":"stdout","text":["Mounted at /content/drive/\n"]}]},{"cell_type":"code","source":["path=('/content/drive/MyDrive/drugbank.xml')\n","\n","print(os.path.exists(path))  # Should return True\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"1kzNOe8-QhMC","executionInfo":{"status":"ok","timestamp":1750520677386,"user_tz":240,"elapsed":1626,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"828bbd51-91f8-4189-ccda-f05ae8887f2a"},"execution_count":3,"outputs":[{"output_type":"stream","name":"stdout","text":["True\n"]}]},{"cell_type":"code","source":[],"metadata":{"id":"p0aI3H8PaQY6"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#File path\n","\n","with open(path, 'rb') as f:\n","    try:\n","        tree = etree.parse(f)\n","        print(\"Parsed with lxml!\")\n","    except etree.XMLSyntaxError as e:\n","        print(\"lxml error:\", e)\n","\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"Td7h0Z1zcLVK","executionInfo":{"status":"ok","timestamp":1750520705902,"user_tz":240,"elapsed":25376,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"7458020d-361a-4f3b-f9f8-cd7003e8aef9"},"execution_count":4,"outputs":[{"output_type":"stream","name":"stdout","text":["Parsed with lxml!\n"]}]},{"cell_type":"code","source":["##Looking at root\n","\n","tree = ET.parse(path)\n","root = tree.getroot()\n","\n","print(\"Root tag:\", root.tag)\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"vHFdMswlcKux","executionInfo":{"status":"ok","timestamp":1750520775158,"user_tz":240,"elapsed":52464,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"7791092f-2c7a-4836-ce24-8140cfcd318d"},"execution_count":5,"outputs":[{"output_type":"stream","name":"stdout","text":["Root tag: {http://www.drugbank.ca}drugbank\n"]}]},{"cell_type":"code","source":["##Lookin at childs\n","for child in root[:5]:\n","    print(\"Tag:\", child.tag)\n","    print(\"Attributes:\", child.attrib)\n","    print(\"Text:\", child.text.strip() if child.text else None)\n","    print(\"---\")\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"QHrhDTZ-iZ4y","executionInfo":{"status":"ok","timestamp":1750005149914,"user_tz":240,"elapsed":67,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"9f1d3ada-7a51-4be5-d425-de003dc3a7e1"},"execution_count":10,"outputs":[{"output_type":"stream","name":"stdout","text":["Tag: {http://www.drugbank.ca}drug\n","Attributes: {'type': 'biotech', 'created': '2005-06-13', 'updated': '2024-11-03'}\n","Text: \n","---\n","Tag: {http://www.drugbank.ca}drug\n","Attributes: {'type': 'biotech', 'created': '2005-06-13', 'updated': '2025-01-02'}\n","Text: \n","---\n","Tag: {http://www.drugbank.ca}drug\n","Attributes: {'type': 'biotech', 'created': '2005-06-13', 'updated': '2024-12-14'}\n","Text: \n","---\n","Tag: {http://www.drugbank.ca}drug\n","Attributes: {'type': 'biotech', 'created': '2005-06-13', 'updated': '2025-01-02'}\n","Text: \n","---\n","Tag: {http://www.drugbank.ca}drug\n","Attributes: {'type': 'biotech', 'created': '2005-06-13', 'updated': '2024-12-03'}\n","Text: \n","---\n"]}]},{"cell_type":"code","source":["##Name space\n","ns = {'db': 'http://www.drugbank.ca'}\n"],"metadata":{"id":"NRLju_G8i4l6","executionInfo":{"status":"ok","timestamp":1750520835415,"user_tz":240,"elapsed":9,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":6,"outputs":[]},{"cell_type":"code","source":["##Total drugs\n","drugs = root.findall('db:drug', namespaces=ns)\n","\n","print(\"Total drugs found:\", len(drugs))\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"YbrIse_hi6gg","executionInfo":{"status":"ok","timestamp":1750520837594,"user_tz":240,"elapsed":30,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"2be0478a-04f7-4f53-babf-4e35fc75b560"},"execution_count":7,"outputs":[{"output_type":"stream","name":"stdout","text":["Total drugs found: 17430\n"]}]},{"cell_type":"code","source":["##looking at all columns available\n","\n","# Set to collect all unique field names\n","all_tags = set()\n","\n","# Function to recursively walk through each element in a drug record\n","def collect_tags(element, path=''):\n","    for child in element:\n","        # Clean up namespace\n","        tag = child.tag.replace(f'{{{ns[\"db\"]}}}', '')\n","        full_path = f\"{path}/{tag}\" if path else tag\n","        all_tags.add(full_path)\n","        collect_tags(child, full_path)  # Recursively dive deeper\n","\n","# Run on first N drugs to limit runtime\n","for drug in drugs[:50]:\n","    collect_tags(drug)\n","\n","# Display all unique tag paths (like column names)\n","sorted_tags = sorted(all_tags)\n","for tag in sorted_tags:\n","    print(tag)\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"6vQVW1Fiesy_","executionInfo":{"status":"ok","timestamp":1750520841813,"user_tz":240,"elapsed":117,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"d5c50309-0cd7-4556-a26c-6f494053211a"},"execution_count":8,"outputs":[{"output_type":"stream","name":"stdout","text":["absorption\n","affected-organisms\n","affected-organisms/affected-organism\n","ahfs-codes\n","atc-codes\n","atc-codes/atc-code\n","atc-codes/atc-code/level\n","average-mass\n","calculated-properties\n","calculated-properties/property\n","calculated-properties/property/kind\n","calculated-properties/property/source\n","calculated-properties/property/value\n","carriers\n","carriers/carrier\n","carriers/carrier/actions\n","carriers/carrier/actions/action\n","carriers/carrier/id\n","carriers/carrier/known-action\n","carriers/carrier/name\n","carriers/carrier/organism\n","carriers/carrier/polypeptide\n","carriers/carrier/polypeptide/amino-acid-sequence\n","carriers/carrier/polypeptide/cellular-location\n","carriers/carrier/polypeptide/chromosome-location\n","carriers/carrier/polypeptide/external-identifiers\n","carriers/carrier/polypeptide/external-identifiers/external-identifier\n","carriers/carrier/polypeptide/external-identifiers/external-identifier/identifier\n","carriers/carrier/polypeptide/external-identifiers/external-identifier/resource\n","carriers/carrier/polypeptide/gene-name\n","carriers/carrier/polypeptide/gene-sequence\n","carriers/carrier/polypeptide/general-function\n","carriers/carrier/polypeptide/go-classifiers\n","carriers/carrier/polypeptide/locus\n","carriers/carrier/polypeptide/molecular-weight\n","carriers/carrier/polypeptide/name\n","carriers/carrier/polypeptide/organism\n","carriers/carrier/polypeptide/pfams\n","carriers/carrier/polypeptide/pfams/pfam\n","carriers/carrier/polypeptide/pfams/pfam/identifier\n","carriers/carrier/polypeptide/pfams/pfam/name\n","carriers/carrier/polypeptide/signal-regions\n","carriers/carrier/polypeptide/specific-function\n","carriers/carrier/polypeptide/synonyms\n","carriers/carrier/polypeptide/synonyms/synonym\n","carriers/carrier/polypeptide/theoretical-pi\n","carriers/carrier/polypeptide/transmembrane-regions\n","carriers/carrier/references\n","carriers/carrier/references/articles\n","carriers/carrier/references/attachments\n","carriers/carrier/references/links\n","carriers/carrier/references/textbooks\n","cas-number\n","categories\n","categories/category\n","categories/category/category\n","categories/category/mesh-id\n","classification\n","classification/alternative-parent\n","classification/class\n","classification/description\n","classification/direct-parent\n","classification/kingdom\n","classification/subclass\n","classification/substituent\n","classification/superclass\n","clearance\n","description\n","dosages\n","dosages/dosage\n","dosages/dosage/form\n","dosages/dosage/route\n","dosages/dosage/strength\n","drug-interactions\n","drug-interactions/drug-interaction\n","drug-interactions/drug-interaction/description\n","drug-interactions/drug-interaction/drugbank-id\n","drug-interactions/drug-interaction/name\n","drugbank-id\n","enzymes\n","enzymes/enzyme\n","enzymes/enzyme/actions\n","enzymes/enzyme/actions/action\n","enzymes/enzyme/id\n","enzymes/enzyme/induction-strength\n","enzymes/enzyme/inhibition-strength\n","enzymes/enzyme/known-action\n","enzymes/enzyme/name\n","enzymes/enzyme/organism\n","enzymes/enzyme/polypeptide\n","enzymes/enzyme/polypeptide/amino-acid-sequence\n","enzymes/enzyme/polypeptide/cellular-location\n","enzymes/enzyme/polypeptide/chromosome-location\n","enzymes/enzyme/polypeptide/external-identifiers\n","enzymes/enzyme/polypeptide/external-identifiers/external-identifier\n","enzymes/enzyme/polypeptide/external-identifiers/external-identifier/identifier\n","enzymes/enzyme/polypeptide/external-identifiers/external-identifier/resource\n","enzymes/enzyme/polypeptide/gene-name\n","enzymes/enzyme/polypeptide/gene-sequence\n","enzymes/enzyme/polypeptide/general-function\n","enzymes/enzyme/polypeptide/go-classifiers\n","enzymes/enzyme/polypeptide/go-classifiers/go-classifier\n","enzymes/enzyme/polypeptide/go-classifiers/go-classifier/category\n","enzymes/enzyme/polypeptide/go-classifiers/go-classifier/description\n","enzymes/enzyme/polypeptide/locus\n","enzymes/enzyme/polypeptide/molecular-weight\n","enzymes/enzyme/polypeptide/name\n","enzymes/enzyme/polypeptide/organism\n","enzymes/enzyme/polypeptide/pfams\n","enzymes/enzyme/polypeptide/pfams/pfam\n","enzymes/enzyme/polypeptide/pfams/pfam/identifier\n","enzymes/enzyme/polypeptide/pfams/pfam/name\n","enzymes/enzyme/polypeptide/signal-regions\n","enzymes/enzyme/polypeptide/specific-function\n","enzymes/enzyme/polypeptide/synonyms\n","enzymes/enzyme/polypeptide/synonyms/synonym\n","enzymes/enzyme/polypeptide/theoretical-pi\n","enzymes/enzyme/polypeptide/transmembrane-regions\n","enzymes/enzyme/references\n","enzymes/enzyme/references/articles\n","enzymes/enzyme/references/articles/article\n","enzymes/enzyme/references/articles/article/citation\n","enzymes/enzyme/references/articles/article/pubmed-id\n","enzymes/enzyme/references/articles/article/ref-id\n","enzymes/enzyme/references/attachments\n","enzymes/enzyme/references/attachments/attachment\n","enzymes/enzyme/references/attachments/attachment/ref-id\n","enzymes/enzyme/references/attachments/attachment/title\n","enzymes/enzyme/references/attachments/attachment/url\n","enzymes/enzyme/references/links\n","enzymes/enzyme/references/links/link\n","enzymes/enzyme/references/links/link/ref-id\n","enzymes/enzyme/references/links/link/title\n","enzymes/enzyme/references/links/link/url\n","enzymes/enzyme/references/textbooks\n","experimental-properties\n","experimental-properties/property\n","experimental-properties/property/kind\n","experimental-properties/property/source\n","experimental-properties/property/value\n","external-identifiers\n","external-identifiers/external-identifier\n","external-identifiers/external-identifier/identifier\n","external-identifiers/external-identifier/resource\n","external-links\n","external-links/external-link\n","external-links/external-link/resource\n","external-links/external-link/url\n","fda-label\n","food-interactions\n","food-interactions/food-interaction\n","general-references\n","general-references/articles\n","general-references/articles/article\n","general-references/articles/article/citation\n","general-references/articles/article/pubmed-id\n","general-references/articles/article/ref-id\n","general-references/attachments\n","general-references/attachments/attachment\n","general-references/attachments/attachment/ref-id\n","general-references/attachments/attachment/title\n","general-references/attachments/attachment/url\n","general-references/links\n","general-references/links/link\n","general-references/links/link/ref-id\n","general-references/links/link/title\n","general-references/links/link/url\n","general-references/textbooks\n","general-references/textbooks/textbook\n","general-references/textbooks/textbook/citation\n","general-references/textbooks/textbook/isbn\n","general-references/textbooks/textbook/ref-id\n","groups\n","groups/group\n","half-life\n","indication\n","international-brands\n","international-brands/international-brand\n","international-brands/international-brand/company\n","international-brands/international-brand/name\n","manufacturers\n","manufacturers/manufacturer\n","mechanism-of-action\n","metabolism\n","mixtures\n","mixtures/mixture\n","mixtures/mixture/ingredients\n","mixtures/mixture/name\n","monoisotopic-mass\n","msds\n","name\n","packagers\n","packagers/packager\n","packagers/packager/name\n","packagers/packager/url\n","patents\n","patents/patent\n","patents/patent/approved\n","patents/patent/country\n","patents/patent/expires\n","patents/patent/number\n","patents/patent/pediatric-extension\n","pathways\n","pathways/pathway\n","pathways/pathway/category\n","pathways/pathway/drugs\n","pathways/pathway/drugs/drug\n","pathways/pathway/drugs/drug/drugbank-id\n","pathways/pathway/drugs/drug/name\n","pathways/pathway/enzymes\n","pathways/pathway/enzymes/uniprot-id\n","pathways/pathway/name\n","pathways/pathway/smpdb-id\n","pdb-entries\n","pharmacodynamics\n","prices\n","prices/price\n","prices/price/cost\n","prices/price/description\n","prices/price/unit\n","products\n","products/product\n","products/product/approved\n","products/product/country\n","products/product/dosage-form\n","products/product/dpd-id\n","products/product/ema-ma-number\n","products/product/ema-product-code\n","products/product/ended-marketing-on\n","products/product/fda-application-number\n","products/product/generic\n","products/product/labeller\n","products/product/name\n","products/product/ndc-id\n","products/product/ndc-product-code\n","products/product/over-the-counter\n","products/product/route\n","products/product/source\n","products/product/started-marketing-on\n","products/product/strength\n","protein-binding\n","reactions\n","reactions/reaction\n","reactions/reaction/enzymes\n","reactions/reaction/left-element\n","reactions/reaction/left-element/drugbank-id\n","reactions/reaction/left-element/name\n","reactions/reaction/right-element\n","reactions/reaction/right-element/drugbank-id\n","reactions/reaction/right-element/name\n","reactions/reaction/sequence\n","route-of-elimination\n","salts\n","salts/salt\n","salts/salt/average-mass\n","salts/salt/cas-number\n","salts/salt/drugbank-id\n","salts/salt/inchikey\n","salts/salt/monoisotopic-mass\n","salts/salt/name\n","salts/salt/unii\n","sequences\n","sequences/sequence\n","snp-adverse-drug-reactions\n","snp-effects\n","snp-effects/effect\n","snp-effects/effect/allele\n","snp-effects/effect/defining-change\n","snp-effects/effect/description\n","snp-effects/effect/gene-symbol\n","snp-effects/effect/protein-name\n","snp-effects/effect/pubmed-id\n","snp-effects/effect/rs-id\n","snp-effects/effect/uniprot-id\n","state\n","synonyms\n","synonyms/synonym\n","synthesis-reference\n","targets\n","targets/target\n","targets/target/actions\n","targets/target/actions/action\n","targets/target/id\n","targets/target/known-action\n","targets/target/name\n","targets/target/organism\n","targets/target/polypeptide\n","targets/target/polypeptide/amino-acid-sequence\n","targets/target/polypeptide/cellular-location\n","targets/target/polypeptide/chromosome-location\n","targets/target/polypeptide/external-identifiers\n","targets/target/polypeptide/external-identifiers/external-identifier\n","targets/target/polypeptide/external-identifiers/external-identifier/identifier\n","targets/target/polypeptide/external-identifiers/external-identifier/resource\n","targets/target/polypeptide/gene-name\n","targets/target/polypeptide/gene-sequence\n","targets/target/polypeptide/general-function\n","targets/target/polypeptide/go-classifiers\n","targets/target/polypeptide/go-classifiers/go-classifier\n","targets/target/polypeptide/go-classifiers/go-classifier/category\n","targets/target/polypeptide/go-classifiers/go-classifier/description\n","targets/target/polypeptide/locus\n","targets/target/polypeptide/molecular-weight\n","targets/target/polypeptide/name\n","targets/target/polypeptide/organism\n","targets/target/polypeptide/pfams\n","targets/target/polypeptide/pfams/pfam\n","targets/target/polypeptide/pfams/pfam/identifier\n","targets/target/polypeptide/pfams/pfam/name\n","targets/target/polypeptide/signal-regions\n","targets/target/polypeptide/specific-function\n","targets/target/polypeptide/synonyms\n","targets/target/polypeptide/synonyms/synonym\n","targets/target/polypeptide/theoretical-pi\n","targets/target/polypeptide/transmembrane-regions\n","targets/target/references\n","targets/target/references/articles\n","targets/target/references/articles/article\n","targets/target/references/articles/article/citation\n","targets/target/references/articles/article/pubmed-id\n","targets/target/references/articles/article/ref-id\n","targets/target/references/attachments\n","targets/target/references/links\n","targets/target/references/links/link\n","targets/target/references/links/link/ref-id\n","targets/target/references/links/link/title\n","targets/target/references/links/link/url\n","targets/target/references/textbooks\n","toxicity\n","transporters\n","transporters/transporter\n","transporters/transporter/actions\n","transporters/transporter/actions/action\n","transporters/transporter/id\n","transporters/transporter/known-action\n","transporters/transporter/name\n","transporters/transporter/organism\n","transporters/transporter/polypeptide\n","transporters/transporter/polypeptide/amino-acid-sequence\n","transporters/transporter/polypeptide/cellular-location\n","transporters/transporter/polypeptide/chromosome-location\n","transporters/transporter/polypeptide/external-identifiers\n","transporters/transporter/polypeptide/external-identifiers/external-identifier\n","transporters/transporter/polypeptide/external-identifiers/external-identifier/identifier\n","transporters/transporter/polypeptide/external-identifiers/external-identifier/resource\n","transporters/transporter/polypeptide/gene-name\n","transporters/transporter/polypeptide/gene-sequence\n","transporters/transporter/polypeptide/general-function\n","transporters/transporter/polypeptide/go-classifiers\n","transporters/transporter/polypeptide/go-classifiers/go-classifier\n","transporters/transporter/polypeptide/go-classifiers/go-classifier/category\n","transporters/transporter/polypeptide/go-classifiers/go-classifier/description\n","transporters/transporter/polypeptide/locus\n","transporters/transporter/polypeptide/molecular-weight\n","transporters/transporter/polypeptide/name\n","transporters/transporter/polypeptide/organism\n","transporters/transporter/polypeptide/pfams\n","transporters/transporter/polypeptide/pfams/pfam\n","transporters/transporter/polypeptide/pfams/pfam/identifier\n","transporters/transporter/polypeptide/pfams/pfam/name\n","transporters/transporter/polypeptide/signal-regions\n","transporters/transporter/polypeptide/specific-function\n","transporters/transporter/polypeptide/synonyms\n","transporters/transporter/polypeptide/synonyms/synonym\n","transporters/transporter/polypeptide/theoretical-pi\n","transporters/transporter/polypeptide/transmembrane-regions\n","transporters/transporter/references\n","transporters/transporter/references/articles\n","transporters/transporter/references/articles/article\n","transporters/transporter/references/articles/article/citation\n","transporters/transporter/references/articles/article/pubmed-id\n","transporters/transporter/references/articles/article/ref-id\n","transporters/transporter/references/attachments\n","transporters/transporter/references/links\n","transporters/transporter/references/textbooks\n","unii\n","volume-of-distribution\n"]}]},{"cell_type":"code","source":["rows = []\n","\n","for drug in drugs:\n","    drug_id = drug.findtext('db:drugbank-id', namespaces=ns)\n","    drug_name = drug.findtext('db:name', namespaces=ns)\n","\n","    # Drug Class\n","    classification = drug.find('db:classification', namespaces=ns)\n","    drug_class = classification.findtext('db:class', namespaces=ns) if classification is not None else None\n","    subclass = classification.findtext('db:subclass', namespaces=ns) if classification is not None else None\n","\n","    # Mechanism / Target\n","    mechanism = drug.findtext('db:mechanism-of-action', namespaces=ns)\n","\n","    # SMILES\n","    smiles = None\n","    for prop in drug.findall('db:calculated-properties/db:property', namespaces=ns):\n","        kind = prop.findtext('db:kind', namespaces=ns)\n","        if kind and kind.lower() == 'smiles':\n","            smiles = prop.findtext('db:value', namespaces=ns)\n","            break\n","\n","    # Side Effects (Toxicity)\n","    toxicity = drug.findtext('db:toxicity', namespaces=ns)\n","\n","    # Dosage & Administration Route\n","    dosage_form = None\n","    dosage_strength = None\n","    dosage_route = None\n","    dosage = drug.find('db:dosages/db:dosage', namespaces=ns)\n","    if dosage is not None:\n","        dosage_form = dosage.findtext('db:form', namespaces=ns)\n","        dosage_strength = dosage.findtext('db:strength', namespaces=ns)\n","        dosage_route = dosage.findtext('db:route', namespaces=ns)\n","\n","    # Route of Elimination (kidney/liver)\n","    elimination_route = drug.findtext('db:route-of-elimination', namespaces=ns)\n","\n","    rows.append({\n","        'drugbank_id': drug_id,\n","        'drug_name': drug_name,\n","        'drug_class': drug_class,\n","        'subclass': subclass,\n","        'mechanism_of_action': mechanism,\n","        'smiles': smiles,\n","        'toxicity': toxicity,\n","        'dosage_form': dosage_form,\n","        'dosage_strength': dosage_strength,\n","        'dosage_route': dosage_route,\n","        'route_of_elimination': elimination_route\n","    })\n","\n","df = pd.DataFrame(rows)\n","df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":293},"id":"GVy-wThVLF7x","executionInfo":{"status":"ok","timestamp":1750520852956,"user_tz":240,"elapsed":850,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"18fb408c-8251-4acd-fc35-057f29429f01"},"execution_count":9,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  drugbank_id            drug_name                        drug_class  \\\n","0     DB00001            Lepirudin  Carboxylic Acids and Derivatives   \n","1     DB00002            Cetuximab  Carboxylic Acids and Derivatives   \n","2     DB00003         Dornase alfa  Carboxylic Acids and Derivatives   \n","3     DB00004  Denileukin diftitox  Carboxylic Acids and Derivatives   \n","4     DB00005           Etanercept  Carboxylic Acids and Derivatives   \n","\n","                               subclass  \\\n","0  Amino Acids, Peptides, and Analogues   \n","1  Amino Acids, Peptides, and Analogues   \n","2  Amino Acids, Peptides, and Analogues   \n","3  Amino Acids, Peptides, and Analogues   \n","4  Amino Acids, Peptides, and Analogues   \n","\n","                                 mechanism_of_action smiles  \\\n","0  Lepirudin is a direct thrombin inhibitor used ...   None   \n","1  The epidermal growth factor receptor (EGFR) is...   None   \n","2  Dornase alfa is a biosynthetic form of human D...   None   \n","3  Denileukin diftitox is a fusion protein compos...   None   \n","4  There are two distinct receptors for TNF (TNFR...   None   \n","\n","                                            toxicity  \\\n","0  The acute toxicity of intravenous lepirudin wa...   \n","1  The intravenous LD<sub>50</sub> is > 300 mg/kg...   \n","2  Adverse reactions occur at a frequency of < 1/...   \n","3  There is limited information regarding the acu...   \n","4                                                      \n","\n","                         dosage_form dosage_strength  \\\n","0  Injection, powder, for suspension      5000000 mg   \n","1                          Injection         5 MG/ML   \n","2                     Aerosol, spray          2.5 mg   \n","3                Injection, solution      150 ug/1mL   \n","4                Injection, solution           25 MG   \n","\n","               dosage_route                               route_of_elimination  \n","0               Intravenous  Lepirudin is mostly excreted through urine (48...  \n","1               Intravenous            There is limited information available.  \n","2  Respiratory (inhalation)                                                     \n","3               Intravenous                                                     \n","4                Parenteral                                                     "],"text/html":["\n","  <div id=\"df-4180a1f7-7d79-4397-ac2c-99d28a2922ff\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>drugbank_id</th>\n","      <th>drug_name</th>\n","      <th>drug_class</th>\n","      <th>subclass</th>\n","      <th>mechanism_of_action</th>\n","      <th>smiles</th>\n","      <th>toxicity</th>\n","      <th>dosage_form</th>\n","      <th>dosage_strength</th>\n","      <th>dosage_route</th>\n","      <th>route_of_elimination</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>Carboxylic Acids and Derivatives</td>\n","      <td>Amino Acids, Peptides, and Analogues</td>\n","      <td>Lepirudin is a direct thrombin inhibitor used ...</td>\n","      <td>None</td>\n","      <td>The acute toxicity of intravenous lepirudin wa...</td>\n","      <td>Injection, powder, for suspension</td>\n","      <td>5000000 mg</td>\n","      <td>Intravenous</td>\n","      <td>Lepirudin is mostly excreted through urine (48...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>Carboxylic Acids and Derivatives</td>\n","      <td>Amino Acids, Peptides, and Analogues</td>\n","      <td>The epidermal growth factor receptor (EGFR) is...</td>\n","      <td>None</td>\n","      <td>The intravenous LD&lt;sub&gt;50&lt;/sub&gt; is &gt; 300 mg/kg...</td>\n","      <td>Injection</td>\n","      <td>5 MG/ML</td>\n","      <td>Intravenous</td>\n","      <td>There is limited information available.</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00003</td>\n","      <td>Dornase alfa</td>\n","      <td>Carboxylic Acids and Derivatives</td>\n","      <td>Amino Acids, Peptides, and Analogues</td>\n","      <td>Dornase alfa is a biosynthetic form of human D...</td>\n","      <td>None</td>\n","      <td>Adverse reactions occur at a frequency of &lt; 1/...</td>\n","      <td>Aerosol, spray</td>\n","      <td>2.5 mg</td>\n","      <td>Respiratory (inhalation)</td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00004</td>\n","      <td>Denileukin diftitox</td>\n","      <td>Carboxylic Acids and Derivatives</td>\n","      <td>Amino Acids, Peptides, and Analogues</td>\n","      <td>Denileukin diftitox is a fusion protein compos...</td>\n","      <td>None</td>\n","      <td>There is limited information regarding the acu...</td>\n","      <td>Injection, solution</td>\n","      <td>150 ug/1mL</td>\n","      <td>Intravenous</td>\n","      <td></td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00005</td>\n","      <td>Etanercept</td>\n","      <td>Carboxylic Acids and Derivatives</td>\n","      <td>Amino Acids, Peptides, and Analogues</td>\n","      <td>There are two distinct receptors for TNF (TNFR...</td>\n","      <td>None</td>\n","      <td></td>\n","      <td>Injection, solution</td>\n","      <td>25 MG</td>\n","      <td>Parenteral</td>\n","      <td></td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-4180a1f7-7d79-4397-ac2c-99d28a2922ff')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-4180a1f7-7d79-4397-ac2c-99d28a2922ff button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-4180a1f7-7d79-4397-ac2c-99d28a2922ff');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-4f170b91-b54b-40cb-8964-1eaf46a5cd38\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-4f170b91-b54b-40cb-8964-1eaf46a5cd38')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-4f170b91-b54b-40cb-8964-1eaf46a5cd38 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df","summary":"{\n  \"name\": \"df\",\n  \"rows\": 17430,\n  \"fields\": [\n    {\n      \"column\": \"drugbank_id\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"DB05423\",\n          \"DB00020\",\n          \"DB08484\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"drug_name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"ORG-34517\",\n          \"Sargramostim\",\n          \"4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"drug_class\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 304,\n        \"samples\": [\n          \"Cycloheptapyrans\",\n          \"Post-transition metal oxoanionic compounds\",\n          \"Benzothiophenes\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"subclass\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 512,\n        \"samples\": [\n          \"CDP-glycerols\",\n          \"Transition metal hydroxides\",\n          \"Benzoyl peroxides\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"mechanism_of_action\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 4065,\n        \"samples\": [\n          \"TRC093 (MT293) is a recombinant humanized IgG1 monoclonal antibody that inhibits angiogenesis, tumor cell growth and metastasis by binding cleaved collagen, which is predominantly produced in the extracellular matrix of tumors. TRC093 targets collagen found in the basement membrane of tumor blood vessels. Collagen is a essential triple helix of polypeptide chains found in the extracellular matrix which is involved with many cellular processs including cell proliferation, adhesion, migration, and angiogenesis (neovascularization - growth of new blood vessels). Matrix metalloproteinase enzymes (MMPs) remodel and denature collagen during angiogenesis, causing changes in bioactive sites which results in altered proliferation, adhesion and migration of cells. TRC093 specifically binds to mice breast cancer blood vessel tumors, inhibiting tumor growth. It is proposed that TRC093 binds to hydroxyproline residues of GPO sequences (the major platelet-activating motif within collagen and essential for collagen folding) when they are exposed by thermal denaturation or partially proteolytically degraded by MMPs. TRC093 may target many different types of cancer as  a critical component of the TRC093 epitope is a GPOG sequence which are present in high numbers in many different types of collagen. \",\n          \"Respiratory tract infections can be caused by numerous strains of bacteria, requiring careful consideration of treatment and antibiotics effective against a broad spectrum of potential pathogens. Cethromycin, like other macrolide antibiotics, binds to the 23S rRNA of the 50S subunit of the bacterial ribosome. This binding, primarily mediated through regions II and V of the rRNA, occludes the peptide exit tunnel and inhibits bacterial protein synthesis. In addition, cethromycin is capable of binding to ribosomal intermediates during ribosome biogenesis, inhibiting the formation of functional 70S bacterial ribosomes. Due to the sequence and structural similarity of ribosomes between species, cethromycin displays broad-spectrum activity against diverse Gram-positive, Gram-negative, and atypical bacteria.[A203369, A203417, A203417]\",\n          \"Induces peripheral immune activation through the activity of regulatory T-cells that surpress inappropriate Th2 cytokeine activity. \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"smiles\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 12306,\n        \"samples\": [\n          \"CC(C)(C)OC[C@H]1N(CCNC1=O)C(=O)C[C@H](N)CC1=CC(F)=C(F)C=C1F\",\n          \"N[C@@H](CCO)C(O)=O\",\n          \"NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO[P@]2(=O)OCC[C@H](O2)C2=CC=NC=C2)[C@@H](O)[C@@H]1O\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"toxicity\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2493,\n        \"samples\": [\n          \"Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].\",\n          \"Reported incidences of agranulocytosis, hyperkalemia, and anaphylaxis. The use of nafamostat has been reported to cause cardiac arrest in patients receiving dialysis due to a sudden change in the patient's condition such as dyspnea. A study suggests that the drug and its metabolites may inhibit the amiloride-sensitive sodium (Na) conductance at the collecting ducts, resulting in an inhibition of K secretion and hyperkalemia [A19240]. Reported LD50 value from intravenous administration in rats is 16.4mg/kg.\",\n          \"Patients experiencing an overdose may present with shock, cyanosis, and coma.[A204053] Treat patients with symptomatic and supportive measures which may include administration of fluids, exchange transfusions, and administration of dopamine.[A204053]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"dosage_form\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 151,\n        \"samples\": [\n          \"Cream; kit\",\n          \"Tablet\",\n          \"Strip\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"dosage_strength\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1450,\n        \"samples\": [\n          \"0.1 mg/1\",\n          \"38.5 mcg/1vial\",\n          \"30 \\u00b5g\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"dosage_route\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 95,\n        \"samples\": [\n          \"Intra-articular\",\n          \"Transdermal\",\n          \"Intraperitoneal; Intravenous; Oral; Subcutaneous\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"route_of_elimination\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1996,\n        \"samples\": [\n          \"Ecallantide undergoes renal elimination [FDA Label].\",\n          \"Following ester cleavage, the nicotinic acid metabolite is expected to enter the endogenous metabolic pool as a part of the vitamin B complex [F12]. The 2-butoxyethanol metabolite is believed to be mainly excreted primarily in the urine and to a certain extent, in exhaled air [F12]. In humans, the urinary elimination of 2-butoxyethanol's metabolite, 2-butoxyacetic acid was also reported [F12].\",\n          \"Studies of distribution, metabolism, and excretion in cats and dogs indicate that rocuronium is eliminated primarily by the liver.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":9}]},{"cell_type":"code","source":["df.to_csv('DrugBankFeatures.csv')"],"metadata":{"id":"E3bP3MXGMI_G","executionInfo":{"status":"ok","timestamp":1750521255250,"user_tz":240,"elapsed":184,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":10,"outputs":[]},{"cell_type":"code","source":["df.columns"],"metadata":{"id":"VXvlkr3MOMhz","executionInfo":{"status":"ok","timestamp":1750521669942,"user_tz":240,"elapsed":27,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"ced0faa8-7779-4772-a076-ea0447c40fe5","colab":{"base_uri":"https://localhost:8080/"}},"execution_count":12,"outputs":[{"output_type":"execute_result","data":{"text/plain":["Index(['drugbank_id', 'drug_name', 'drug_class', 'subclass',\n","       'mechanism_of_action', 'smiles', 'toxicity', 'dosage_form',\n","       'dosage_strength', 'dosage_route', 'route_of_elimination'],\n","      dtype='object')"]},"metadata":{},"execution_count":12}]},{"cell_type":"code","source":["for drug in drugs[:5]:\n","    drugbank_id = drug.find('db:drugbank-id', namespaces=ns)\n","    name = drug.find('db:name', namespaces=ns)\n","    description = drug.find('db:description', namespaces=ns)\n","\n","    print(\"ID:\", drugbank_id.text if drugbank_id is not None else None)\n","    print(\"Name:\", name.text if name is not None else None)\n","    print(\"Description:\", description.text[:100] + \"...\" if description is not None else None)\n","    print(\"---\")\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"8Q7xNcC8i9IV","executionInfo":{"status":"ok","timestamp":1750005157534,"user_tz":240,"elapsed":32,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"4c9378f2-49da-4a35-fef0-ff32708cdc6c"},"execution_count":13,"outputs":[{"output_type":"stream","name":"stdout","text":["ID: DB00001\n","Name: Lepirudin\n","Description: Lepirudin is a recombinant hirudin formed by 65 amino acids that acts as a highly specific and direc...\n","---\n","ID: DB00002\n","Name: Cetuximab\n","Description: Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to...\n","---\n","ID: DB00003\n","Name: Dornase alfa\n","Description: Dornase alfa is a biosynthetic form of human deoxyribunuclease I (DNase I) enzyme. It is produced in...\n","---\n","ID: DB00004\n","Name: Denileukin diftitox\n","Description: Denileukin diftitox is an IL2-receptor-directed cytotoxin, is a recombinant DNA-derived fusion prote...\n","---\n","ID: DB00005\n","Name: Etanercept\n","Description: Dimeric fusion protein consisting of the extracellular ligand-binding portion of the human 75 kiloda...\n","---\n"]}]},{"cell_type":"code","source":["import pandas as pd\n","\n","records = []\n","for drug in drugs:\n","    record = {\n","        \"drugbank_id\": drug.findtext('db:drugbank-id', namespaces=ns),\n","        \"name\": drug.findtext('db:name', namespaces=ns),\n","        \"type\": drug.attrib.get(\"type\"),\n","        \"created\": drug.attrib.get(\"created\"),\n","        \"updated\": drug.attrib.get(\"updated\"),\n","    }\n","    records.append(record)\n","\n","df = pd.DataFrame(records)\n","df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"tiCHoSDvi0hu","executionInfo":{"status":"ok","timestamp":1750005160449,"user_tz":240,"elapsed":204,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"8f15cb36-6cfe-420a-a594-4b7ac077c3bd"},"execution_count":14,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  drugbank_id                 name     type     created     updated\n","0     DB00001            Lepirudin  biotech  2005-06-13  2024-11-03\n","1     DB00002            Cetuximab  biotech  2005-06-13  2025-01-02\n","2     DB00003         Dornase alfa  biotech  2005-06-13  2024-12-14\n","3     DB00004  Denileukin diftitox  biotech  2005-06-13  2025-01-02\n","4     DB00005           Etanercept  biotech  2005-06-13  2024-12-03"],"text/html":["\n","  <div id=\"df-818b4b4f-9aa2-4b22-82cc-12397201f7e0\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>drugbank_id</th>\n","      <th>name</th>\n","      <th>type</th>\n","      <th>created</th>\n","      <th>updated</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2024-11-03</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2025-01-02</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00003</td>\n","      <td>Dornase alfa</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2024-12-14</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00004</td>\n","      <td>Denileukin diftitox</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2025-01-02</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00005</td>\n","      <td>Etanercept</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2024-12-03</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-818b4b4f-9aa2-4b22-82cc-12397201f7e0')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-818b4b4f-9aa2-4b22-82cc-12397201f7e0 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-818b4b4f-9aa2-4b22-82cc-12397201f7e0');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-9dbc1de0-942d-4767-b6dd-86756f55e7cd\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-9dbc1de0-942d-4767-b6dd-86756f55e7cd')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-9dbc1de0-942d-4767-b6dd-86756f55e7cd button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df","summary":"{\n  \"name\": \"df\",\n  \"rows\": 17430,\n  \"fields\": [\n    {\n      \"column\": \"drugbank_id\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"DB05423\",\n          \"DB00020\",\n          \"DB08484\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"ORG-34517\",\n          \"Sargramostim\",\n          \"4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"type\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"small molecule\",\n          \"biotech\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"created\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"num_unique_values\": 988,\n        \"samples\": [\n          \"2015-10-16\",\n          \"2017-11-27\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"updated\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"num_unique_values\": 501,\n        \"samples\": [\n          \"2024-02-15\",\n          \"2022-02-18\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":14}]},{"cell_type":"code","source":["##Looking at interactions\n","##making basic drug interaction table\n","interaction_rows = []\n","\n","for drug in drugs:\n","    source_id = drug.findtext('db:drugbank-id', namespaces=ns)\n","    source_name = drug.findtext('db:name', namespaces=ns)\n","\n","    interactions = drug.findall('db:drug-interactions/db:drug-interaction', namespaces=ns)\n","    for inter in interactions:\n","        target_id = inter.findtext('db:drugbank-id', namespaces=ns)\n","        target_name = inter.findtext('db:name', namespaces=ns)\n","        description = inter.findtext('db:description', namespaces=ns)\n","\n","        interaction_rows.append({\n","            'source_id': source_id,\n","            'source_name': source_name,\n","            'target_id': target_id,\n","            'target_name': target_name,\n","            'description': description\n","        })\n","\n","interactions_df = pd.DataFrame(interaction_rows)\n","interactions_df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"PAJWjkupjLCL","executionInfo":{"status":"ok","timestamp":1750006310811,"user_tz":240,"elapsed":15666,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"c1c586b0-175e-4114-da23-c5f33abb6013"},"execution_count":36,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  source_id source_name target_id           target_name  \\\n","0   DB00001   Lepirudin   DB06605              Apixaban   \n","1   DB00001   Lepirudin   DB06695  Dabigatran etexilate   \n","2   DB00001   Lepirudin   DB01254             Dasatinib   \n","3   DB00001   Lepirudin   DB01609           Deferasirox   \n","4   DB00001   Lepirudin   DB01586  Ursodeoxycholic acid   \n","\n","                                         description  \n","0  Apixaban may increase the anticoagulant activi...  \n","1  Dabigatran etexilate may increase the anticoag...  \n","2  The risk or severity of bleeding and hemorrhag...  \n","3  The risk or severity of gastrointestinal bleed...  \n","4  The risk or severity of bleeding and bruising ...  "],"text/html":["\n","  <div id=\"df-9c1e263e-8752-4e80-8691-a43b6970b650\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>source_id</th>\n","      <th>source_name</th>\n","      <th>target_id</th>\n","      <th>target_name</th>\n","      <th>description</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>DB06605</td>\n","      <td>Apixaban</td>\n","      <td>Apixaban may increase the anticoagulant activi...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>DB06695</td>\n","      <td>Dabigatran etexilate</td>\n","      <td>Dabigatran etexilate may increase the anticoag...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>DB01254</td>\n","      <td>Dasatinib</td>\n","      <td>The risk or severity of bleeding and hemorrhag...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>DB01609</td>\n","      <td>Deferasirox</td>\n","      <td>The risk or severity of gastrointestinal bleed...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>DB01586</td>\n","      <td>Ursodeoxycholic acid</td>\n","      <td>The risk or severity of bleeding and bruising ...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-9c1e263e-8752-4e80-8691-a43b6970b650')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-9c1e263e-8752-4e80-8691-a43b6970b650 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-9c1e263e-8752-4e80-8691-a43b6970b650');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-f316a9ce-a4d5-41bd-905d-39a285e6d44c\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f316a9ce-a4d5-41bd-905d-39a285e6d44c')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-f316a9ce-a4d5-41bd-905d-39a285e6d44c button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"interactions_df"}},"metadata":{},"execution_count":36}]},{"cell_type":"code","source":["interactions_df.to_csv(\"drug_interactions.csv\", index=False)"],"metadata":{"id":"JxZ1GNfrcAMO","executionInfo":{"status":"ok","timestamp":1750005212321,"user_tz":240,"elapsed":8541,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":16,"outputs":[]},{"cell_type":"code","source":["import matplotlib.pyplot as plt\n","\n","top_drugs = interactions_df['source_name'].value_counts().nlargest(20)\n","\n","plt.figure(figsize=(10, 8))\n","top_drugs.sort_values().plot(kind='barh')\n","plt.xlabel(\"Number of Interactions\")\n","plt.title(\"Top 20 Drugs by Number of Interactions\")\n","plt.tight_layout()\n","plt.show()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":807},"id":"oWb6Q6aKcRrJ","executionInfo":{"status":"ok","timestamp":1750005381046,"user_tz":240,"elapsed":336,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"d30d9ee1-62ad-44f9-8644-d9d3f8e721c2"},"execution_count":17,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x800 with 1 Axes>"],"image/png":"iVBORw0KGgoAAAANSUhEUgAAA90AAAMWCAYAAADs4eXxAAAAOnRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjEwLjAsIGh0dHBzOi8vbWF0cGxvdGxpYi5vcmcvlHJYcgAAAAlwSFlzAAAPYQAAD2EBqD+naQAAyrhJREFUeJzs3XlUVdX///HXxeEyCYiioqKooKDgrDmmaYZjmpbzgENmzgNaVs4TfhxScyg1Qc0yU/PTJ1MyEivKecgBTSnCCtMcQERR4f7+8Ov9eQUUkStCz8dady3OPnt4n4N31Zu9zz4Gk8lkEgAAAAAAyHY2OR0AAAAAAAB5FUk3AAAAAABWQtINAAAAAICVkHQDAAAAAGAlJN0AAAAAAFgJSTcAAAAAAFZC0g0AAAAAgJWQdAMAAAAAYCUk3QAAAAAAWAlJNwAASFdMTIwMBoPmzp2b06HkmIiICBkMBm3cuDGnQ8mUv//+Wy+//LKKFCkig8GgBQsW5HRIT627v9uIiIicDgVAHkfSDQDIVgaDIVMfa/+P7tmzZzVlyhTVrVtXhQsXVtGiRdW0aVN988036da/cuWKBg4cKDc3Nzk4OOi5557TwYMHMzVW06ZNzddlY2MjJycnVapUSb169dKOHTuy87LypNDQUBkMBtna2urPP/9Mc75p06by8/PLgchyn1GjRiksLEzjx4/X2rVr1bJlywzrGgwGDR06NEvjfPzxx7kmoV+6dKlCQ0NzOgwA/2L5czoAAEDesnbtWovjNWvWaMeOHWnKfX19rRrHf//7X82ePVsdOnRQnz59dPv2ba1Zs0YtWrTQqlWr1LdvX3Pd1NRUtWnTRkeOHNHYsWNVtGhRLV26VE2bNtWBAwfk7e390PFKly6tWbNmSZKuXbumM2fOaPPmzfroo4/UuXNnffTRRypQoIDVrjcvSE5OVnBwsN57772cDiXX+vbbb9W+fXsFBQVZdZyPP/5Yx44d08iRI606TnZYunSpihYtqsDAQIvyZ599VtevX1fBggVzJjAA/xok3QCAbNWzZ0+L4927d2vHjh1pyq3tueeeU2xsrIoWLWouGzRokKpXr66JEydaJN0bN27Ujz/+qM8++0wvv/yyJKlz586qWLGiJk2apI8//vih4zk7O6e5xuDgYA0fPlxLly6Vp6enZs+enWH71NRU3bx5U7a2to96qXlG9erVtWLFCo0fP14lS5bM6XCeqGvXrsnBweGx+zl//rxcXFweP6Ac8KS/AzY2Nv/q7xuAJ4fl5QCAJ+7atWsaM2aMPDw8ZDQaValSJc2dO1cmk8mi3t3lr+vWrVOlSpVka2urWrVq6bvvvnvoGFWqVLFIuCXJaDSqdevW+uOPP3T16lVz+caNG1W8eHF17NjRXObm5qbOnTvrv//9r5KTk7N0nfny5dOiRYtUuXJlLV68WPHx8eleW5UqVWQ0GrV9+/YMnzO9+3z1/ctkP/vsM1WuXFm2trby8/PT559/rsDAQHl6elrUW79+vWrVqqVChQrJyclJ/v7+WrhwYaav5d1331XZsmVlZ2enJk2a6NixY+ZzISEhMhgMOnToUJp2M2fOVL58+dJdNn6/t956SykpKQoODn5gvYzuhXTnvk6ePNl8PHnyZBkMBv3yyy/q2bOnnJ2d5ebmpgkTJshkMuns2bNq3769nJycVKJECc2bNy/dMVNSUvTWW2+pRIkScnBw0IsvvqizZ8+mqbdnzx61bNlSzs7Osre3V5MmTRQZGWlR525MJ06cUPfu3VW4cGE1atTogdf866+/6pVXXpGrq6vs7e1Vr149bd261Xz+7hJ9k8mkJUuWmB93eBR3/+1t2LBBM2bMUOnSpWVra6vmzZvrzJkz5npNmzbV1q1b9fvvv5vHufffW3JysiZNmiQvLy8ZjUZ5eHho3Lhxab5HGX0HJGnu3Llq0KCBihQpIjs7O9WqVSvD5+o/+ugj1a1bV/b29ipcuLCeffZZff3115IkT09PHT9+XLt27TLH2rRpU4vrvf+79tlnn6lWrVqys7NT0aJF1bNnzzT/fgMDA+Xo6Kg///xTHTp0kKOjo9zc3BQUFKSUlBSLuo/73QOQ+5F0AwCeKJPJpBdffFHvvvuuWrZsqfnz56tSpUoaO3asRo8enab+rl27NHLkSPXs2VNTp07VxYsX1bJlS4uk71GcO3dO9vb2sre3N5cdOnRINWvWlI2N5X8W69atq6SkJP3yyy9ZGku6k3h369ZNSUlJ+uGHHyzOffvttxo1apS6dOmihQsXpkmUH2br1q3q0qWLChQooFmzZqljx47q37+/Dhw4YFFvx44d6tatmwoXLqzZs2crODhYTZs2TZMMZmTNmjVatGiRhgwZovHjx+vYsWNq1qyZ/v77b0nSyy+/LDs7O61bty5N23Xr1qlp06YqVarUQ8cpV66cevfurRUrVuivv/7KVGyZ1aVLF6Wmpio4OFjPPPOMpk+frgULFqhFixYqVaqUZs+eLS8vLwUFBaX7R50ZM2Zo69ateuONNzR8+HDt2LFDzz//vK5fv26u8+233+rZZ59VQkKCJk2apJkzZ+rKlStq1qyZ9u7dm6bPV155RUlJSZo5c6ZeffXVDGP/+++/1aBBA4WFhWnw4MGaMWOGbty4oRdffFGff/65pDtLpe8+wtGiRQutXbs2zSMdmRUcHKzPP/9cQUFBGj9+vHbv3q0ePXqYz7/99tuqXr26ihYtah7n7vPdqampevHFFzV37ly1a9dO7733njp06KB3331XXbp0STNWRt+BhQsXqkaNGpo6dapmzpyp/Pnz65VXXrH4Q4MkTZkyRb169VKBAgU0depUTZkyRR4eHvr2228lSQsWLFDp0qXl4+NjjvXtt9/O8NpDQ0PVuXNn5cuXT7NmzdKrr76qzZs3q1GjRrpy5YpF3ZSUFAUEBKhIkSKaO3eumjRponnz5mn58uXmOo/73QOQR5gAALCiIUOGmO79z82WLVtMkkzTp0+3qPfyyy+bDAaD6cyZM+YySSZJpv3795vLfv/9d5Otra3ppZdeeuRYTp8+bbK1tTX16tXLotzBwcHUr1+/NPW3bt1qkmTavn37A/tt0qSJqUqVKhme//zzz02STAsXLjSXSTLZ2NiYjh8/blF3586dJkmmnTt3WpT/9ttvJkmmkJAQc5m/v7+pdOnSpqtXr5rLIiIiTJJMZcuWNZeNGDHC5OTkZLp9+/YDr+N+d8e0s7Mz/fHHH+byPXv2mCSZRo0aZS7r1q2bqWTJkqaUlBRz2cGDB9PEnJ6QkBCTJNO+fftM0dHRpvz585uGDx9uPn///U3vXtwlyTRp0iTz8aRJk0ySTAMHDjSX3b5921S6dGmTwWAwBQcHm8svX75ssrOzM/Xp08dcdvf3UapUKVNCQoK5fMOGDRa/09TUVJO3t7cpICDAlJqaaq6XlJRkKleunKlFixZpYurWrdsD78tdI0eONEkyff/99+ayq1evmsqVK2fy9PS0uOeSTEOGDMlUv/fXvXutvr6+puTkZHP5woULTZJMR48eNZe1adPG4t/YXWvXrjXZ2NhYxGoymUzvv/++SZIpMjLSYvz0vgMm0537dq+bN2+a/Pz8TM2aNTOXnT592mRjY2N66aWXLO6ByWSy+B1UqVLF1KRJkzRj3P9du3nzpqlYsWImPz8/0/Xr1831vvzyS5Mk08SJE81lffr0MUkyTZ061aLPGjVqmGrVqmU+zup3D0Dewkw3AOCJ+uqrr5QvXz4NHz7conzMmDEymUzatm2bRXn9+vVVq1Yt83GZMmXUvn17hYWFpVnG+SBJSUl65ZVXZGdnl2b58vXr12U0GtO0ufu8572zmVnh6OgoSRZL2iWpSZMmqly5cpb6/Ouvv3T06FH17t3b3P/dPv39/S3quri46Nq1a1neSb1Dhw4WM9V169bVM888o6+++spc1rt3b/3111/auXOnuWzdunWys7NTp06dMj1W+fLl1atXLy1fvlxxcXFZijc9AwYMMP+cL18+1a5dWyaTSf379zeXu7i4qFKlSvr111/TtO/du7cKFSpkPn755Zfl7u5uvgeHDx/W6dOn1b17d128eFH//POP/vnnH127dk3NmzfXd999p9TUVIs+Bw0alKnYv/rqK9WtW9diCbqjo6MGDhyomJgYnThxInM3IZP69u1rsblY48aNJSnd+3K/zz77TL6+vvLx8THfg3/++UfNmjWTJIt/H1LG3wE7Ozvzz5cvX1Z8fLwaN25s8UaBLVu2KDU1VRMnTkyzSuVRl9ZL0v79+3X+/HkNHjzY4lnvNm3ayMfHJ80su5T2d9i4cWOL+/S43z0AeQNJNwDgifr9999VsmRJiwRG+v+7mf/+++8W5entHF6xYkUlJSXpwoULmRozJSVFXbt21YkTJ7Rx48Y0m3TZ2dml+9z2jRs3zOcfR2JioiSlueZy5cpluc+798nLyyvNufvLBg8erIoVK6pVq1YqXbq0+vXrZ352NjMy+h3ExMSYj1u0aCF3d3fzEvPU1FR98sknat++fZrrfph33nlHt2/ffuiz3Y+iTJkyFsfOzs6ytbVN89y/s7OzLl++nKb9/ffAYDDIy8vLfA9Onz4tSerTp4/c3NwsPitXrlRycrLFM/1S5n//v//+uypVqpSmPKPvzOO6/14VLlxYktK9L/c7ffq0jh8/nuYeVKxYUdKdjd7uldE9+PLLL1WvXj3Z2trK1dVVbm5uWrZsmcU9jI6Olo2NTZb/cHW/u/cxvXvt4+OT5j7b2trKzc3Noqxw4cIW9+lxv3sA8gZ2LwcA5HmvvvqqvvzyS61bt84843Yvd3f3dGdV75Y97k7ad58/vz8ZTi+Zz2iG7lFm9e9XrFgxHT58WGFhYdq2bZu2bdumkJAQ9e7dW6tXr85yv/fKly+funfvrhUrVmjp0qWKjIzUX3/9laVd68uXL6+ePXtq+fLlevPNN9Ocz8o9ypcvX6bKJKXZ0C8z7s5iz5kzR9WrV0+3zr0rEqTH/2OOtTzOfUlNTZW/v7/mz5+f7nkPDw+L4/Tuwffff68XX3xRzz77rJYuXSp3d3cVKFBAISEhmXqTwJOS0X2615P47gF4+pF0AwCeqLJly+qbb77R1atXLWZAT548aT5/r7sziPf65ZdfZG9vn2aWKT1jx45VSEiIFixYoG7duqVbp3r16vr++++VmppqsUx1z549sre3N8/SZUVKSoo+/vhj2dvbP3SHaun/zyrev2nT/bNsd+/TvbtK35VeWcGCBdWuXTu1a9dOqampGjx4sD744ANNmDAh3dnye2X0O7h/47fevXtr3rx5+t///qdt27bJzc1NAQEBD+w7I++8844++uijdF+zltl7lJ3uvwcmk0lnzpxR1apVJUkVKlSQJDk5Oen555/P1rHLli2rU6dOpSnP6DvzJGT0h48KFSroyJEjat68eZaWeEvSpk2bZGtrq7CwMIvHPkJCQtKMlZqaqhMnTmT4h44HxXq/u/fx1KlTaf44d+rUqSzf58f57gHIG1heDgB4olq3bq2UlBQtXrzYovzdd9+VwWBQq1atLMp/+ukni+c4z549q//+97964YUXHjrTNGfOHM2dO1dvvfWWRowYkWG9l19+WX///bc2b95sLvvnn3/02WefqV27duk+750ZKSkpGj58uKKiojR8+HA5OTk9tE3ZsmWVL1++NDtoL1261OK4ZMmS8vPz05o1a8zL16U7u70fPXrUou7Fixctjm1sbMzJYmZeh7ZlyxaLVybt3btXe/bsSfO7qlq1qqpWraqVK1dq06ZN6tq1q/Lnz9rf9ytUqKCePXvqgw8+0Llz5yzOOTk5qWjRog+9R9lpzZo1aV4zFxcXZ74HtWrVUoUKFTR37lyL38ddmX0UIj2tW7fW3r179dNPP5nLrl27puXLl8vT0zPbllc/CgcHhzTL5aU777f/888/tWLFijTnrl+/rmvXrj2073z58slgMFisXIiJidGWLVss6nXo0EE2NjaaOnVqmufl752Vd3BwSPMHmvTUrl1bxYoV0/vvv2/xvdi2bZuioqLUpk2bh/Zxv8f97gHIG5jpBgA8Ue3atdNzzz2nt99+WzExMapWrZq+/vpr/fe//9XIkSPNM4Z3+fn5KSAgQMOHD5fRaDQnVlOmTHngOJ9//rnGjRsnb29v+fr66qOPPrI436JFCxUvXlzSnaS7Xr166tu3r06cOKGiRYtq6dKlSklJeeg4d8XHx5vHSEpK0pkzZ7R582ZFR0era9eumjZtWqb6cXZ21iuvvKL33ntPBoNBFSpU0JdffpnmWVjpzjuw27dvr4YNG6pv3766fPmyFi9eLD8/P4vEb8CAAbp06ZKaNWum0qVL6/fff9d7772n6tWrm58LfhAvLy81atRIr7/+upKTk7VgwQIVKVJE48aNS1O3d+/eCgoKkqQsLS2/19tvv621a9fq1KlTqlKlisW5AQMGKDg4WAMGDFDt2rX13XffPdar3R7G1dVVjRo1Ut++ffX3339rwYIF8vLyMr/qy8bGRitXrlSrVq1UpUoV9e3bV6VKldKff/6pnTt3ysnJSf/73/+yNPabb76pTz75RK1atdLw4cPl6uqq1atX67ffftOmTZvSbCL2JNSqVUuffvqpRo8erTp16sjR0VHt2rVTr169tGHDBg0aNEg7d+5Uw4YNlZKSopMnT2rDhg0KCwtT7dq1H9h3mzZtNH/+fLVs2VLdu3fX+fPntWTJEnl5eennn3821/Py8tLbb7+tadOmqXHjxurYsaOMRqP27dunkiVLatasWeZYly1bpunTp8vLy0vFihVL9zGTAgUKaPbs2erbt6+aNGmibt266e+//za/ymzUqFGPfJ8e97sHII/Iya3TAQB53/2vDDOZ7rzuaNSoUaaSJUuaChQoYPL29jbNmTPH4jU/JtP/f6XRRx99ZPL29jYZjUZTjRo10rxOKz13X8uU0ef+Pi5dumTq37+/qUiRIiZ7e3tTkyZNTPv27cvUNTZp0sSib0dHR5O3t7epZ8+epq+//jrdNnrAq50uXLhg6tSpk8ne3t5UuHBh02uvvWY6duxYuq/JWr9+vcnHx8dkNBpNfn5+pi+++MLUqVMnk4+Pj7nOxo0bTS+88IKpWLFipoIFC5rKlCljeu2110xxcXEPvK67r+aaM2eOad68eSYPDw+T0Wg0NW7c2HTkyJF028TFxZny5ctnqlix4gP7vte9rwy7391XM93/SrakpCRT//79Tc7OzqZChQqZOnfubDp//nyGrwy7cOFCmn4dHBzSjHf/68nuvlbqk08+MY0fP95UrFgxk52dnalNmzam33//PU37Q4cOmTp27GgqUqSIyWg0msqWLWvq3LmzKTw8/KExPUh0dLTp5ZdfNrm4uJhsbW1NdevWNX355Zdp6j3o39XD6t691s8++8yiXnqvaEtMTDR1797d5OLikuYVdTdv3jTNnj3bVKVKFZPRaDQVLlzYVKtWLdOUKVNM8fHxmYr1ww8/NH/nfXx8TCEhIeb7dr9Vq1aZatSoYR6rSZMmph07dpjPnzt3ztSmTRtToUKFTJLMrw/L6PV8n376qbk/V1dXU48ePSxemWcyZfzv5/4Ys/rdA5C3GEymLOwWAgDAE2AwGDRkyJA0S9HxYNWrV5ebm1uOvKbon3/+kbu7uyZOnKgJEyY88fEBAHja8Ew3AAC51K1bt3T79m2LsoiICB05ckRNmzbNkZhCQ0OVkpKiXr165cj4AAA8bXimGwCAXOrPP//U888/r549e6pkyZI6efKk3n//fZUoUUKDBg16orF8++23OnHihGbMmKEOHTqk2dkcAIB/K5JuAAByqcKFC6tWrVpauXKlLly4IAcHB7Vp00bBwcEqUqTIE41l6tSp+vHHH9WwYUO99957T3RsAACeZjzTDQAAAACAlfBMNwAAAAAAVkLSDQAAAACAlfBMN54aqamp+uuvv1SoUCEZDIacDgcAAAAAMmQymXT16lWVLFlSNjYZz2eTdOOp8ddff8nDwyOnwwAAAACATDt79qxKly6d4XmSbjw1ChUqJOnOP1onJ6ccjgYAAAAAMpaQkCAPDw9zHpMRkm48Ne4uKXdyciLpBgAAAJArPOzRWDZSAwAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALASXhmGp47fpDDZGO1zOgwAAAAAT4GY4DY5HcJjYaYbAAAAAAArIekGAAAAAMBKSLqfAgaDQVu2bMnpMCw0bdpUI0eOzOkwAAAAACBXI+l+As6dO6dhw4apfPnyMhqN8vDwULt27RQeHp7ToWVo8+bNmjZtWk6HAQAAAAC5GhupWVlMTIwaNmwoFxcXzZkzR/7+/rp165bCwsI0ZMgQnTx5MqdDTJerq2tOhwAAAAAAuR4z3VY2ePBgGQwG7d27V506dVLFihVVpUoVjR49Wrt37063zdGjR9WsWTPZ2dmpSJEiGjhwoBITE83nDQZDmo+np6ckKSUlRf3791e5cuVkZ2enSpUqaeHChRb9BwYGqkOHDpoyZYrc3Nzk5OSkQYMG6ebNm+Y69y8v9/T01MyZM9WvXz8VKlRIZcqU0fLlyy36PXv2rDp37iwXFxe5urqqffv2iomJebwbCAAAAAC5GEm3FV26dEnbt2/XkCFD5ODgkOa8i4tLmrJr164pICBAhQsX1r59+/TZZ5/pm2++0dChQ8114uLizJ8zZ87Iy8tLzz77rCQpNTVVpUuX1meffaYTJ05o4sSJeuutt7RhwwaLccLDwxUVFaWIiAh98skn2rx5s6ZMmfLA65k3b55q166tQ4cOafDgwXr99dd16tQpSdKtW7cUEBCgQoUK6fvvv1dkZKQcHR3VsmVLi2QeAAAAAP5NWF5uRWfOnJHJZJKPj0+m23z88ce6ceOG1qxZY07UFy9erHbt2mn27NkqXry4SpQoIUkymUzq1KmTnJ2d9cEHH0iSChQoYJE8lytXTj/99JM2bNigzp07m8sLFiyoVatWyd7eXlWqVNHUqVM1duxYTZs2TTY26f8tpnXr1ho8eLAk6Y033tC7776rnTt3qlKlSvr000+VmpqqlStXymAwSJJCQkLk4uKiiIgIvfDCC2n6S05OVnJysvk4ISEh0/cJAAAAAHIDZrqtyGQyPXKbqKgoVatWzWJmvGHDhkpNTTXPKt/11ltv6aefftJ///tf2dnZmcuXLFmiWrVqyc3NTY6Ojlq+fLliY2Mt2larVk329vbm4/r16ysxMVFnz57NMLaqVauafzYYDCpRooTOnz8vSTpy5IjOnDmjQoUKydHRUY6OjnJ1ddWNGzcUHR2dbn+zZs2Ss7Oz+ePh4ZGJOwQAAAAAuQcz3Vbk7e0tg8Fglc3SPvroI7377ruKiIhQqVKlzOXr169XUFCQ5s2bp/r166tQoUKaM2eO9uzZ89hjFihQwOLYYDAoNTVVkpSYmKhatWpp3bp1adq5ubml29/48eM1evRo83FCQgKJNwAAAIA8haTbilxdXRUQEKAlS5Zo+PDhaZ7rvnLlSprnun19fRUaGqpr166Z60dGRsrGxkaVKlWSJP30008aMGCAPvjgA9WrV8+ifWRkpBo0aGBeBi4p3ZnmI0eO6Pr16+YZ8t27d8vR0THLSW/NmjX16aefqlixYnJycspUG6PRKKPRmKXxAAAAACA3YHm5lS1ZskQpKSmqW7euNm3apNOnTysqKkqLFi1S/fr109Tv0aOHbG1t1adPHx07dkw7d+7UsGHD1KtXLxUvXlznzp3TSy+9pK5duyogIEDnzp3TuXPndOHCBUl3Ztf379+vsLAw/fLLL5owYYL27duXZpybN2+qf//+OnHihL766itNmjRJQ4cOzfB57ofp0aOHihYtqvbt2+v777/Xb7/9poiICA0fPlx//PFHlvoEAAAAgNyOpNvKypcvr4MHD+q5557TmDFj5OfnpxYtWig8PFzLli1LU9/e3l5hYWG6dOmS6tSpo5dfflnNmzfX4sWLJUknT57U33//rdWrV8vd3d38qVOnjiTptddeU8eOHdWlSxc988wzunjxosWs913NmzeXt7e3nn32WXXp0kUvvviiJk+enOXrtLe313fffacyZcqoY8eO8vX1Vf/+/XXjxo1Mz3wDAAAAQF5jMGVlty/kaoGBgbpy5Yq2bNmS06FYSEhIuLOh2sgNsjHaP7wBAAAAgDwvJrhNToeQrrv5S3x8/AMnGpnpBgAAAADASki6AQAAAACwEnYv/xcKDQ3N6RAAAAAA4F+BpBtPnWNTAth8DQAAAECewPJyAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACsh6QYAAAAAwEpIugEAAAAAsBKSbgAAAAAArISkGwAAAAAAKyHpBgAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALCS/DkdAHA/v0lhsjHa53QYAAAAANIRE9wmp0PIVZjpBgAAAADASki6AQAAAACwEpJuAAAAAACsJE8n3QaDQVu2bMnwfEREhAwGg65cufLEYsotmjZtqpEjR+Z0GAAAAACQq+XqpPvcuXMaNmyYypcvL6PRKA8PD7Vr107h4eE5HVqut3nzZk2bNi2nwwAAAACAXC3X7l4eExOjhg0bysXFRXPmzJG/v79u3bqlsLAwDRkyRCdPnnwicdy8eVMFCxZ85HYmk0kpKSnKn//p/BW4urrmdAgAAAAAkOvl2pnuwYMHy2AwaO/everUqZMqVqyoKlWqaPTo0dq9e7e53j///KOXXnpJ9vb28vb21hdffPHAfjdt2qQqVarIaDTK09NT8+bNszjv6empadOmqXfv3nJyctLAgQMVExMjg8Gg9evXq0GDBrK1tZWfn5927dplbnd3Kfu2bdtUq1YtGY1G/fDDD0pOTtbw4cNVrFgx2draqlGjRtq3b1+admFhYapRo4bs7OzUrFkznT9/Xtu2bZOvr6+cnJzUvXt3JSUlmdtt375djRo1kouLi4oUKaK2bdsqOjrafH7y5MkyGAxpPqGhoZLSLi/39PTUzJkz1a9fPxUqVEhlypTR8uXLLe7N2bNn1blzZ7m4uMjV1VXt27dXTEzMQ3+XAAAAAJBX5cqk+9KlS9q+fbuGDBkiBweHNOddXFzMP0+ZMkWdO3fWzz//rNatW6tHjx66dOlSuv0eOHBAnTt3VteuXXX06FFNnjxZEyZMMCeid82dO1fVqlXToUOHNGHCBHP52LFjNWbMGB06dEj169dXu3btdPHiRYu2b775poKDgxUVFaWqVatq3Lhx2rRpk1avXq2DBw/Ky8tLAQEBaWKcPHmyFi9erB9//NGc3C5YsEAff/yxtm7dqq+//lrvvfeeuf61a9c0evRo7d+/X+Hh4bKxsdFLL72k1NRUSVJQUJDi4uLMn7lz58re3l61a9fO8L7PmzdPtWvX1qFDhzR48GC9/vrrOnXqlCTp1q1bCggIUKFChfT9998rMjJSjo6OatmypW7evJluf8nJyUpISLD4AAAAAEBekiuT7jNnzshkMsnHx+ehdQMDA9WtWzd5eXlp5syZSkxM1N69e9OtO3/+fDVv3lwTJkxQxYoVFRgYqKFDh2rOnDkW9Zo1a6YxY8aoQoUKqlChgrl86NCh6tSpk3x9fbVs2TI5Ozvrww8/tGg7depUtWjRQhUqVJDRaNSyZcs0Z84ctWrVSpUrV9aKFStkZ2eXpt306dPVsGFD1ahRQ/3799euXbu0bNky1ahRQ40bN9bLL7+snTt3mut36tRJHTt2lJeXl6pXr65Vq1bp6NGjOnHihCTJ0dFRJUqUUIkSJRQTE6N33nlHISEh8vPzy/Betm7dWoMHD5aXl5feeOMNFS1a1Dzmp59+qtTUVK1cuVL+/v7y9fVVSEiIYmNjFRERkW5/s2bNkrOzs/nj4eGR4dgAAAAAkBvlyqTbZDJlum7VqlXNPzs4OMjJyUnnz59Pt25UVJQaNmxoUdawYUOdPn1aKSkp5rKMZoPr169v/jl//vyqXbu2oqKiLOrc2zY6Olq3bt2yGLNAgQKqW7dumnb3Xkfx4sVlb2+v8uXLW5Tde12nT59Wt27dVL58eTk5OcnT01OSFBsba9FvbGysOnTooKCgIHXu3Dnd60ovBoPBoBIlSpjHPHLkiM6cOaNChQrJ0dFRjo6OcnV11Y0bNyyWtd9r/Pjxio+PN3/Onj37wPEBAAAAILd5Onfxeghvb28ZDIZMbZZWoEABi2ODwWBeYp1V6S1pt3bbe6/DYDA89LratWunsmXLasWKFSpZsqRSU1Pl5+dnsdT72rVrevHFF1W/fn1NnTr1kWK4f8zExETVqlVL69atS9POzc0t3f6MRqOMRuNDxwUAAACA3CpXznS7uroqICBAS5Ys0bVr19Kcz+p7t319fRUZGWlRFhkZqYoVKypfvnwPbX/vBm63b9/WgQMH5Ovrm2H9ChUqqGDBghZj3rp1S/v27VPlypWzcAV3XLx4UadOndI777yj5s2by9fXV5cvX7aoYzKZ1LNnT6Wmpmrt2rUyGAxZHk+SatasqdOnT6tYsWLy8vKy+Dg7Oz9W3wAAAACQW+XKpFuSlixZopSUFNWtW1ebNm3S6dOnFRUVpUWLFlks834UY8aMUXh4uKZNm6ZffvlFq1ev1uLFixUUFJTpmD7//HOdPHlSQ4YM0eXLl9WvX78M6zs4OOj111/X2LFjtX37dp04cUKvvvqqkpKS1L9//yxdgyQVLlxYRYoU0fLly3XmzBl9++23Gj16tEWdyZMn65tvvtEHH3ygxMREnTt3TufOndP169ezNGaPHj1UtGhRtW/fXt9//71+++03RUREaPjw4frjjz+yfC0AAAAAkJvlyuXlklS+fHkdPHhQM2bM0JgxYxQXFyc3NzfVqlVLy5Yty1KfNWvW1IYNGzRx4kRNmzZN7u7umjp1qgIDAzPVPjg4WMHBwTp8+LC8vLz0xRdfqGjRog9tk5qaql69eunq1auqXbu2wsLCVLhw4SxdgyTZ2Nho/fr1Gj58uPz8/FSpUiUtWrRITZs2NdfZtWuXEhMT1aBBA4u2ISEhmb7ee9nb2+u7777TG2+8oY4dO+rq1asqVaqUmjdvLicnpyxfCwAAAADkZgbTo+xKhnTFxMSoXLlyOnTokKpXr57T4eRaCQkJd3YxH7lBNkb7nA4HAAAAQDpigtvkdAhPhbv5S3x8/AMnGnPt8nIAAAAAAJ52JN0AAAAAAFgJy8vx1Mjs8gwAAAAAyGksLwcAAAAAIIeRdAMAAAAAYCUk3QAAAAAAWAlJNwAAAAAAVkLSDQAAAACAlZB0AwAAAABgJSTdAAAAAABYCUk3AAAAAABWQtINAAAAAICVkHQDAAAAAGAlJN0AAAAAAFgJSTcAAAAAAFZC0g0AAAAAgJWQdAMAAAAAYCUk3QAAAAAAWAlJNwAAAAAAVkLSDQAAAACAleTP6QCA+/lNCpON0T6nwwAAAAByrZjgNjkdAv4PM90AAAAAAFgJSTcAAAAAAFZC0m1FTZs21ciRI7PUNjAwUB06dMjWeNITExMjg8Ggw4cPS5IiIiJkMBh05coVq48NAAAAAHkdSfc9fvrpJ+XLl09t2mTP8w+bN2/WtGnTzMeenp5asGBBptouXLhQoaGhjzTeo/SfkQYNGiguLk7Ozs6P1Q8AAAAAgKTbwocffqhhw4bpu+++019//fXY/bm6uqpQoUKP1CYlJUWpqalydnaWi4vLY8fwqAoWLKgSJUrIYDA88bEBAAAAIK8h6f4/iYmJ+vTTT/X666+rTZs2FrPMd5dch4WFqUaNGrKzs1OzZs10/vx5bdu2Tb6+vnJyclL37t2VlJRkbnfv8vKmTZvq999/16hRo2QwGMxJbWhoqFxcXPTFF1+ocuXKMhqNio2NTbO8vGnTpho6dKiGDh0qZ2dnFS1aVBMmTJDJZMqw/2vXrsnJyUkbN260uNYtW7bIwcFBV69eTXMf7l9efje+sLAw+fr6ytHRUS1btlRcXJxFu5UrV8rX11e2trby8fHR0qVLs/qrAAAAAIA8g6T7/2zYsEE+Pj6qVKmSevbsqVWrVpkT2rsmT56sxYsX68cff9TZs2fVuXNnLViwQB9//LG2bt2qr7/+Wu+99166/W/evFmlS5fW1KlTFRcXZ5G0JiUlafbs2Vq5cqWOHz+uYsWKpdvH6tWrlT9/fu3du1cLFy7U/PnztXLlygz7d3BwUNeuXRUSEmLRT0hIiF5++eVMz8InJSVp7ty5Wrt2rb777jvFxsYqKCjIfH7dunWaOHGiZsyYoaioKM2cOVMTJkzQ6tWrH9hvcnKyEhISLD4AAAAAkJfwnu7/8+GHH6pnz56SpJYtWyo+Pl67du1S06ZNzXWmT5+uhg0bSpL69++v8ePHKzo6WuXLl5ckvfzyy9q5c6feeOONNP27uroqX758KlSokEqUKGFx7tatW1q6dKmqVav2wBg9PDz07rvvymAwqFKlSjp69Kjeffddvfrqqxn2P2DAAPNz2u7u7jp//ry++uorffPNN5m+N7du3dL777+vChUqSJKGDh2qqVOnms9PmjRJ8+bNU8eOHSVJ5cqV04kTJ/TBBx+oT58+GfY7a9YsTZkyJdNxAAAAAEBuw0y3pFOnTmnv3r3q1q2bJCl//vzq0qWLPvzwQ4t6VatWNf9cvHhx2dvbmxPuu2Xnz59/5PELFixo0XdG6tWrZ/Gsdf369XX69GmlpKRk2KZu3bqqUqWKedb5o48+UtmyZfXss89mOj57e3tzwi3JnLxL0rVr1xQdHa3+/fvL0dHR/Jk+fbqio6Mf2O/48eMVHx9v/pw9ezbTMQEAAABAbsBMt+7Mct++fVslS5Y0l5lMJhmNRi1evNhcVqBAAfPPBoPB4vhuWWpq6iOPb2dnZ9WNywYMGKAlS5bozTffVEhIiPr27ftI46V3nXeX3icmJkqSVqxYoWeeecaiXr58+R7Yr9FolNFozHQcAAAAAJDb/OuT7tu3b2vNmjWaN2+eXnjhBYtzHTp00CeffCIfH59sGatgwYIPnJV+mD179lgc7969W97e3ubkNqP+e/bsqXHjxmnRokU6ceLEA5d8P6rixYurZMmS+vXXX9WjR49s6xcAAAAA8oJ/fdL95Zdf6vLly+rfv3+ad1N36tRJH374oebMmZMtY3l6euq7775T165dZTQaVbRo0UdqHxsbq9GjR+u1117TwYMH9d5772nevHkP7b9w4cLq2LGjxo4dqxdeeEGlS5fOluu5a8qUKRo+fLicnZ3VsmVLJScna//+/bp8+bJGjx6drWMBAAAAQG7yr3+m+8MPP9Tzzz+fJuGW7iTd+/fv188//5wtY02dOlUxMTGqUKGC3NzcHrl97969df36ddWtW1dDhgzRiBEjNHDgwEz1379/f928eVP9+vV77Ou434ABA7Ry5UqFhITI399fTZo0UWhoqMqVK5ftYwEAAABAbmIw3f9eLDyVmjZtqurVq2vBggVZar927VqNGjVKf/31lwoWLJi9wWWThIQEOTs7y2PkBtkY7XM6HAAAACDXigluk9Mh5Hl385f4+Hg5OTllWO9fv7w8r0tKSlJcXJyCg4P12muvPbUJNwAAAADkRf/65eV53X/+8x/5+PioRIkSGj9+fE6HAwAAAAD/Kiwvx1Mjs8szAAAAACCnZTZ/YaYbAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACsh6QYAAAAAwEpIugEAAAAAsBKSbgAAAAAArISkGwAAAAAAKyHpBgAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACvJn9MBAPfzmxQmG6N9TocBAAAA5EoxwW1yOgTcg5luAAAAAACshKQbAAAAAAArIel+wiIiImQwGHTlypWcDiVDgYGB6tChQ06HAQAAAAC5Hs90P6LAwEBduXJFW7ZsyVL7Bg0aKC4uTs7OztkbWDZauHChTCZTTocBAAAAALkeSfcTVrBgQZUoUeKx+rh586YKFiyYTRGl9TT/QQAAAAAAchOWlz+Gpk2batiwYRo5cqQKFy6s4sWLa8WKFbp27Zr69u2rQoUKycvLS9u2bTO3uX95eWhoqFxcXLRlyxZ5e3vL1tZWAQEBOnv2rLnN5MmTVb16da1cuVLlypWTra2tJGn79u1q1KiRXFxcVKRIEbVt21bR0dHmdjExMTIYDNqwYYMaN24sOzs71alTR7/88ov27dun2rVry9HRUa1atdKFCxfM7e5fXt60aVMNHz5c48aNk6urq0qUKKHJkydb3IsrV65owIABcnNzk5OTk5o1a6YjR45k490GAAAAgNyHpPsxrV69WkWLFtXevXs1bNgwvf7663rllVfUoEEDHTx4UC+88IJ69eqlpKSkDPtISkrSjBkztGbNGkVGRurKlSvq2rWrRZ0zZ85o06ZN2rx5sw4fPixJunbtmkaPHq39+/crPDxcNjY2eumll5SammrRdtKkSXrnnXd08OBB5c+fX927d9e4ceO0cOFCff/99zpz5owmTpz40Ot0cHDQnj179J///EdTp07Vjh07zOdfeeUVnT9/Xtu2bdOBAwdUs2ZNNW/eXJcuXXrEOwoAAAAAeQfLyx9TtWrV9M4770iSxo8fr+DgYBUtWlSvvvqqJGnixIlatmyZfv75Z9WrVy/dPm7duqXFixfrmWeekXQnwfX19dXevXtVt25dSXeWlK9Zs0Zubm7mdp06dbLoZ9WqVXJzc9OJEyfk5+dnLg8KClJAQIAkacSIEerWrZvCw8PVsGFDSVL//v0VGhr6wOusWrWqJk2aJEny9vbW4sWLFR4erhYtWuiHH37Q3r17df78eRmNRknS3LlztWXLFm3cuFEDBw5Mt8/k5GQlJyebjxMSEh4YAwAAAADkNsx0P6aqVauaf86XL5+KFCkif39/c1nx4sUlSefPn8+wj/z586tOnTrmYx8fH7m4uCgqKspcVrZsWYuEW5JOnz6tbt26qXz58nJycpKnp6ckKTY2NsMY78Zzf4wPiu/+PiTJ3d3d3ObIkSNKTExUkSJF5OjoaP789ttvFsvd7zdr1iw5OzubPx4eHg+MAQAAAAByG2a6H1OBAgUsjg0Gg0WZwWCQpDRLvh+Vg4NDmrJ27dqpbNmyWrFihUqWLKnU1FT5+fnp5s2bGcZ4N577yx4WX3rXebdNYmKi3N3dFRERkaadi4tLhn2OHz9eo0ePNh8nJCSQeAMAAADIU0i6nwK3b9/W/v37zUvJT506pStXrsjX1zfDNhcvXtSpU6e0YsUKNW7cWJL0ww8/PJF471ezZk2dO3dO+fPnN8+2Z4bRaDQvRwcAAACAvIjl5U+BAgUKaNiwYdqzZ48OHDigwMBA1atXz5yEp6dw4cIqUqSIli9frjNnzujbb7+1mDV+kp5//nnVr19fHTp00Ndff62YmBj9+OOPevvtt7V///4ciQkAAAAAngYk3U8Be3t7vfHGG+revbsaNmwoR0dHffrppw9sY2Njo/Xr1+vAgQPy8/PTqFGjNGfOnCcUsSWDwaCvvvpKzz77rPr27auKFSuqa9eu+v33383PkAMAAADAv5HBZDKZcjqIf7PQ0FCNHDnS/N7uf7OEhIQ7G6qN3CAbo31OhwMAAADkSjHBbXI6hH+Fu/lLfHy8nJycMqzHTDcAAAAAAFZC0g0AAAAAgJWwvBxPjcwuzwAAAACAnMbycgAAAAAAchhJNwAAAAAAVkLSDQAAAACAlZB0AwAAAABgJSTdAAAAAABYCUk3AAAAAABWQtINAAAAAICVkHQDAAAAAGAlJN0AAAAAAFgJSTcAAAAAAFZC0g0AAAAAgJWQdAMAAAAAYCUk3QAAAAAAWAlJNwAAAAAAVkLSDQAAAACAlZB0AwAAAABgJSTdAAAAAABYSf6cDgC4n9+kMNkY7XM6DAAAACDHxQS3yekQ8JiY6QYAAAAAwEpIugEAAAAAsBKS7nQEBgaqQ4cOOR1GjomIiJDBYNCVK1dyOhQAAAAAyNVyddJ97tw5DRs2TOXLl5fRaJSHh4fatWun8PDwnA4tV2vQoIHi4uLk7Oyc06EAAAAAQK6WazdSi4mJUcOGDeXi4qI5c+bI399ft27dUlhYmIYMGaKTJ08+cp8pKSkyGAxWiDZ3KViwoEqUKJHTYQAAAABArpdrZ7oHDx4sg8GgvXv3qlOnTqpYsaKqVKmi0aNHa/fu3ZKk+fPny9/fXw4ODvLw8NDgwYOVmJho7iM0NFQuLi764osvVLlyZRmNRsXGxprPT5kyRW5ubnJyctKgQYN08+ZN87nt27erUaNGcnFxUZEiRdS2bVtFR0ebz8fExMhgMGjDhg1q3Lix7OzsVKdOHf3yyy/at2+fateuLUdHR7Vq1UoXLlwwt9u3b59atGihokWLytnZWU2aNNHBgwctYjYYDGk+kydPNtdZuXKlfH19ZWtrKx8fHy1dujRNXOvXr1eDBg1ka2srPz8/7dq1y1zn/uXld+9TWFiYfH195ejoqJYtWyouLs7id/KgcQEAAADg3yhXJt2XLl3S9u3bNWTIEDk4OKQ57+LiIkmysbHRokWLdPz4ca1evVrffvutxo0bZ1E3KSlJs2fP1sqVK3X8+HEVK1ZMkhQeHq6oqChFRETok08+0ebNmzVlyhRzu2vXrmn06NHav3+/wsPDZWNjo5deekmpqakW/U+aNEnvvPOODh48qPz586t79+4aN26cFi5cqO+//15nzpzRxIkTzfWvXr2qPn366IcfftDu3bvl7e2t1q1b6+rVq5KkLl26KC4uzvz55JNPlD9/fjVs2FCStG7dOk2cOFEzZsxQVFSUZs6cqQkTJmj16tUWcY0dO1ZjxozRoUOHVL9+fbVr104XL17M8J4nJSVp7ty5Wrt2rb777jvFxsYqKCjIfD6z4wIAAADAv0muXF5+5swZmUwm+fj4PLDeyJEjzT97enpq+vTpGjRokMUM7K1bt7R06VJVq1bNom3BggW1atUq2dvbq0qVKpo6darGjh2radOmycbGRp06dbKov2rVKrm5uenEiRPy8/MzlwcFBSkgIECSNGLECHXr1k3h4eHmJLl///4KDQ0112/WrJlFv8uXL5eLi4t27dqltm3bys7OTnZ2dpKk6OhoDRkyRDNnzlSLFi0k3Uny582bp44dO0qSypUrpxMnTuiDDz5Qnz59zP0OHTrUfA3Lli3T9u3b9eGHH6b5o8S99+n9999XhQoVzO2nTp1qPp/Zce+VnJys5ORk83FCQkK69QAAAAAgt8qVM90mkylT9b755hs1b95cpUqVUqFChdSrVy9dvHhRSUlJ5joFCxZU1apV07StVq2a7O3tzcf169dXYmKizp49K0k6ffq0unXrpvLly8vJyUmenp6SZLE8XZJF38WLF5ck+fv7W5SdP3/efPz333/r1Vdflbe3t5ydneXk5KTExMQ0/cbHx6tt27Zq06aNxo4dK+nO7Ht0dLT69+8vR0dH82f69OkWS9/vXs9d+fPnV+3atRUVFZXhvbS3tzcn3JLk7u5ujvtRxr3XrFmz5OzsbP54eHhkWBcAAAAAcqNcOdPt7e0tg8HwwM3SYmJi1LZtW73++uuaMWOGXF1d9cMPP6h///66efOmOaG2s7PL0uZp7dq1U9myZbVixQqVLFlSqamp8vPzs3juW5IKFChg/vnuOPeX3bskvU+fPrp48aIWLlyosmXLymg0qn79+hb9pqSkqEuXLnJyctLy5cvN5XefV1+xYoWeeeYZizjy5cv3yNeY0XXcjfvuHz+yOu748eM1evRo83FCQgKJNwAAAIA8JVcm3a6urgoICNCSJUs0fPjwNM91X7lyRQcOHFBqaqrmzZsnG5s7E/obNmzI9BhHjhzR9evXzUu5d+/eLUdHR3l4eOjixYs6deqUVqxYocaNG0uSfvjhh2y5tsjISC1dulStW7eWJJ09e1b//POPRZ1Ro0bp6NGj2r9/v2xtbc3lxYsXV8mSJfXrr7+qR48eDxxn9+7devbZZyVJt2/f1oEDBzR06NAsxfwo497LaDTKaDRmaUwAAAAAyA1yZdItSUuWLFHDhg1Vt25dTZ06VVWrVtXt27e1Y8cOLVu2TOvXr9etW7f03nvvqV27doqMjNT777+f6f5v3ryp/v3765133lFMTIwmTZqkoUOHysbGRoULF1aRIkW0fPlyubu7KzY2Vm+++Wa2XJe3t7fWrl2r2rVrKyEhQWPHjjUn/pIUEhKipUuX6vPPP5fBYNC5c+ckybyke8qUKRo+fLicnZ3VsmVLJScna//+/bp8+bLFrPKSJUvk7e0tX19fvfvuu7p8+bL69euX5bgzOy4AAAAA/Jvkyme6Jal8+fI6ePCgnnvuOY0ZM0Z+fn5q0aKFwsPDtWzZMlWrVk3z58/X7Nmz5efnp3Xr1mnWrFmZ7r958+by9vbWs88+qy5duujFF180v5bLxsZG69ev14EDB+Tn56dRo0Zpzpw52XJdH374oS5fvqyaNWuqV69eGj58uHlHdUnatWuXUlJS9OKLL8rd3d38mTt3riRpwIABWrlypUJCQuTv768mTZooNDRU5cqVsxgnODhYwcHBqlatmn744Qd98cUXKlq0aJbjzuy4AAAAAPBvYjBldlcy5AkxMTEqV66cDh06pOrVq+d0OBYSEhLubKg2coNsjPYPbwAAAADkcTHBbXI6BGTgbv4SHx8vJyenDOvl2pluAAAAAACediTdAAAAAABYSa7dSA1Z4+npmen3nAMAAAAAHg9JN546x6YEPPCZCAAAAADILVheDgAAAACAlZB0AwAAAABgJSTdAAAAAABYCUk3AAAAAABWQtINAAAAAICVkHQDAAAAAGAlJN0AAAAAAFgJSTcAAAAAAFZC0g0AAAAAgJWQdAMAAAAAYCUk3QAAAAAAWAlJNwAAAAAAVkLSDQAAAACAlZB0AwAAAABgJSTdAAAAAABYCUk3AAAAAABWkj+nAwDu5zcpTDZG+5wOAwAAAHgiYoLb5HQIsCJmugEAAAAAsBKSbgAAAAAArISkGwAAAAAAKyHpfspERETIYDDoypUr2danwWDQli1bsq0/AAAAAEDmkHRng8DAQBkMBg0aNCjNuSFDhshgMCgwMPDJB/Z/4uLi1KpVqxwbHwAAAAD+rUi6s4mHh4fWr1+v69evm8tu3Lihjz/+WGXKlMnByKQSJUrIaDTmaAwAAAAA8G9E0p1NatasKQ8PD23evNlctnnzZpUpU0Y1atQwl6WmpmrWrFkqV66c7OzsVK1aNW3cuPGBfW/atElVqlSR0WiUp6en5s2bZz43depUlSxZUhcvXjSXtWnTRs8995xSU1MlpV1e/scff6hbt25ydXWVg4ODateurT179kiSoqOj1b59exUvXlyOjo6qU6eOvvnmG4t4PD09NX36dPXu3VuOjo4qW7asvvjiC124cEHt27eXo6Ojqlatqv379z/6jQQAAACAPISkOxv169dPISEh5uNVq1apb9++FnVmzZqlNWvW6P3339fx48c1atQo9ezZU7t27Uq3zwMHDqhz587q2rWrjh49qsmTJ2vChAkKDQ2VJL399tvy9PTUgAEDJElLlizRjz/+qNWrV8vGJu2vNzExUU2aNNGff/6pL774QkeOHNG4cePMCXpiYqJat26t8PBwHTp0SC1btlS7du0UGxtr0c+7776rhg0b6tChQ2rTpo169eql3r17q2fPnjp48KAqVKig3r17y2QyZXi/kpOTlZCQYPEBAAAAgLzEYHpQVoRMCQwM1JUrV7RixQp5eHjo1KlTkiQfHx+dPXtWAwYMkIuLiz744AO5urrqm2++Uf369c3tBwwYoKSkJH388ceKiIjQc889p8uXL8vFxUU9evTQhQsX9PXXX5vrjxs3Tlu3btXx48clSb/++quqV6+uwYMHa9GiRVq5cqW6d+9urm8wGPT555+rQ4cOWr58uYKCghQTEyNXV9dMXZ+fn58GDRqkoUOHSroz0924cWOtXbtWknTu3Dm5u7trwoQJmjp1qiRp9+7dql+/vuLi4lSiRIl0+508ebKmTJmSptxj5AbZGO0zFRsAAACQ28UEt8npEJAFCQkJcnZ2Vnx8vJycnDKsx0x3NnJzc1ObNm0UGhqqkJAQtWnTRkWLFjWfP3PmjJKSktSiRQs5OjqaP2vWrFF0dHS6fUZFRalhw4YWZQ0bNtTp06eVkpIiSSpfvrzmzp2r2bNn68UXX7RIuO93+PBh1ahRI8OEOzExUUFBQfL19ZWLi4scHR0VFRWVZqa7atWq5p+LFy8uSfL3909Tdv78+QxjGT9+vOLj482fs2fPZlgXAAAAAHKj/DkdQF7Tr18/84zwkiVLLM4lJiZKkrZu3apSpUpZnHvcjc6+++475cuXTzExMbp9+7by50//V2tnZ/fAfoKCgrRjxw7NnTtXXl5esrOz08svv6ybN29a1CtQoID5Z4PBkGHZ3WXr6TEajWzwBgAAACBPY6Y7m7Vs2VI3b97UrVu3FBAQYHGucuXKMhqNio2NlZeXl8XHw8Mj3f58fX0VGRlpURYZGamKFSsqX758kqRPP/1UmzdvVkREhGJjYzVt2rQM46tataoOHz6sS5cupXs+MjJSgYGBeumll+Tv768SJUooJibmEe4AAAAAAOAuZrqzWb58+RQVFWX++V6FChVSUFCQRo0apdTUVDVq1Ejx8fGKjIyUk5OT+vTpk6a/MWPGqE6dOpo2bZq6dOmin376SYsXL9bSpUsl3dmJ/PXXX9fs2bPVqFEjhYSEqG3btmrVqpXq1auXpr9u3bpp5syZ6tChg2bNmiV3d3cdOnRIJUuWVP369eXt7a3NmzerXbt2MhgMmjBhwgNnqwEAAAAAGWOm2wqcnJwyfJB+2rRpmjBhgmbNmiVfX1+1bNlSW7duVbly5dKtX7NmTW3YsEHr16+Xn5+fJk6cqKlTpyowMFAmk0mBgYGqW7eueUl7QECAXn/9dfXs2dO8nP1eBQsW1Ndff61ixYqpdevW8vf3V3BwsPkPBPPnz1fhwoXVoEEDtWvXTgEBAapZs2Y23RkAAAAA+Hdh93I8Ne7u/sfu5QAAAPg3Yffy3IndywEAAAAAyGEk3QAAAAAAWAkbqeGpc2xKwAOXZwAAAABAbsFMNwAAAAAAVkLSDQAAAACAlZB0AwAAAABgJSTdAAAAAABYCUk3AAAAAABWQtINAAAAAICVkHQDAAAAAGAlJN0AAAAAAFgJSTcAAAAAAFZC0g0AAAAAgJWQdAMAAAAAYCUk3QAAAAAAWAlJNwAAAAAAVkLSDQAAAACAlZB0AwAAAABgJSTdAAAAAABYSf6cDgC4n9+kMNkY7XM6DAAAAOCJiAluk9MhwIqY6QYAAAAAwEpIugEAAAAAsBKSbgAAAAAArISkG1kSGBioDh065HQYAAAAAPBUI+l+igQGBspgMMhgMKhAgQIqXry4WrRooVWrVik1NTWnw7OwcOFChYaG5nQYAAAAAPBUI+l+yrRs2VJxcXGKiYnRtm3b9Nxzz2nEiBFq27atbt++ndPhmTk7O8vFxSWnwwAAAACApxpJ91PGaDSqRIkSKlWqlGrWrKm33npL//3vf7Vt2zbzzHJsbKzat28vR0dHOTk5qXPnzvr7778lSSdPnpS9vb0+/vhjc58bNmyQnZ2dTpw4IUm6cuWKBgwYIDc3Nzk5OalZs2Y6cuSIuf7kyZNVvXp1ffDBB/Lw8JC9vb06d+6s+Ph4c537l5c3bdpUw4cP17hx4+Tq6qoSJUpo8uTJ1rtRAAAAAJALkHTnAs2aNVO1atW0efNmpaamqn379rp06ZJ27dqlHTt26Ndff1WXLl0kST4+Ppo7d64GDx6s2NhY/fHHHxo0aJBmz56typUrS5JeeeUVnT9/Xtu2bdOBAwdUs2ZNNW/eXJcuXTKPeebMGW3YsEH/+9//tH37dh06dEiDBw9+YJyrV6+Wg4OD9uzZo//85z+aOnWqduzYkWH95ORkJSQkWHwAAAAAIC/Jn9MBIHN8fHz0888/Kzw8XEePHtVvv/0mDw8PSdKaNWtUpUoV7du3T3Xq1NHgwYP11VdfqWfPnipYsKDq1KmjYcOGSZJ++OEH7d27V+fPn5fRaJQkzZ07V1u2bNHGjRs1cOBASdKNGze0Zs0alSpVSpL03nvvqU2bNpo3b55KlCiRboxVq1bVpEmTJEne3t5avHixwsPD1aJFi3Trz5o1S1OmTMm+mwQAAAAATxmS7lzCZDLJYDAoKipKHh4e5oRbkipXriwXFxdFRUWpTp06kqRVq1apYsWKsrGx0fHjx2UwGCRJR44cUWJioooUKWLR//Xr1xUdHW0+LlOmjDnhlqT69esrNTVVp06demDSfS93d3edP38+w2saP368Ro8ebT5OSEiwuC4AAAAAyO1IunOJqKgolStXLtP1jxw5omvXrsnGxkZxcXFyd3eXJCUmJsrd3V0RERFp2jzuxmgFChSwODYYDA/cdd1oNJpn2wEAAAAgLyLpzgW+/fZbHT16VKNGjVLp0qV19uxZnT171jwrfOLECV25csX8zPalS5cUGBiot99+W3FxcerRo4cOHjwoOzs71axZU+fOnVP+/Pnl6emZ4ZixsbH666+/VLJkSUnS7t27ZWNjo0qVKln9egEAAAAgr2AjtadMcnKyzp07pz///FMHDx7UzJkz1b59e7Vt21a9e/fW888/L39/f3MivXfvXvXu3VtNmjRR7dq1JUmDBg2Sh4eH3nnnHc2fP18pKSkKCgqSJD3//POqX7++OnTooK+//loxMTH68ccf9fbbb2v//v3mOGxtbdWnTx8dOXJE33//vYYPH67OnTtnuLQcAAAAAJAWM91Pme3bt8vd3V358+dX4cKFVa1aNS1atEh9+vSRjc2dv5H897//1bBhw/Tss8/KxsZGLVu21HvvvSfpzqZqX331lQ4dOqT8+fMrf/78+uijj9SoUSO1bdtWrVq10ldffaW3335bffv21YULF1SiRAk9++yzKl68uDkOLy8vdezYUa1bt9alS5fUtm1bLV26NEfuCQAAAADkVgaTyWTK6SDwdJk8ebK2bNmiw4cPP9FxExIS5OzsLI+RG2RjtH+iYwMAAAA5JSa4TU6HgCy4m7/Ex8fLyckpw3osLwcAAAAAwEpIugEAAAAAsBKWl+OpkdnlGQAAAACQ01heDgAAAABADiPpBgAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACsh6QYAAAAAwEpIugEAAAAAsBKSbgAAAAAArISkGwAAAAAAKyHpBgAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAAryZ/TAQD385sUJhujfU6HAQAAADwRMcFtcjoEWBEz3QAAAAAAWAlJNwAAAAAAVkLSncvExMTIYDDo8OHDmW4zefJkVa9e/YF1AgMD1aFDB/Nx06ZNNXLkyCzFCAAAAAC4g6T7CTp79qz69eunkiVLqmDBgipbtqxGjBihixcvZroPDw8PxcXFyc/PL9NtgoKCFB4e/kixbt68WdOmTXukNgAAAAAASyTdT8ivv/6q2rVr6/Tp0/rkk0905swZvf/++woPD1f9+vV16dKlTPWTL18+lShRQvnzZ34PPEdHRxUpUuSR4nV1dVWhQoUeqQ0AAAAAwBJJ9xMyZMgQFSxYUF9//bWaNGmiMmXKqFWrVvrmm2/0559/6u2335YkGQwGbdmyxaKti4uLQkNDJaVdXh4RESGDwaDw8HDVrl1b9vb2atCggU6dOmVuf//y8pSUFI0ePVouLi4qUqSIxo0bJ5PJZDHm/cvLPT09NXPmTPXr10+FChVSmTJltHz5cos2Z8+eVefOneXi4iJXV1e1b99eMTExj3XfAAAAACA3I+l+Ai5duqSwsDANHjxYdnZ2FudKlCihHj166NNPP02T+D6Kt99+W/PmzdP+/fuVP39+9evXL8O68+bNU2hoqFatWqUffvhBly5d0ueff/7QMebNm6fatWvr0KFDGjx4sF5//XVzcn/r1i0FBASoUKFC+v777xUZGSlHR0e1bNlSN2/eTLe/5ORkJSQkWHwAAAAAIC8h6X4CTp8+LZPJJF9f33TP+/r66vLly7pw4UKWx5gxY4aaNGmiypUr680339SPP/6oGzdupFt3wYIFGj9+vDp27ChfX1+9//77cnZ2fugYrVu31uDBg+Xl5aU33nhDRYsW1c6dOyVJn376qVJTU7Vy5Ur5+/vL19dXISEhio2NVURERLr9zZo1S87OzuaPh4dHlq8fAAAAAJ5GJN1P0MNmsgsWLJjlvqtWrWr+2d3dXZJ0/vz5NPXi4+MVFxenZ555xlyWP39+1a5d+5HGMBgMKlGihHmMI0eO6MyZMypUqJAcHR3l6OgoV1dX3bhxQ9HR0en2N378eMXHx5s/Z8+ezdzFAgAAAEAukfnduJBlXl5eMhgMioqK0ksvvZTmfFRUlNzc3OTi4iKDwZAmOb9169ZDxyhQoID5Z4PBIElKTU19zMgzHuPuOHfHSExMVK1atbRu3bo07dzc3NLtz2g0ymg0ZmuMAAAAAPA0Yab7CShSpIhatGihpUuX6vr16xbnzp07p3Xr1ikwMFDSnQQ1Li7OfP706dNKSkrKtlicnZ3l7u6uPXv2mMtu376tAwcOPFa/NWvW1OnTp1WsWDF5eXlZfDKzdB0AAAAA8iKS7idk8eLFSk5OVkBAgL777judPXtW27dvV4sWLVSxYkVNnDhRktSsWTMtXrxYhw4d0v79+zVo0KA0M8yPa8SIEQoODtaWLVt08uRJDR48WFeuXHmsPnv06KGiRYuqffv2+v777/Xbb78pIiJCw4cP1x9//JE9gQMAAABALkPS/YR4e3tr3759Kl++vDp37qyyZcuqVatWqlixonmnb+nODuEeHh5q3LixunfvrqCgINnb22drLGPGjFGvXr3Up08f1a9fX4UKFUp32fujsLe313fffacyZcqYN2jr37+/bty4IScnp2yKHAAAAAByF4Ppcd5ThccyadIkzZ8/Xzt27FC9evVyOpwcl5CQcGcX85EbZGPM3j80AAAAAE+rmOA2OR0CsuBu/hIfH//AiUY2UstBU6ZMkaenp3bv3q26devKxoaFBwAAAACQl5B057C+ffvmdAgAAAAAACsh6cZT59iUAJ4DBwAAAJAnsJ4ZAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACsh6QYAAAAAwEpIugEAAAAAsBKSbgAAAAAArISkGwAAAAAAKyHpBgAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACvJn9MBAPfzmxQmG6N9TocBAAAAWF1McJucDgFWxkw3AAAAAABWQtINAAAAAICVkHQ/ITExMTIYDDp8+HBOh/JQkydPVvXq1XM6DAAAAADI9Ui673Hu3DkNGzZM5cuXl9FolIeHh9q1a6fw8PCcDu2JCgoK+tddMwAAAABYAxup/Z+YmBg1bNhQLi4umjNnjvz9/XXr1i2FhYVpyJAhOnnyZE6HaHUmk0kpKSlydHSUo6NjTocDAAAAALkeM93/Z/DgwTIYDNq7d686deqkihUrqkqVKho9erR2796tfv36qW3bthZtbt26pWLFiunDDz+UJKWmpuo///mPvLy8ZDQaVaZMGc2YMSPDMXft2qW6devKaDTK3d1db775pm7fvm0+v3HjRvn7+8vOzk5FihTR888/r2vXrkmSAgMD1aFDB02ZMkVubm5ycnLSoEGDdPPmTXP75ORkDR8+XMWKFZOtra0aNWqkffv2mc9HRETIYDBo27ZtqlWrloxGo3744Yc0y8vvjjV37ly5u7urSJEiGjJkiG7dumUxVlBQkEqVKiUHBwc988wzioiIyNLvAgAAAADyCpJuSZcuXdL27ds1ZMgQOTg4pDnv4uKiAQMGaPv27YqLizOXf/nll0pKSlKXLl0kSePHj1dwcLAmTJigEydO6OOPP1bx4sXTHfPPP/9U69atVadOHR05ckTLli3Thx9+qOnTp0uS4uLi1K1bN/Xr109RUVGKiIhQx44dZTKZzH2Eh4ebz33yySfavHmzpkyZYj4/btw4bdq0SatXr9bBgwfl5eWlgIAAXbp0ySKWN998U8HBwYqKilLVqlXTjXfnzp2Kjo7Wzp07tXr1aoWGhio0NNR8fujQofrpp5+0fv16/fzzz3rllVfUsmVLnT59+iF3HwAAAADyLpaXSzpz5oxMJpN8fHwyrNOgQQNVqlRJa9eu1bhx4yRJISEheuWVV+To6KirV69q4cKFWrx4sfr06SNJqlChgho1apRuf0uXLpWHh4cWL14sg8EgHx8f/fXXX3rjjTc0ceJExcXF6fbt2+rYsaPKli0rSfL397foo2DBglq1apXs7e1VpUoVTZ06VWPHjtW0adN0/fp1LVu2TKGhoWrVqpUkacWKFdqxY4c+/PBDjR071tzP1KlT1aJFiwfeo8KFC2vx4sXKly+ffHx81KZNG4WHh+vVV19VbGysQkJCFBsbq5IlS0q681z49u3bFRISopkzZ6bbZ3JyspKTk83HCQkJD4wBAAAAAHIbZroli9njBxkwYIBCQkIkSX///be2bdumfv36SZKioqKUnJys5s2bZ6qvqKgo1a9fXwaDwVzWsGFDJSYm6o8//lC1atXUvHlz+fv765VXXtGKFSt0+fJliz6qVasme3t783H9+vWVmJios2fPKjo6Wrdu3VLDhg3N5wsUKKC6desqKirKop/atWs/NN4qVaooX7585mN3d3edP39eknT06FGlpKSoYsWK5ufBHR0dtWvXLkVHR2fY56xZs+Ts7Gz+eHh4PDQOAAAAAMhNSLoleXt7y2AwPHSztN69e+vXX3/VTz/9pI8++kjlypVT48aNJUl2dnbZGlO+fPm0Y8cObdu2TZUrV9Z7772nSpUq6bfffsvWcSSlu6T+fgUKFLA4NhgMSk1NlSQlJiYqX758OnDggA4fPmz+REVFaeHChRn2OX78eMXHx5s/Z8+efbwLAQAAAICnDEm3JFdXVwUEBGjJkiXmjcrudeXKFUlSkSJF1KFDB4WEhCg0NFR9+/Y11/H29padnV2mX7Xl6+urn376yWKWPTIyUoUKFVLp0qUl3UlsGzZsqClTpujQoUMqWLCgPv/8c3P9I0eO6Pr16+bj3bt3y9HRUR4eHqpQoYIKFiyoyMhI8/lbt25p3759qly5cuZuTCbVqFFDKSkpOn/+vLy8vCw+JUqUyLCd0WiUk5OTxQcAAAAA8hKS7v+zZMkSpaSkqG7dutq0aZNOnz6tqKgoLVq0SPXr1zfXGzBggFavXq2oqCjzs9uSZGtrqzfeeEPjxo3TmjVrFB0drd27d5t3Nr/f4MGDdfbsWQ0bNkwnT57Uf//7X02aNEmjR4+WjY2N9uzZo5kzZ2r//v2KjY3V5s2bdeHCBfn6+pr7uHnzpvr3768TJ07oq6++0qRJkzR06FDZ2NjIwcFBr7/+usaOHavt27frxIkTevXVV5WUlKT+/ftn672rWLGievTood69e2vz5s367bfftHfvXs2aNUtbt27N1rEAAAAAIDdhI7X/U758eR08eFAzZszQmDFjFBcXJzc3N9WqVUvLli0z13v++efl7u6uKlWqmDcNu2vChAnKnz+/Jk6cqL/++kvu7u4aNGhQuuOVKlVKX331lcaOHatq1arJ1dVV/fv31zvvvCNJcnJy0nfffacFCxYoISFBZcuW1bx588yboklS8+bN5e3trWeffVbJycnq1q2bJk+ebD4fHBys1NRU9erVS1evXlXt2rUVFhamwoULZ+OduyMkJETTp0/XmDFj9Oeff6po0aKqV69emtesAQAAAMC/icGU2V3EIOnO88ulSpVSSEiIOnbsmGNxBAYG6sqVK9qyZUuOxZDdEhIS7myoNnKDbIz2D28AAAAA5HIxwW1yOgRk0d38JT4+/oGPyjLTnUmpqan6559/NG/ePLm4uOjFF1/M6ZAAAAAAAE85ku5Mio2NVbly5VS6dGmFhoYqf35uHQAAAADgwcgcM8nT0zPT7/N+EkJDQ3M6BAAAAADAQ2Q56Y6OjlZISIiio6O1cOFCFStWTNu2bVOZMmVUpUqV7IwR/zLHpgTw+jAAAAAAeUKWXhm2a9cu+fv7a8+ePdq8ebMSExMl3Xlv9KRJk7I1QAAAAAAAcqssJd1vvvmmpk+frh07dqhgwYLm8mbNmmn37t3ZFhwAAAAAALlZlpLuo0eP6qWXXkpTXqxYMf3zzz+PHRQAAAAAAHlBlpJuFxcXxcXFpSk/dOiQSpUq9dhBAQAAAACQF2Qp6e7ataveeOMNnTt3TgaDQampqYqMjFRQUJB69+6d3TECAAAAAJArZSnpnjlzpnx8fOTh4aHExERVrlxZzz77rBo0aKB33nknu2MEAAAAACBXMpge4+XTsbGxOnbsmBITE1WjRg15e3tnZ2z4l0lISJCzs7Pi4+N5ZRgAAACAp1pm85csv6dbksqUKaMyZco8ThcAAAAAAORZWUq6TSaTNm7cqJ07d+r8+fNKTU21OL958+ZsCQ4AAAAAgNwsS0n3yJEj9cEHH+i5555T8eLFZTAYsjsuAAAAAAByvSwl3WvXrtXmzZvVunXr7I4HAAAAAIA8I0u7lzs7O6t8+fLZHQsAAAAAAHlKlpLuyZMna8qUKbp+/Xp2xwMAAAAAQJ6RpeXlnTt31ieffKJixYrJ09NTBQoUsDh/8ODBbAkOAAAAAIDcLEtJd58+fXTgwAH17NmTjdQAAAAAAMhAlpLurVu3KiwsTI0aNcrueAAAAAAAyDOylHR7eHjIyckpu2MBJEl+k8JkY7TP6TAAAACAbBcT3CanQ8ATlqWN1ObNm6dx48YpJiYmm8MBAAAAACDvyNJMd8+ePZWUlKQKFSrI3t4+zUZqly5dypbgAAAAAADIzbKUdC9YsCCbw8DTJDQ0VCNHjtSVK1dyOhQAAAAAyNWyvHs5skdgYKBWr14tSSpQoIDKlCmj3r1766233lL+/Fn69Ty2Ll26qHXr1jkyNgAAAADkJY+d1d24cUM3b960KGOTtUfTsmVLhYSEKDk5WV999ZWGDBmiAgUKaPz48Rb1bt68qYIFC1o9Hjs7O9nZ2Vl9HAAAAADI67K0kdq1a9c0dOhQFStWTA4ODipcuLDFB4/GaDSqRIkSKlu2rF5//XU9//zz+uKLLxQYGKgOHTpoxowZKlmypCpVqiRJOnr0qJo1ayY7OzsVKVJEAwcOVGJiokWfq1atUpUqVWQ0GuXu7q6hQ4eaz82fP1/+/v5ycHCQh4eHBg8ebNE+NDRULi4u5uPJkyerevXqWrt2rTw9PeXs7KyuXbvq6tWr5jqpqamaNWuWypUrJzs7O1WrVk0bN2600h0DAAAAgNwhS0n3uHHj9O2332rZsmUyGo1auXKlpkyZopIlS2rNmjXZHeO/jp2dnXn1QHh4uE6dOqUdO3boyy+/1LVr1xQQEKDChQtr3759+uyzz/TNN99YJNXLli3TkCFDNHDgQB09elRffPGFvLy8zOdtbGy0aNEiHT9+XKtXr9a3336rcePGPTCm6OhobdmyRV9++aW+/PJL7dq1S8HBwebzs2bN0po1a/T+++/r+PHjGjVqlHr27Kldu3Zl890BAAAAgNwjS8vL//e//2nNmjVq2rSp+vbtq8aNG8vLy0tly5bVunXr1KNHj+yO81/BZDIpPDxcYWFhGjZsmC5cuCAHBwetXLnSvKx8xYoVunHjhtasWSMHBwdJ0uLFi9WuXTvNnj1bxYsX1/Tp0zVmzBiNGDHC3HedOnXMP48cOdL8s6enp6ZPn65BgwZp6dKlGcaWmpqq0NBQFSpUSJLUq1cvhYeHa8aMGUpOTtbMmTP1zTffqH79+pKk8uXL64cfftAHH3ygJk2apNtncnKykpOTzccJCQmPeMcAAAAA4OmWpaT70qVLKl++vKQ7z2/ffUVYo0aN9Prrr2dfdP8SX375pRwdHXXr1i2lpqaqe/fumjx5soYMGSJ/f3+L57ijoqJUrVo1c8ItSQ0bNlRqaqpOnTolg8Ggv/76S82bN89wvG+++UazZs3SyZMnlZCQoNu3b+vGjRtKSkqSvb19um08PT3NCbckubu76/z585KkM2fOKCkpSS1atLBoc/PmTdWoUSPDOGbNmqUpU6Y8+OYAAAAAQC6WpeXl5cuX12+//SZJ8vHx0YYNGyTdmQG/91lgZM5zzz2nw4cP6/Tp07p+/bpWr15tTqrvTa4z42EboMXExKht27aqWrWqNm3apAMHDmjJkiWSlGZDvHvd/y52g8Gg1NRUSTI/D75161YdPnzY/Dlx4sQDn+seP3684uPjzZ+zZ89m6hoBAAAAILfI0kx33759deTIETVp0kRvvvmm2rVrp8WLF+vWrVuaP39+dseY5zk4OFg8c/0gvr6+Cg0N1bVr18wJeWRkpGxsbFSpUiUVKlRInp6eCg8P13PPPZem/YEDB5Samqp58+bJxubO31zu/tEkqypXriyj0ajY2NgMl5Knx2g0ymg0PtbYAAAAAPA0y1LSPWrUKPPPzz//vE6ePKkDBw7Iy8tLVatWzbbgkFaPHj00adIk9enTR5MnT9aFCxc0bNgw9erVS8WLF5d0Z7fxQYMGqVixYmrVqpWuXr2qyMhIDRs2TF5eXrp165bee+89tWvXTpGRkXr//fcfK6ZChQopKChIo0aNUmpqqho1aqT4+HhFRkbKycmJ97oDAAAA+Nd67Pd0S1LZsmVVtmzZ7OgKD2Fvb6+wsDCNGDFCderUkb29vTp16mSxwqBPnz66ceOG3n33XQUFBalo0aJ6+eWXJUnVqlXT/PnzNXv2bI0fP17PPvusZs2apd69ez9WXNOmTZObm5tmzZqlX3/9VS4uLqpZs6beeuutx+oXAAAAAHIzg8lkMmWlYXh4uMLDw3X+/Hnzs713rVq1KluCw79LQkKCnJ2d5TFyg2yM6W/oBgAAAORmMcFtcjoEZJO7+Ut8fLycnJwyrJelme4pU6Zo6tSpql27ttzd3WUwGLIcKAAAAAAAeVWWku73339foaGh6tWrV3bHAwAAAABAnpGlV4bdvHlTDRo0yO5YAAAAAADIU7L0TPcbb7whR0dHTZgwwRox4V8qs89EAAAAAEBOs+oz3Tdu3NDy5cv1zTffqGrVqipQoIDFed7VDQAAAABAFpPun3/+WdWrV5ckHTt2zOIcm6oBAAAAAHBHlpLunTt3ZqreH3/8oZIlS8rGJkuPjgMAAAAAkKtZNRuuXLmyYmJirDkEAAAAAABPLasm3VnYow0AAAAAgDyDdd8AAAAAAFgJSTcAAAAAAFZC0g0AAAAAgJVYNenm9WEAAAAAgH8zNlIDAAAAAMBKHivpPnPmjMLCwnT9+nVJaZPsEydOqGzZso8zBAAAAAAAuVaWku6LFy/q+eefV8WKFdW6dWvFxcVJkvr3768xY8aY63l4eChfvnzZEykAAAAAALlMlpLuUaNGKX/+/IqNjZW9vb25vEuXLtq+fXu2BQcAAAAAQG6WPyuNvv76a4WFhal06dIW5d7e3vr999+zJTAAAAAAAHK7LM10X7t2zWKG+65Lly7JaDQ+dlAAAAAAAOQFWUq6GzdurDVr1piPDQaDUlNT9Z///EfPPfdctgUHAAAAAEBulqXl5f/5z3/UvHlz7d+/Xzdv3tS4ceN0/PhxXbp0SZGRkdkdI/5l/CaFycaYdiUFAAAAkJvFBLfJ6RCQA7I00+3n56dffvlFjRo1Uvv27XXt2jV17NhRhw4dUoUKFbI7RgAAAAAAcqUszXRLkrOzs95+++3sjAUAAAAAgDwlSzPdISEh+uyzz9KUf/bZZ1q9evVjBwUAAAAAQF6QpaR71qxZKlq0aJryYsWKaebMmY8dVE4xGAzasmWLVceIiYmRwWDQ4cOHrTrO45g8ebKqV6+e02EAAAAAQK6XpaQ7NjZW5cqVS1NetmxZxcbGPnZQ1nLu3DkNGzZM5cuXl9FolIeHh9q1a6fw8PAnFoOHh4fi4uLk5+f3xMZ8VEFBQU/0ngAAAABAXpWlZ7qLFSumn3/+WZ6enhblR44cUZEiRbIjrmwXExOjhg0bysXFRXPmzJG/v79u3bqlsLAwDRkyRCdPnnwiceTLl08lSpR4rD5SUlJkMBhkY5Olv5k8lKOjoxwdHa3SNwAAAAD8m2Qpa+vWrZuGDx+unTt3KiUlRSkpKfr22281YsQIde3aNbtjzBaDBw+WwWDQ3r171alTJ1WsWFFVqlTR6NGjtXv37nTbHD16VM2aNZOdnZ2KFCmigQMHKjEx0Xw+MDBQHTp00MyZM1W8eHG5uLho6tSpun37tsaOHStXV1eVLl1aISEh5jb3Ly+PiIiQwWDQ1q1bVbVqVdna2qpevXo6duyYuU1oaKhcXFz0xRdfqHLlyjIajYqNjdW+ffvUokULFS1aVM7OzmrSpIkOHjxocQ0Gg0EffPCB2rZtK3t7e/n6+uqnn37SmTNn1LRpUzk4OKhBgwaKjo42t7l/efnd65w7d67c3d1VpEgRDRkyRLdu3TLXSU5OVlBQkEqVKiUHBwc988wzioiIyMqvCgAAAADyjCwl3dOmTdMzzzyj5s2by87OTnZ2dnrhhRfUrFmzp/KZ7kuXLmn79u0aMmSIHBwc0px3cXFJU3bt2jUFBASocOHC2rdvnz777DN98803Gjp0qEW9b7/9Vn/99Ze+++47zZ8/X5MmTVLbtm1VuHBh7dmzR4MGDdJrr72mP/7444Exjh07VvPmzdO+ffvk5uamdu3aWSS1SUlJmj17tlauXKnjx4+rWLFiunr1qvr06aMffvhBu3fvlre3t1q3bq2rV69a9D1t2jT17t1bhw8flo+Pj7p3767XXntN48eP1/79+2UymdJc1/127typ6Oho7dy5U6tXr1ZoaKhCQ0PN54cOHaqffvpJ69ev188//6xXXnlFLVu21OnTpzPsMzk5WQkJCRYfAAAAAMhLHjnpNplMOnfunEJDQ3Xq1CmtW7dOmzdvVnR0tFatWqWCBQtaI87HcubMGZlMJvn4+GS6zccff6wbN25ozZo18vPzU7NmzbR48WKtXbtWf//9t7meq6urFi1apEqVKqlfv36qVKmSkpKS9NZbb8nb21vjx49XwYIF9cMPPzxwvEmTJqlFixby9/fX6tWr9ffff+vzzz83n79165aWLl2qBg0aqFKlSrK3t1ezZs3Us2dP+fj4yNfXV8uXL1dSUpJ27dpl0Xffvn3VuXNnVaxYUW+88YZiYmLUo0cPBQQEyNfXVyNGjHjorHThwoW1ePFi+fj4qG3btmrTpo35ue/Y2FjzjvaNGzdWhQoVFBQUpEaNGlnM8t9v1qxZcnZ2Nn88PDweGAMAAAAA5DaP/Ey3yWSSl5eXjh8/Lm9vb3l7e1sjrmxlMpkeuU1UVJSqVatmMTPesGFDpaam6tSpUypevLgkqUqVKhbPVhcvXtxik7R8+fKpSJEiOn/+/APHq1+/vvlnV1dXVapUSVFRUeayggULqmrVqhZt/v77b73zzjuKiIjQ+fPnlZKSoqSkpDSb2d3b7m7c/v7+FmU3btxQQkKCnJyc0o2vSpUqypcvn/nY3d1dR48elXRnGX5KSooqVqxo0SY5OfmBz/iPHz9eo0ePNh8nJCSQeAMAAADIUx456baxsZG3t7cuXryYKxJuSfL29pbBYLDKZmkFChSwODYYDOmWpaamPtY4dnZ2MhgMFmV9+vTRxYsXtXDhQpUtW1ZGo1H169fXzZs3M4zxbh/plT0oxgddU2JiovLly6cDBw5YJOaSHrghm9FolNFozPA8AAAAAOR2WXqmOzg4WGPHjrXY7Otp5urqqoCAAC1ZskTXrl1Lc/7KlStpynx9fXXkyBGL+pGRkbKxsVGlSpWyPcZ7N3O7fPmyfvnlF/n6+j6wTWRkpIYPH67WrVurSpUqMhqN+ueff7I9toepUaOGUlJSdP78eXl5eVl8HnendgAAAADIzbKUdPfu3Vt79+5VtWrVZGdnJ1dXV4vP02jJkiVKSUlR3bp1tWnTJp0+fVpRUVFatGiRxdLuu3r06CFbW1v16dNHx44d086dOzVs2DD16tXLvEQ7O02dOlXh4eE6duyYAgMDVbRoUXXo0OGBbby9vbV27VpFRUVpz5496tGjh+zs7LI9toepWLGievTood69e2vz5s367bfftHfvXs2aNUtbt2594vEAAAAAwNMiS+/pXrBgQTaHYX3ly5fXwYMHNWPGDI0ZM0ZxcXFyc3NTrVq1tGzZsjT17e3tFRYWphEjRqhOnTqyt7dXp06dNH/+fKvEFxwcrBEjRuj06dOqXr26/ve//z10U7oPP/xQAwcOVM2aNeXh4aGZM2cqKCjIKvE9TEhIiKZPn64xY8bozz//VNGiRVWvXj21bds2R+IBAAAAgKeBwZSVXcaQbSIiIvTcc8/p8uXL6b667N8kISHhzi7mIzfIxmif0+EAAAAA2SomuE1Oh4BsdDd/iY+Pz3BDaimLM9337459vzJlymSlWwAAAAAA8pQsJd2enp5pdtK+V0pKSpYDAgAAAAAgr8hS0n3o0CGL41u3bunQoUOaP3++ZsyYkS2B/Vs0bdo0S+8Rz8uOTQl44PIMAAAAAMgtspR0V6tWLU1Z7dq1VbJkSc2ZM0cdO3Z87MAAAAAAAMjtsvTKsIxUqlRJ+/bty84uAQAAAADItbI0052QkGBxbDKZFBcXp8mTJ8vb2ztbAgMAAAAAILfLUtLt4uKSZiM1k8kkDw8PrV+/PlsCAwAAAAAgt8tS0r1z506LYxsbG7m5ucnLy0v582epSwAAAAAA8pwsZchNmjTJ7jgAAAAAAMhzsjwtHR0drQULFigqKkqSVLlyZY0YMUIVKlTItuAAAAAAAMjNsrR7eVhYmCpXrqy9e/eqatWqqlq1qvbs2aMqVapox44d2R0jAAAAAAC5ksFkMpketVGNGjUUEBCg4OBgi/I333xTX3/9tQ4ePJhtAeLfIyEhQc7OzoqPj5eTk1NOhwMAAAAAGcps/pKlme6oqCj1798/TXm/fv104sSJrHQJAAAAAECek6Wk283NTYcPH05TfvjwYRUrVuxxYwIAAAAAIE/I0kZqr776qgYOHKhff/1VDRo0kCRFRkYqODhYY8aMydYAAQAAAADIrbL0TLfJZNKCBQs0b948/fXXX5KkUqVKKSgoSMOHD5fBYMj2QJH38Uw3AAAAgNzCqs9037hxQ6+99pr++OMPxcfH6/Dhwxo9erR8fHxIuAEAAAAA+D9ZSrrbt2+vNWvWSJJSUlL0wgsvaP78+erQoYOWLVuWrQECAAAAAJBbZSnpPnjwoBo3bixJ2rhxo4oXL67ff/9da9as0aJFi7I1QAAAAAAAcqssJd1JSUkqVKiQJOnrr79Wx44dZWNjo3r16un333/P1gABAAAAAMitsrR7uZeXl7Zs2aKXXnpJYWFhGjVqlCTp/PnzbICFx+Y3KUw2RvucDgMAAAB4bDHBbXI6BOSwLM10T5w4UUFBQfL09NQzzzyj+vXrS7oz612jRo1sDRAAAAAAgNwqSzPdL7/8sho1aqS4uDhVq1bNXN68eXO99NJL2RYcAAAAAAC5WZZmuiWpRIkSqlGjhmxs/n8XdevWlY+PT7YEltMMBoO2bNli9XEmT56s6tWrW32cR/E0xgQAAAAAuVGWk25rCwwMVIcOHXI6DKsLCgpSeHh4Todh4WmMCQAAAAByoywtL0f2cXR0lKOjY06HYeFpjAkAAAAAcqOndqb7QY4dO6ZWrVrJ0dFRxYsXV69evfTPP/9IkpYvX66SJUsqNTXVok379u3Vr18/8/GyZctUoUIFFSxYUJUqVdLatWvTjBMXF6dWrVrJzs5O5cuX18aNG83nIiIiZDAYdOXKFXPZ4cOHZTAYFBMTI0kKDQ2Vi4uLtmzZIm9vb9na2iogIEBnz541t7l3KffXX38tW1tbiz4lacSIEWrWrJkk6eLFi+rWrZtKlSole3t7+fv765NPPrGon5qaqv/85z/y8vKS0WhUmTJlNGPGDPP5N954QxUrVpS9vb3Kly+vCRMm6NatW+nGJP3/VQdz586Vu7u7ihQpoiFDhli0SU5OVlBQkEqVKiUHBwc988wzioiISHNPAQAAAODfJNcl3VeuXFGzZs1Uo0YN7d+/X9u3b9fff/+tzp07S5JeeeUVXbx4UTt37jS3uXTpkrZv364ePXpIkj7//HONGDFCY8aM0bFjx/Taa6+pb9++Fm0kacKECerUqZOOHDmiHj16qGvXroqKinqkeJOSkjRjxgytWbNGkZGRunLlirp27Zpu3ebNm8vFxUWbNm0yl6WkpOjTTz81x37jxg3VqlVLW7du1bFjxzRw4ED16tVLe/fuNbcZP368goODNWHCBJ04cUIff/yxihcvbj5fqFAhhYaG6sSJE1q4cKFWrFihd99994HXsXPnTkVHR2vnzp1avXq1QkNDFRoaaj4/dOhQ/fTTT1q/fr1+/vlnvfLKK2rZsqVOnz6dYZ/JyclKSEiw+AAAAABAXmIwmUymnA4iPYGBgbpy5UqazcymT5+u77//XmFhYeayP/74Qx4eHjp16pQqVqyoDh06qEiRIvrwww8l3Zn9njJlis6ePSsbGxs1bNhQVapU0fLly819dO7cWdeuXdPWrVsl3dlIbdCgQVq2bJm5Tr169VSzZk0tXbpUEREReu6553T58mW5uLhIujPTXaNGDf3222/y9PRUaGio+vbtq927d+uZZ56RJJ08eVK+vr7as2eP6tatq8mTJ2vLli06fPiwJGnkyJE6evSo+Znqr7/+Wi+++KLOnTtnHud+bdu2lY+Pj+bOnaurV6/Kzc1Nixcv1oABAzJ1r+fOnav169dr//79kpQmpsDAQEVERCg6Olr58uUz3y8bGxutX79esbGxKl++vGJjY1WyZElzv88//7zq1q2rmTNnpjvu5MmTNWXKlDTlHiM38J5uAAAA5Am8pzvvSkhIkLOzs+Lj4+Xk5JRhvVw3033kyBHt3LnT/Nyxo6Ojecf06OhoSVKPHj20adMmJScnS5LWrVunrl27mndaj4qKUsOGDS36bdiwYZpZ7LvvH7/3+FFnuvPnz686deqYj318fOTi4pJhPz169FBERIT++usvc+xt2rQxJ9wpKSmaNm2a/P395erqKkdHR4WFhSk2NtZ8bcnJyWrevHmGMX366adq2LChSpQoIUdHR73zzjvm9hmpUqWKOeGWJHd3d50/f16SdPToUaWkpKhixYoWv5ddu3aZfyfpGT9+vOLj482fe5fdAwAAAEBekOs2UktMTFS7du00e/bsNOfc3d0lSe3atZPJZNLWrVtVp04dff/99w9dPv2o7ibw9y4UuPcZ56yqU6eOKlSooPXr1+v111/X559/brGMe86cOVq4cKEWLFggf39/OTg4aOTIkbp586Ykyc7O7oH9//TTT+rRo4emTJmigIAAOTs7a/369Zo3b94D2xUoUMDi2GAwmJ+bT0xMVL58+XTgwAGLxFzSAzdkMxqNMhqNDxwXAAAAAHKzXJd016xZU5s2bZKnp6fy508/fFtbW3Xs2FHr1q3TmTNnVKlSJdWsWdN83tfXV5GRkerTp4+5LDIyUpUrV7boZ/fu3erdu7fFcY0aNSRJbm5uku5stla4cGFJMi/Hvtft27e1f/9+1a1bV5J06tQpXblyRb6+vhleY48ePbRu3TqVLl1aNjY2atPm/y9JiYyMVPv27dWzZ09JdzZN++WXX8yxe3t7y87OTuHh4ekuL//xxx9VtmxZvf322+ay33//PcNYMqNGjRpKSUnR+fPn1bhx48fqCwAAAADykqc66Y6Pj0+TyA4cOFArVqxQt27dNG7cOLm6uurMmTNav369Vq5caZ5p7dGjh9q2bavjx4+bE9S7xo4dq86dO6tGjRp6/vnn9b///U+bN2/WN998Y1Hvs88+U+3atdWoUSOtW7dOe/fuNT8n7uXlJQ8PD02ePFkzZszQL7/8ku5scYECBTRs2DAtWrRI+fPn19ChQ1WvXj1zEp6eHj16mPt9+eWXLWaDvb29tXHjRv34448qXLiw5s+fr7///tucdNva2uqNN97QuHHjVLBgQTVs2FAXLlzQ8ePH1b9/f3l7eys2Nlbr169XnTp1tHXrVn3++eeZ/6Wko2LFiurRo4d69+6tefPmqUaNGrpw4YLCw8NVtWpViz8aAAAAAMC/yVP9THdERIRq1Khh8Zk2bZoiIyOVkpKiF154Qf7+/ho5cqRcXFzMS74lqVmzZnJ1ddWpU6fUvXt3i347dOighQsXau7cuapSpYo++OADhYSEqGnTphb1pkyZovXr16tq1apas2aNPvnkE3NyW6BAAX3yySc6efKkqlatqtmzZ2v69OlprsHe3l5vvPGGunfvroYNG8rR0VGffvrpA6/by8tLdevW1c8//2zetfyud955RzVr1lRAQICaNm2qEiVKqEOHDhZ1JkyYoDFjxmjixIny9fVVly5dzM9fv/jiixo1apSGDh2q6tWr68cff9SECRMeGE9mhISEqHfv3hozZowqVaqkDh06aN++fSpTpsxj9w0AAAAAudVTu3t5XhAaGqqRI0emee820nd39z92LwcAAEBewe7leVee3b0cAAAAAIDcgqQbAAAAAAArYXk5nhqZXZ4BAAAAADmN5eUAAAAAAOQwkm4AAAAAAKyEpBsAAAAAACsh6QYAAAAAwEpIugEAAAAAsBKSbgAAAAAArISkGwAAAAAAKyHpBgAAAADASki6AQAAAACwEpJuAAAAAACshKQbAAAAAAArIekGAAAAAMBKSLoBAAAAALASkm4AAAAAAKyEpBsAAAAAACsh6QYAAAAAwEpIugEAAAAAsJL8OR0AcD+/SWGyMdrndBgAAADAY4kJbpPTIeApwEw3AAAAAABWQtINAAAAAICVkHTnsNDQULm4uOR0GBaexpgAAAAAIDci6X6AwMBAGQwGGQwGFShQQOXKldO4ceN048aNbBujS5cu+uWXX7Ktv+zwNMYEAAAAALkRG6k9RMuWLRUSEqJbt27pwIED6tOnjwwGg2bPnp0t/dvZ2cnOzi5b+souT2NMAAAAAJAbMdP9EEajUSVKlJCHh4c6dOig559/Xjt27JAkJScna/jw4SpWrJhsbW3VqFEj7du3z9w2IiJCBoNBW7duVdWqVWVra6t69erp2LFj5jr3LuX+5ZdfZDAYdPLkSYsY3n33XVWoUEGSlJKSov79+6tcuXKys7NTpUqVtHDhwjRxr1q1SlWqVJHRaJS7u7uGDh1qPjd//nz5+/vLwcFBHh4eGjx4sBITE9ONSZImT56s6tWra+3atfL09JSzs7O6du2qq1evmuukpqZq1qxZ5riqVaumjRs3ZuGOAwAAAEDeQdL9CI4dO6Yff/xRBQsWlCSNGzdOmzZt0urVq3Xw4EF5eXkpICBAly5dsmg3duxYzZs3T/v27ZObm5vatWunW7dupem/YsWKql27ttatW2dRvm7dOnXv3l3SneS2dOnS+uyzz3TixAlNnDhRb731ljZs2GCuv2zZMg0ZMkQDBw7U0aNH9cUXX8jLy8t83sbGRosWLdLx48e1evVqffvttxo3btwDrz06Olpbtvy/9u49vuf6///4/T1s7Oy80WbDzJyWIUZCyeaUQ0Waw4QIsTJJB8ey6eOQcvwkm3yVVMJHopI5LITMIUsj+0yfhhJmjR1fvz9cvH69bWPk3RvdrpfL+3LZ6/V8vp6vx+vVq839/Xy9X+/VWrdundatW6ctW7YoNjbWbI+JidF7772nhQsX6vvvv9dzzz2nvn37asuWLSU8uwAAAABw97EYhmHYu4jbVWRkpP7v//5PZcuWVV5enrKzs+Xg4KCVK1cqPDxc5cuXV3x8vBmIc3Nz5efnp6ioKI0dO1YJCQlq166dVqxYod69e0uSfv/9d91zzz2Kj49Xr169FB8fr6ioKJ07d06S9Oabb2ru3Lk6evSopMuz34GBgUpOTlbdunWLrHPkyJE6efKkObNcvXp1DRw4UK+99lqJjvPjjz/WsGHD9Ntvv0lSoZomTZqkf/3rXzp58qTc3NwkXX7DYevWrdq5c6eys7NVoUIFffXVVwoNDTXHHTx4sLKysvT+++8Xud/s7GxlZ2ebyxkZGfLx8ZFP1Eq+pxsAAAB3PL6n++6WkZEhDw8PnT9/Xu7u7sX24zPd19GuXTstWLBAf/zxh2bPnq3SpUvr0Ucf1YEDB5Sbm6tWrVqZfcuUKaP77rtPycnJVmP8OYhWqFDBDNFFeeKJJxQdHa2dO3eqRYsWWr58uUJCQqwC97x587RkyRKlpaXp4sWLysnJ0b333itJOn36tH755Rc99NBDxR7TV199pZiYGP3www/KyMhQXl6eLl26pKysLDk7Fx12/fz8zMAtSd7e3jp9+rQk6ejRo8rKytLDDz9stU1OTo4aN25cbB0xMTGaPHlyse0AAAAAcKfj9vLrcHFxUe3atRUcHKwlS5Zo165devfdd222Py8vLz344IPm7PD777+viIgIs33FihWKjo7WoEGD9MUXXygpKUkDBw5UTk6OJF33AWipqanq0qWLGjVqpE8++UR79+7VvHnzJMkcoyhlypSxWrZYLCooKJAk8/Pgn332mZKSkszX4cOHr/m57vHjx+v8+fPm68SJE9esHQAAAADuNMx03wAHBwe99NJLev7553X06FE5OjoqMTFRNWrUkHT59vLdu3crKirKarudO3fK19dXknT27Fn9+OOPCgoKKnY/EREReuGFF9SnTx/99NNPeuKJJ8y2xMREtWzZUsOHDzfXHTt2zPzZzc1Nfn5+2rRpk9q1a1do7L1796qgoEAzZ86Ug8Pl91z+/Hnwm1GvXj05OTkpLS1Nbdq0KfF2Tk5OcnJy+kv7BgAAAIDbGaH7Bj3++OMaO3asFixYoGeeeUZjx45VhQoV5OvrqzfeeENZWVkaNGiQ1TZTpkxRxYoVVbVqVb388suqVKmSunfvXuw+evbsqWeeeUbPPPOM2rVrp2rVqpltAQEBeu+997Rx40b5+/tr2bJl2r17t/z9/c0+kyZN0rBhw1SlShV17NhRFy5cUGJiop599lnVrl1bubm5evvtt9W1a1clJiZq4cKFf+mcuLm5KTo6Ws8995wKCgp0//336/z580pMTJS7u7sGDBjwl8YHAAAAgDsVofsGlS5dWiNHjtQbb7yh48ePq6CgQP369dOFCxfUtGlTbdy4UeXLl7faJjY2VqNHj1ZKSoruvfde/ec//zGfgF4UNzc3de3aVStXrtSSJUus2oYOHap9+/apd+/eslgs6tOnj4YPH67PP//c7DNgwABdunRJs2fPVnR0tCpVqqTHHntMkhQcHKxZs2Zp+vTpGj9+vB544AHFxMSof//+f+m8TJ06VZUrV1ZMTIx++ukneXp6KiQkRC+99NJfGhcAAAAA7mQ8vdyGrjy9/OzZs1bfe42iXXn6H08vBwAAwN2Ap5ff3Ur69HIepAYAAAAAgI0QugEAAAAAsBFuL8dto6S3ZwAAAACAvXF7OQAAAAAAdkboBgAAAADARgjdAAAAAADYCKEbAAAAAAAbIXQDAAAAAGAjhG4AAAAAAGyE0A0AAAAAgI0QugEAAAAAsBFCNwAAAAAANkLoBgAAAADARgjdAAAAAADYCKEbAAAAAAAbIXQDAAAAAGAjhG4AAAAAAGyE0A0AAAAAgI0QugEAAAAAsBFCNwAAAAAANlLa3gUAV2swcaMcnJztXQYAAABQSGpsZ3uXgDsMM90AAAAAANgIoRsAAAAAABshdNtJ27ZtFRUVZe8yJEkJCQmyWCw6d+5csX3i4+Pl6el5Q+NaLBatXr36L9UGAAAAAHcyQvcNioyMVPfu3QutL0lwvV21bNlS6enp8vDwsHcpAAAAAHBX4UFq/3C5ublydHSUl5eXvUsBAAAAgLsOM902cObMGfXp00fVq1eXs7OzGjZsqA8++OCa25w9e1b9+/dX+fLl5ezsrI4dOyolJcVsv3J79+rVqxUQEKCyZcsqLCxMJ06csBpnzZo1CgkJUdmyZVWzZk1NnjxZeXl5ZrvFYtGCBQv0yCOPyMXFRa+//nqRs/Tx8fHy9fWVs7OzevTooTNnzhSqecGCBapVq5YcHR0VGBioZcuW3eQZAwAAAIC7E6HbBi5duqQmTZros88+06FDh/T000+rX79++vbbb4vdJjIyUnv27NHatWu1Y8cOGYahTp06KTc31+yTlZWl119/Xe+9954SExN17tw5PfHEE2b7tm3b1L9/f40ePVqHDx/WokWLFB8fr9dff91qX5MmTVKPHj108OBBPfXUU4Vq2bVrlwYNGqSRI0cqKSlJ7dq102uvvWbV59NPP9Xo0aM1ZswYHTp0SEOHDtXAgQO1efPmmz1tAAAAAHDX4fbym7Bu3Tq5urparcvPzzd/rl69uqKjo83lZ599Vhs3btTKlSt13333FRovJSVFa9euVWJiolq2bClJWr58uXx8fLR69Wo9/vjjki7fCj537lw1b95ckrR06VIFBQXp22+/1X333afJkyfrxRdf1IABAyRJNWvW1NSpU/XCCy9o4sSJ5v6efPJJDRw40Fz+6aefrOqZM2eOwsPD9cILL0iS6tSpo2+++UYbNmww+8yYMUORkZEaPny4JOn555/Xzp07NWPGDLVr165E5zE7O1vZ2dnmckZGRom2AwAAAIA7BTPdN6Fdu3ZKSkqyei1evNhsz8/P19SpU9WwYUNVqFBBrq6u2rhxo9LS0oocLzk5WaVLlzbDtCRVrFhRgYGBSk5ONteVLl1azZo1M5fr1q0rT09Ps8/+/fs1ZcoUubq6mq8hQ4YoPT1dWVlZ5nZNmza95vElJydb1SJJoaGhhfq0atXKal2rVq2s6r2emJgYeXh4mC8fH58SbwsAAAAAdwJmum+Ci4uLateubbXu559/Nn/+17/+pTlz5ujNN99Uw4YN5eLioqioKOXk5Ni0rszMTE2ePFk9e/Ys1Fa2bFnzZxcXF5vWUVLjx4/X888/by5nZGQQvAEAAADcVQjdNpCYmKhu3bqpb9++kqSCggL9+OOPqlevXpH9g4KClJeXp127dpm3l585c0ZHjhyx2iYvL0979uwxb1E/cuSIzp07p6CgIElSSEiIjhw5UugNgRsVFBSkXbt2Wa3buXNnoT6JiYnmrexXjru4YyyKk5OTnJyc/lKtAAAAAHA7I3TbQEBAgD7++GN98803Kl++vGbNmqVTp04VG0gDAgLUrVs3DRkyRIsWLZKbm5tefPFFVa9eXd26dTP7lSlTRs8++6zeeustlS5dWiNHjlSLFi3MED5hwgR16dJFvr6+euyxx+Tg4KD9+/fr0KFDhR6Edi2jRo1Sq1atNGPGDHXr1k0bN260+jy3JI0dO1a9evVS48aN1b59e/3nP//RqlWr9NVXX93EGQMAAACAuxOf6baBV155RSEhIQoLC1Pbtm3l5eWl7t27X3ObuLg4NWnSRF26dFFoaKgMw9D69etVpkwZs4+zs7PGjRunJ598Uq1atZKrq6s+/PBDsz0sLEzr1q3TF198oWbNmqlFixaaPXu2atSocUP1t2jRQu+8847mzJmj4OBgffHFF3rllVes+nTv3l1z5szRjBkzVL9+fS1atEhxcXFq27btDe0LAAAAAO5mFsMwDHsXgeuLj49XVFSU1Xdp320yMjIuP1AtaqUcnJztXQ4AAABQSGpsZ3uXgNvElfxy/vx5ubu7F9uPmW4AAAAAAGyE0A0AAAAAgI0Quu8QkZGRd/Wt5QAAAABwN+Lp5bjtHJocds3PRAAAAADAnYKZbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOl7V0AcLUGEzfKwcnZ3mUAAAAAptTYzvYuAXcoZroBAAAAALARQjcAAAAAADZC6AYAAAAAwEYI3SXUtm1bRUVF2X2MW6Ekdfj5+enNN9/8W+oBAAAAgLvVHR+6IyMjZbFYNGzYsEJtI0aMkMViUWRkZInHS0hIkMVi0blz525dkQAAAACAf6Q7PnRLko+Pj1asWKGLFy+a6y5duqT3339fvr6+dqwMAAAAAPBPdleE7pCQEPn4+GjVqlXmulWrVsnX11eNGze26ltQUKCYmBj5+/urXLlyCg4O1scffyxJSk1NVbt27SRJ5cuXLzRLXlBQoBdeeEEVKlSQl5eXJk2aZLY99dRT6tKli9W+cnNzVaVKFb377rtF1p2dna3o6GhVr15dLi4uat68uRISEsz2+Ph4eXp6auPGjQoKCpKrq6vCw8OVnp5uNc7ixYsVFBSksmXLqm7dupo/f/51z1leXp5GjhwpDw8PVapUSa+++qoMwyiyb2pqqiwWi5KSksx1586dk8Visar30KFD6tixo1xdXVW1alX169dPv/3223VrAQAAAIC71V0RuqXLoTcuLs5cXrJkiQYOHFioX0xMjN577z0tXLhQ33//vZ577jn17dtXW7ZskY+Pjz755BNJ0pEjR5Senq45c+aY2y5dulQuLi7atWuX3njjDU2ZMkVffvmlJGnw4MHasGGDVSBet26dsrKy1Lt37yJrHjlypHbs2KEVK1bowIEDevzxxxUeHq6UlBSzT1ZWlmbMmKFly5Zp69atSktLU3R0tNm+fPlyTZgwQa+//rqSk5M1bdo0vfrqq1q6dOk1z9fSpUtVunRpffvtt5ozZ45mzZqlxYsXX3Obazl37pwefPBBNW7cWHv27NGGDRt06tQp9erVq9htsrOzlZGRYfUCAAAAgLtJaXsXcKv07dtX48eP13//+19JUmJiolasWGE1E5udna1p06bpq6++UmhoqCSpZs2a2r59uxYtWqQ2bdqoQoUKkqQqVarI09PTah+NGjXSxIkTJUkBAQGaO3euNm3apIcfflgtW7ZUYGCgli1bphdeeEGSFBcXp8cff1yurq6F6k1LS1NcXJzS0tJUrVo1SVJ0dLQ2bNiguLg4TZs2TdLl2fKFCxeqVq1aki4H9SlTppjjTJw4UTNnzlTPnj0lSf7+/jp8+LAWLVqkAQMGFHu+fHx8NHv2bFksFgUGBurgwYOaPXu2hgwZUrITfpW5c+eqcePGZt3S5Tc+fHx89OOPP6pOnTqFtomJidHkyZNvan8AAAAAcCe4a0J35cqV1blzZ8XHx8swDHXu3FmVKlWy6nP06FFlZWXp4Ycftlqfk5NT6Db0ojRq1Mhq2dvbW6dPnzaXBw8erH//+9964YUXdOrUKX3++ef6+uuvixzr4MGDys/PLxRGs7OzVbFiRXPZ2dnZDNxX7/OPP/7QsWPHNGjQIKuwnJeXJw8Pj2seS4sWLWSxWMzl0NBQzZw5U/n5+SpVqtQ1ty3K/v37tXnz5iLfYDh27FiRoXv8+PF6/vnnzeWMjAz5+Pjc8L4BAAAA4HZ114Ru6fIt5iNHjpQkzZs3r1B7ZmamJOmzzz5T9erVrdqcnJyuO36ZMmWsli0WiwoKCszl/v3768UXX9SOHTv0zTffyN/fX61bty5yrMzMTJUqVUp79+4tFHL/HFyL2ueVz15fOZ533nlHzZs3t+p3M8G5OA4Olz+F8OfPfOfm5lr1yczMVNeuXTV9+vRC23t7exc5rpOTU4nOOwAAAADcqe6q0B0eHq6cnBxZLBaFhYUVaq9Xr56cnJyUlpamNm3aFDmGo6OjJCk/P/+G91+xYkV1795dcXFx2rFjR5GfKb+icePGys/P1+nTp4sN5tdTtWpVVatWTT/99JMiIiJuaNtdu3ZZLe/cuVMBAQFFhvXKlStLktLT0807Av78UDXp8sPsPvnkE/n5+al06bvqsgIAAACAm3ZXpaNSpUopOTnZ/Plqbm5uio6O1nPPPaeCggLdf//9On/+vBITE+Xu7q4BAwaoRo0aslgsWrdunTp16qRy5coVect0cQYPHqwuXbooPz//mp+prlOnjiIiItS/f3/NnDlTjRs31q+//qpNmzapUaNG6ty5c4n2N3nyZI0aNUoeHh4KDw9Xdna29uzZo7Nnz1rdun21tLQ0Pf/88xo6dKi+++47vf3225o5c2aRfcuVK6cWLVooNjZW/v7+On36tF555RWrPiNGjNA777yjPn36mE94P3r0qFasWKHFixff0pl3AAAAALhT3DVPL7/C3d1d7u7uxbZPnTpVr776qmJiYhQUFKTw8HB99tln8vf3lyRVr15dkydP1osvvqiqVauat6uXVPv27eXt7a2wsDDzAWnFiYuLU//+/TVmzBgFBgaqe/fu2r179w19t/jgwYO1ePFixcXFqWHDhmrTpo3i4+PN4ylO//79dfHiRd13330aMWKERo8eraeffrrY/kuWLFFeXp6aNGmiqKgovfbaa1bt1apVU2JiovLz89WhQwc1bNhQUVFR8vT0NG9PBwAAAIB/GotR3Jcz46ZkZmaqevXqiouLM58ojpLJyMiQh4eHfKJWysHJ2d7lAAAAAKbU2JLdiYp/jiv55fz589ec+L2rbi+3p4KCAv3222+aOXOmPD099cgjj9i7JAAAAACAnRG6b5G0tDT5+/vrnnvuUXx8PA8TAwAAAABwezluHyW9PQMAAAAA7K2k+YUnXAEAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABspbe8CgKs1mLhRDk7O9i4DAAAAUGpsZ3uXgDscM90AAAAAANgIoRsAAAAAABshdAMAAAAAYCN3ROi2WCxavXp1ifsnJCTIYrHo3LlzNqvJlvv5u+ovzqRJk3TvvffaZd8AAAAAcDexa+iOjIyUxWKRxWJRmTJlVLVqVT388MNasmSJCgoKzH7p6enq2LGjHSv9Z4mOjtamTZvsXQYAAAAA3PHsPtMdHh6u9PR0paam6vPPP1e7du00evRodenSRXl5eZIkLy8vOTk52bnS20d+fr7VmxK3mqurqypWrGiz8QEAAADgn8LuodvJyUleXl6qXr26QkJC9NJLL2nNmjX6/PPPFR8fL8n69vLU1FRZLBatWLFCLVu2VNmyZdWgQQNt2bKl0Nh79+5V06ZN5ezsrJYtW+rIkSNW7WvWrFFISIjKli2rmjVravLkyWbQv7LfxYsXq0ePHnJ2dlZAQIDWrl1b4v2kpqbKwcFBe/bsser/5ptvqkaNGmZwXr9+verUqaNy5cqpXbt2Sk1NteofHx8vT09PrV27VvXq1ZOTk5PS0tK0e/duPfzww6pUqZI8PDzUpk0bfffdd1bbWiwWLVq0SF26dJGzs7OCgoK0Y8cOHT16VG3btpWLi4tatmypY8eOmdtcfXt5ZGSkunfvrhkzZsjb21sVK1bUiBEjlJuba/bJzs5WdHS0qlevLhcXFzVv3lwJCQmFzhUAAAAA/JPYPXQX5cEHH1RwcLBWrVpVbJ+xY8dqzJgx2rdvn0JDQ9W1a1edOXPGqs/LL7+smTNnas+ePSpdurSeeuops23btm3q37+/Ro8ercOHD2vRokWKj4/X66+/bjXG5MmT1atXLx04cECdOnVSRESEfv/99xLtx8/PT+3bt1dcXJxV/7i4OEVGRsrBwUEnTpxQz5491bVrVyUlJWnw4MF68cUXCx1vVlaWpk+frsWLF+v7779XlSpVdOHCBQ0YMEDbt2/Xzp07FRAQoE6dOunChQtW206dOlX9+/dXUlKS6tatqyeffFJDhw7V+PHjtWfPHhmGoZEjR17jv4i0efNmHTt2TJs3b9bSpUsVHx9vvikiSSNHjtSOHTu0YsUKHThwQI8//rjCw8OVkpJS7JjZ2dnKyMiwegEAAADA3eS2DN2SVLdu3UIzvn82cuRIPfroowoKCtKCBQvk4eGhd99916rP66+/rjZt2qhevXp68cUX9c033+jSpUuSLofpF198UQMGDFDNmjX18MMPa+rUqVq0aJHVGJGRkerTp49q166tadOmKTMzU99++22J9zN48GB98MEHys7OliR99913OnjwoAYOHChJWrBggWrVqqWZM2cqMDBQERERioyMLHS8ubm5mj9/vlq2bKnAwEA5OzvrwQcfVN++fVW3bl0FBQXp3//+t7KysgrN+g8cOFC9evVSnTp1NG7cOKWmpioiIkJhYWEKCgrS6NGjrzsrXb58ec2dO1d169ZVly5d1LlzZ/Nz32lpaYqLi9NHH32k1q1bq1atWoqOjtb9999f6A2HP4uJiZGHh4f58vHxuWYNAAAAAHCnuW1Dt2EYslgsxbaHhoaaP5cuXVpNmzZVcnKyVZ9GjRqZP3t7e0uSTp8+LUnav3+/pkyZIldXV/M1ZMgQpaenKysrq8gxXFxc5O7ubo5Rkv10795dpUqV0qeffirp8q3i7dq1k5+fnyQpOTlZzZs3L/bYrnB0dLTajySdOnVKQ4YMUUBAgDw8POTu7q7MzEylpaUVW1/VqlUlSQ0bNrRad+nSpWvONNevX1+lSpWyOs4rx3jw4EHl5+erTp06Vudzy5YtVretX238+PE6f/68+Tpx4kSxfQEAAADgTlTa3gUUJzk5Wf7+/n9pjDJlypg/XwnwVz5HnZmZqcmTJ6tnz56FtitbtmyRY1wZ5+qHmF1rP46Ojurfv7/i4uLUs2dPvf/++5ozZ84NH0u5cuUKvQkxYMAAnTlzRnPmzFGNGjXk5OSk0NBQ5eTkXLe+a9VclGudh8zMTJUqVUp79+61CubS5YeyFcfJyYkH5AEAAAC4q92Wofvrr7/WwYMH9dxzzxXbZ+fOnXrggQckSXl5edq7d+91P5f8ZyEhITpy5Ihq1679l+u9nsGDB6tBgwaaP3++8vLyrIJ+UFBQoYez7dy5s0TjJiYmav78+erUqZMk6cSJE/rtt99uXeEl1LhxY+Xn5+v06dNq3br1375/AAAAALhd2T10Z2dn6+TJk8rPz9epU6e0YcMGxcTEqEuXLurfv3+x282bN08BAQEKCgrS7NmzdfbsWasHpV3PhAkT1KVLF/n6+uqxxx6Tg4OD9u/fr0OHDum11167FYdmCgoKUosWLTRu3Dg99dRTKleunNk2bNgwzZw5U2PHjtXgwYO1d+9eqweUXUtAQICWLVumpk2bKiMjQ2PHjrUa++9Sp04dRUREqH///po5c6YaN26sX3/9VZs2bVKjRo3UuXPnv70mAAAAALgd2P0z3Rs2bJC3t7f8/PwUHh6uzZs366233tKaNWsK3ar8Z7GxsYqNjVVwcLC2b9+utWvXqlKlSiXeb1hYmNatW6cvvvhCzZo1U4sWLTR79mzVqFHjVhxWIYMGDVJOTk6hNwZ8fX31ySefaPXq1QoODtbChQs1bdq0Eo357rvv6uzZswoJCVG/fv00atQoValSxRblX1dcXJz69++vMWPGKDAwUN27d9fu3bvl6+trl3oAAAAA4HZgMQzDsHcRNyI1NVX+/v7at2+f1XdJ3+6mTp2qjz76SAcOHLB3KbetjIyMy08xj1opBydne5cDAAAAKDWWuzZRtCv55fz583J3dy+2n91nuu92mZmZOnTokObOnatnn33W3uUAAAAAAP5GhG4bGzlypJo0aaK2bdve0GfOAQAAAAB3vjvu9nLcvUp6ewYAAAAA2Bu3lwMAAAAAYGeEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOl7V0AcLUGEzfKwcnZ3mUAAADgHyg1trO9S8BdhpluAAAAAABshNANAAAAAICNELr/JllZWXr00Ufl7u4ui8Wic+fO2aWO+Ph4eXp62mXfAAAAAPBPQ+i+jsjISFksFsXGxlqtX716tSwWS4nHWbp0qbZt26ZvvvlG6enp8vDwuNWlAgAAAABuM4TuEihbtqymT5+us2fP3vQYx44dU1BQkBo0aCAvL68bCuwAAAAAgDsTobsE2rdvLy8vL8XExBTbZ/v27WrdurXKlSsnHx8fjRo1Sn/88YckqW3btpo5c6a2bt0qi8Witm3bSpKWLVumpk2bys3NTV5eXnryySd1+vRpc8wrs+xXvxISEiRJZ8+eVf/+/VW+fHk5OzurY8eOSklJsaorPj5evr6+cnZ2Vo8ePXTmzJlCtS9YsEC1atWSo6OjAgMDtWzZMqt2i8WixYsXq0ePHnJ2dlZAQIDWrl1r1efQoUPq2LGjXF1dVbVqVfXr10+//fZbic8xAAAAANyNCN0lUKpUKU2bNk1vv/22fv7550Ltx44dU3h4uB599FEdOHBAH374obZv366RI0dKklatWqUhQ4YoNDRU6enpWrVqlSQpNzdXU6dO1f79+7V69WqlpqYqMjLSHHfOnDlKT083X6NHj1aVKlVUt25dSZdD+Z49e7R27Vrt2LFDhmGoU6dOys3NlSTt2rVLgwYN0siRI5WUlKR27drptddes6r9008/1ejRozVmzBgdOnRIQ4cO1cCBA7V582arfpMnT1avXr104MABderUSREREfr9998lSefOndODDz6oxo0ba8+ePdqwYYNOnTqlXr16XfO8ZmdnKyMjw+oFAAAAAHcTi2EYhr2LuJ1FRkbq3LlzWr16tUJDQ1WvXj29++67Wr16tXr06CHDMDR48GCVKlVKixYtMrfbvn272rRpoz/++ENly5ZVVFSUkpKSzFnqouzZs0fNmjXThQsX5OrqatW2atUqRURE6KuvvlKrVq2UkpKiOnXqKDExUS1btpQknTlzRj4+Plq6dKkef/xxPfnkkzp//rw+++wzc5wnnnhCGzZsMB/k1qpVK9WvX1///ve/zT69evXSH3/8YW5nsVj0yiuvaOrUqZKkP/74Q66urvr8888VHh6u1157Tdu2bdPGjRvNMX7++Wf5+PjoyJEjqlOnTpHHO2nSJE2ePLnQep+olXxPNwAAAOyC7+lGSWVkZMjDw0Pnz5+Xu7t7sf2Y6b4B06dP19KlS5WcnGy1fv/+/YqPj5erq6v5CgsLU0FBgY4fP17seHv37lXXrl3l6+srNzc3tWnTRpKUlpZm1W/fvn3q16+f5s6dq1atWkmSkpOTVbp0aTVv3tzsV7FiRQUGBpr1JScnW7VLUmhoqNVycnKyOeYVrVq1KnSMjRo1Mn92cXGRu7u7eSv8/v37tXnzZqvjvzIbf+zYsWKPf/z48Tp//rz5OnHiRLF9AQAAAOBOVNreBdxJHnjgAYWFhWn8+PFWt4FnZmZq6NChGjVqVKFtfH19ixzrjz/+UFhYmMLCwrR8+XJVrlxZaWlpCgsLU05Ojtnv5MmTeuSRRzR48GANGjTolh9TSZUpU8Zq2WKxqKCgQNLl4+/ataumT59eaDtvb+9ix3RycpKTk9OtLRQAAAAAbiOE7hsUGxure++9V4GBgea6kJAQHT58WLVr1y7xOD/88IPOnDmj2NhY+fj4SLp8e/mfXbp0Sd26dVPdunU1a9Ysq7agoCDl5eVp165dVreXHzlyRPXq1TP77Nq1y2q7nTt3FhonMTFRAwYMMNclJiaaY5RESEiIPvnkE/n5+al0aS4pAAAAALiC28tvUMOGDRUREaG33nrLXDdu3Dh988035gPLUlJStGbNGvNBakXx9fWVo6Oj3n77bf30009au3at+ZnpK4YOHaoTJ07orbfe0q+//qqTJ0/q5MmTysnJUUBAgLp166YhQ4Zo+/bt2r9/v/r27avq1aurW7dukqRRo0Zpw4YNmjFjhlJSUjR37lxt2LDBah9jx45VfHy8FixYoJSUFM2aNUurVq1SdHR0ic/JiBEj9Pvvv6tPnz7avXu3jh07po0bN2rgwIHKz88v8TgAAAAAcLchdN+EKVOmmLdWS5c/77xlyxb9+OOPat26tRo3bqwJEyaoWrVqxY5RuXJlxcfH66OPPlK9evUUGxurGTNmWPXZsmWL0tPTVa9ePXl7e5uvb775RpIUFxenJk2aqEuXLgoNDZVhGFq/fr15K3iLFi30zjvvaM6cOQoODtYXX3yhV155xWof3bt315w5czRjxgzVr19fixYtUlxcnPm1ZiVRrVo1JSYmKj8/Xx06dFDDhg0VFRUlT09POThwiQEAAAD45+Lp5bhtXHn6H08vBwAAgL3w9HKUFE8vBwAAAADAzgjdAAAAAADYCI+axm3n0OSwa96eAQAAAAB3Cma6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwkdL2LgC4WoOJG+Xg5GzvMgAAAHCXSY3tbO8S8A/ETDcAAAAAADZC6AYAAAAAwEYI3Xe41NRUWSwWJSUl3dJx27Ztq6ioqFs6JgAAAAD80xC6b4ETJ07oqaeeUrVq1eTo6KgaNWpo9OjROnPmzC3dT2RkpLp37261zsfHR+np6WrQoMEt3deqVas0derUWzomAAAAAPzTELr/op9++klNmzZVSkqKPvjgAx09elQLFy7Upk2bFBoaqt9//92m+y9VqpS8vLxUuvStfSZehQoV5ObmdkvHBAAAAIB/GkL3XzRixAg5Ojrqiy++UJs2beTr66uOHTvqq6++0v/+9z+9/PLLkiSLxaLVq1dbbevp6an4+Hhz+cSJE+rVq5c8PT1VoUIFdevWTampqZKkSZMmaenSpVqzZo0sFossFosSEhIK3V6en5+vQYMGyd/fX+XKlVNgYKDmzJljtd8rM+aTJ09W5cqV5e7urmHDhiknJ8fsc/Xt5X5+fpo2bZqeeuopubm5ydfXV//+97+txr1W/QAAAADwT0To/gt+//13bdy4UcOHD1e5cuWs2ry8vBQREaEPP/xQhmFcd6zc3FyFhYXJzc1N27ZtU2JiolxdXRUeHq6cnBxFR0erV69eCg8PV3p6utLT09WyZctC4xQUFOiee+7RRx99pMOHD2vChAl66aWXtHLlSqt+mzZtUnJyshISEvTBBx9o1apVmjx58jVrnDlzppo2bap9+/Zp+PDheuaZZ3TkyJES1Q8AAAAA/0R8T/dfkJKSIsMwFBQUVGR7UFCQzp49q19//fW6Y3344YcqKCjQ4sWLZbFYJElxcXHy9PRUQkKCOnTooHLlyik7O1teXl7FjlOmTBmr8Ozv768dO3Zo5cqV6tWrl7ne0dFRS5YskbOzs+rXr68pU6Zo7Nixmjp1qhwcin4vplOnTho+fLgkady4cZo9e7Y2b96swMDAEtV/tezsbGVnZ5vLGRkZ1z1PAAAAAHAnIXTfAtebyXZ0dLzuGPv379fRo0cLfY760qVLOnbs2A3VM2/ePC1ZskRpaWm6ePGicnJydO+991r1CQ4OlrOzs7kcGhqqzMxMnThxQjVq1Chy3EaNGpk/WywWeXl56fTp0zddf0xMzHVn1wEAAADgTkbo/gtq164ti8Wi5ORk9ejRo1B7cnKyKleuLE9PT1kslkLhPDc31/w5MzNTTZo00fLlywuNU7ly5RLXtGLFCkVHR2vmzJkKDQ2Vm5ub/vWvf2nXrl03cGRFK1OmjNWyxWJRQUGBpJurf/z48Xr++efN5YyMDPn4+PzlOgEAAADgdkHo/gsqVqyohx9+WPPnz9dzzz1n9bnukydPavny5RoxYoSky8EzPT3dbE9JSVFWVpa5HBISog8//FBVqlSRu7t7kftzdHRUfn7+NWtKTExUy5YtzdvAJRU507x//35dvHjRrHnnzp1ydXW96dBbkvqv5uTkJCcnp5vaHwAAAADcCXiQ2l80d+5cZWdnKywsTFu3btWJEye0YcMGPfzww6pTp44mTJggSXrwwQc1d+5c7du3T3v27NGwYcOsZo4jIiJUqVIldevWTdu2bdPx48eVkJCgUaNG6eeff5Z0+QniBw4c0JEjR/Tbb79ZzZRfERAQoD179mjjxo368ccf9eqrr2r37t2F+uXk5GjQoEE6fPiw1q9fr4kTJ2rkyJHFfp77ekpSPwAAAAD80xC6/6KAgADt3r1bNWvWVK9evVSjRg117NhRderUMZ/gLV1+8rePj49at26tJ598UtHR0VafqXZ2dtbWrVvl6+urnj17KigoSIMGDdKlS5fMmeMhQ4YoMDBQTZs2VeXKlZWYmFionqFDh6pnz57q3bu3mjdvrjNnzljNel/x0EMPKSAgQA888IB69+6tRx55RJMmTbrp81CS+gEAAADgn8ZilOT7rHBDJk6cqFmzZunLL79UixYt7F1OIZGRkTp37lyh7w23t4yMDHl4eMgnaqUcnJyvvwEAAABwA1JjO9u7BNxFruSX8+fPX3Oikc9028DkyZPl5+ennTt36r777rvpW7YBAAAAAHc2QreNDBw40N4lAAAAAADsjNvLcdso6e0ZAAAAAGBvJc0v3PcMAAAAAICNELoBAAAAALARQjcAAAAAADZC6AYAAAAAwEYI3QAAAAAA2AihGwAAAAAAGyF0AwAAAABgI4RuAAAAAABshNANAAAAAICNELoBAAAAALARQjcAAAAAADZC6AYAAAAAwEYI3QAAAAAA2AihGwAAAAAAGyF0AwAAAABgI4RuAAAAAABshNANAAAAAICNlLZ3AcDVGkzcKAcnZ3uXAQAAgLtIamxne5eAfyhmugEAAAAAsBFCNwAAAAAANkLovs1YLBatXr3arjX4+fnpzTffvGaf26FOAAAAALjd8ZnuEkhISFC7du2KbW/btq02b958S/aVnp6u8uXL35Kxbtbu3bvl4uJi1xoAAAAA4G5A6C6Bli1bKj09vdD6tWvXatiwYRo+fPgt25eXl9ctG+tmVa5c2d4lAAAAAMBdgdvLS8DR0VFeXl5Wr7Nnzyo6OlovvfSSHn/8cUnSli1bdN9998nJyUne3t568cUXlZeXZ47Ttm1bjRo1Si+88IIqVKggLy8vTZo0yWpff75tOycnRyNHjpS3t7fKli2rGjVqKCYmxuw7a9YsNWzYUC4uLvLx8dHw4cOVmZlptsfHx8vT01Pr1q1TYGCgnJ2d9dhjjykrK0tLly6Vn5+fypcvr1GjRik/P9/c7urby1NSUvTAAw+obNmyqlevnr788stC5+jEiRPq1auXPD09VaFCBXXr1k2pqal/4awDAAAAwJ2P0H0Tzp07p27duqlt27aaOnWqJOl///ufOnXqpGbNmmn//v1asGCB3n33Xb322mtW2y5dulQuLi7atWuX3njjDU2ZMqXIECtJb731ltauXauVK1fqyJEjWr58ufz8/Mx2BwcHvfXWW/r++++1dOlSff3113rhhResxsjKytJbb72lFStWaMOGDUpISFCPHj20fv16rV+/XsuWLdOiRYv08ccfF1lDQUGBevbsKUdHR+3atUsLFy7UuHHjrPrk5uYqLCxMbm5u2rZtmxITE+Xq6qrw8HDl5OTc6OkFAAAAgLsGt5ffoIKCAj355JMqXbq0li9fLovFIkmaP3++fHx8NHfuXFksFtWtW1e//PKLxo0bpwkTJsjB4fL7G40aNdLEiRMlSQEBAZo7d642bdqkhx9+uNC+0tLSFBAQoPvvv18Wi0U1atSwao+KijJ/9vPz02uvvaZhw4Zp/vz55vrc3FwtWLBAtWrVkiQ99thjWrZsmU6dOiVXV1fVq1dP7dq10+bNm9W7d+9CNXz11Vf64YcftHHjRlWrVk2SNG3aNHXs2NHs8+GHH6qgoECLFy82z0dcXJw8PT2VkJCgDh06FHkus7OzlZ2dbS5nZGQUc9YBAAAA4M7ETPcNeumll7Rjxw6tWbNGbm5u5vrk5GSFhoaaoVOSWrVqpczMTP3888/mukaNGlmN5+3trdOnTxe5r8jISCUlJSkwMFCjRo3SF198YdX+1Vdf6aGHHlL16tXl5uamfv366cyZM8rKyjL7ODs7m4FbkqpWrSo/Pz+5urparSuuhuTkZPn4+JiBW5JCQ0Ot+uzfv19Hjx6Vm5ubXF1d5erqqgoVKujSpUs6duxYkeNKUkxMjDw8PMyXj49PsX0BAAAA4E5E6L4BK1as0IwZM7RixQoFBATc1BhlypSxWrZYLCooKCiyb0hIiI4fP66pU6fq4sWL6tWrlx577DFJUmpqqrp06aJGjRrpk08+0d69ezVv3jxJsrqlu6j93UgNJZGZmakmTZooKSnJ6vXjjz/qySefLHa78ePH6/z58+brxIkTN10DAAAAANyOuL28hJKSkjRo0CDFxsYqLCysUHtQUJA++eQTGYZhznYnJibKzc1N99xzz03v193dXb1791bv3r312GOPKTw8XL///rv27t2rgoICzZw507x1feXKlTe9n+IEBQXpxIkTSk9Pl7e3tyRp586dVn1CQkL04YcfqkqVKnJ3dy/x2E5OTnJycrql9QIAAADA7YSZ7hL47bff1L17d7Vt21Z9+/bVyZMnrV6//vqrhg8frhMnTujZZ5/VDz/8oDVr1mjixIl6/vnnzVB8o2bNmqUPPvhAP/zwg3788Ud99NFH8vLykqenp2rXrq3c3Fy9/fbb+umnn7Rs2TItXLjwFh+51L59e9WpU0cDBgzQ/v37tW3bNr388stWfSIiIlSpUiV169ZN27Zt0/Hjx5WQkKBRo0ZZ3VoPAAAAAP80hO4S+Oyzz/Tf//5X69evl7e3d6FXs2bNVL16da1fv17ffvutgoODNWzYMA0aNEivvPLKTe/Xzc1Nb7zxhpo2bapmzZopNTVV69evl4ODg4KDgzVr1ixNnz5dDRo00PLly62+TuxWcXBw0KeffqqLFy/qvvvu0+DBg/X6669b9XF2dtbWrVvl6+urnj17KigoSIMGDdKlS5duaOYbAAAAAO42FsMwDHsXAUiXn17u4eEhn6iVcnBytnc5AAAAuIukxna2dwm4y1zJL+fPn7/mZCMz3QAAAAAA2AihGwAAAAAAGyF0AwAAAABgI3xlGG47hyaH8QA2AAAAAHcFZroBAAAAALARQjcAAAAAADZC6AYAAAAAwEYI3QAAAAAA2AihGwAAAAAAGyF0AwAAAABgI4RuAAAAAABshNANAAAAAICNELoBAAAAALARQjcAAAAAADZC6AYAAAAAwEYI3QAAAAAA2AihGwAAAAAAGyF0AwAAAABgI4RuAAAAAABshNANAAAAAICNlLZ3AcDVGkzcKAcnZ3uXAQAAgDtYamxne5cASGKmGwAAAAAAmyF0AwAAAABgI4RuAAAAAABshNBdQm3btlVUVJS9y/hbxMfHy9PT095lAAAAAMAdj9D9J5GRkbJYLIVeR48etXdpf6vevXvrxx9/tHcZAAAAAHDH4+nlVwkPD1dcXJzVusqVK9upGvsoV66cypUrZ+8yAAAAAOCOx0z3VZycnOTl5WX1KlWqVKF+FotFq1evtlrn6emp+Ph4SVLLli01btw4q/Zff/1VZcqU0datWyVJZ8+eVf/+/VW+fHk5OzurY8eOSklJMft6eXlp2rRp5vbffPONHB0dtWnTJknSsWPH1K1bN1WtWlWurq5q1qyZvvrqK6t9+vn56bXXXlP//v3l6uqqGjVqaO3atfr111/VrVs3ubq6qlGjRtqzZ4+5zdW3l0+aNEn33nuvli1bJj8/P3l4eOiJJ57QhQsXzD4FBQWKiYmRv7+/ypUrp+DgYH388cclPOsAAAAAcHcidNtIRESEVqxYIcMwzHUffvihqlWrptatW0u6fDv7nj17tHbtWu3YsUOGYahTp07Kzc1V5cqVtWTJEk2aNEl79uzRhQsX1K9fP40cOVIPPfSQJCkzM1OdOnXSpk2btG/fPoWHh6tr165KS0uzqmX27Nlq1aqV9u3bp86dO6tfv37q37+/+vbtq++++061atVS//79rWq92rFjx7R69WqtW7dO69at05YtWxQbG2u2x8TE6L333tPChQv1/fff67nnnlPfvn21ZcuWYsfMzs5WRkaG1QsAAAAA7iaE7qusW7dOrq6u5uvxxx+/qXF69eqlX375Rdu3bzfXvf/+++rTp48sFotSUlK0du1aLV68WK1bt1ZwcLCWL1+u//3vf+YMeqdOnTRkyBBFRERo2LBhcnFxUUxMjDlecHCwhg4dqgYNGiggIEBTp05VrVq1tHbtWqtaOnXqpKFDhyogIEATJkxQRkaGmjVrpscff1x16tTRuHHjlJycrFOnThV7PAUFBYqPj1eDBg3UunVr9evXz5xxz87O1rRp07RkyRKFhYWpZs2aioyMVN++fbVo0aJix4yJiZGHh4f58vHxuZlTDQAAAAC3LT7TfZV27dppwYIF5rKLi8tNjVO5cmV16NBBy5cvV+vWrXX8+HHt2LHDDKHJyckqXbq0mjdvbm5TsWJFBQYGKjk52Vw3Y8YMNWjQQB999JH27t0rJycnsy0zM1OTJk3SZ599pvT0dOXl5enixYuFZrobNWpk/ly1alVJUsOGDQutO336tLy8vIo8Hj8/P7m5uZnL3t7eOn36tCTp6NGjysrK0sMPP2y1TU5Ojho3blzsORo/fryef/55czkjI4PgDQAAAOCuQui+iouLi2rXrn3dfhaLpdDt2Lm5uVbLERERGjVqlN5++229//77atiwoVXYLYljx47pl19+UUFBgVJTU622j46O1pdffqkZM2aodu3aKleunB577DHl5ORYjVGmTBmruotbV1BQUGwdf+5/ZZsr/TMzMyVJn332mapXr27V789vElzNycnpmu0AAAAAcKcjdN+kypUrKz093VxOSUlRVlaWVZ9u3brp6aef1oYNG/T++++rf//+ZltQUJDy8vK0a9cutWzZUpJ05swZHTlyRPXq1ZN0eaa4b9++6t27twIDAzV48GAdPHhQVapUkSQlJiYqMjJSPXr0kHQ5/KamptrysItUr149OTk5KS0tTW3atPnb9w8AAAAAtytC90168MEHNXfuXIWGhio/P1/jxo0rNBvs4uKi7t2769VXX1VycrL69OljtgUEBKhbt24aMmSIFi1aJDc3N7344ouqXr26unXrJkl6+eWXdf78eb311ltydXXV+vXr9dRTT2ndunXmGKtWrVLXrl1lsVj06quvXnO22lbc3NwUHR2t5557TgUFBbr//vt1/vx5JSYmyt3dXQMGDPjbawIAAACA2wEPUrtJM2fOlI+Pj1q3bq0nn3xS0dHRcnZ2LtQvIiJC+/fvV+vWreXr62vVFhcXpyZNmqhLly4KDQ2VYRhav369ypQpo4SEBL355ptatmyZ3N3d5eDgoGXLlmnbtm3mZ85nzZql8uXLq2XLluratavCwsIUEhLytxz/1aZOnapXX31VMTExCgoKUnh4uD777DP5+/vbpR4AAAAAuB1YjGt9TxTwN8rIyLj8FPOolXJwKvwGBgAAAFBSqbGd7V0C7nJX8sv58+fl7u5ebD9mugEAAAAAsBFCNwAAAAAANsKD1HDbOTQ57Jq3ZwAAAADAnYKZbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABvhe7px2zAMQ5KUkZFh50oAAAAA4Nqu5JYrOaY4hG7cNs6cOSNJ8vHxsXMlAAAAAFAyFy5ckIeHR7HthG7cNipUqCBJSktLu+ZFC5RURkaGfHx8dOLECbm7u9u7HNwFuKZgC1xXuNW4pnCrcU0VzTAMXbhwQdWqVbtmP0I3bhsODpcfMeDh4cH/zLil3N3duaZwS3FNwRa4rnCrcU3hVuOaKqwkk4U8SA0AAAAAABshdAMAAAAAYCOEbtw2nJycNHHiRDk5Odm7FNwluKZwq3FNwRa4rnCrcU3hVuOa+mssxvWebw4AAAAAAG4KM90AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbtwW5s2bJz8/P5UtW1bNmzfXt99+a++ScJuaNGmSLBaL1atu3bpm+6VLlzRixAhVrFhRrq6uevTRR3Xq1CmrMdLS0tS5c2c5OzurSpUqGjt2rPLy8v7uQ4GdbN26VV27dlW1atVksVi0evVqq3bDMDRhwgR5e3urXLlyat++vVJSUqz6/P7774qIiJC7u7s8PT01aNAgZWZmWvU5cOCAWrdurbJly8rHx0dvvPGGrQ8NdnS96yoyMrLQ767w8HCrPlxX+LOYmBg1a9ZMbm5uqlKlirp3764jR45Y9blVf/MSEhIUEhIiJycn1a5dW/Hx8bY+PNhBSa6ptm3bFvpdNWzYMKs+XFM3jtANu/vwww/1/PPPa+LEifruu+8UHByssLAwnT592t6l4TZVv359paenm6/t27ebbc8995z+85//6KOPPtKWLVv0yy+/qGfPnmZ7fn6+OnfurJycHH3zzTdaunSp4uPjNWHCBHscCuzgjz/+UHBwsObNm1dk+xtvvKG33npLCxcu1K5du+Ti4qKwsDBdunTJ7BMREaHvv/9eX375pdatW6etW7fq6aefNtszMjLUoUMH1ahRQ3v37tW//vUvTZo0Sf/+979tfnywj+tdV5IUHh5u9bvrgw8+sGrnusKfbdmyRSNGjNDOnTv15ZdfKjc3Vx06dNAff/xh9rkVf/OOHz+uzp07q127dkpKSlJUVJQGDx6sjRs3/q3HC9sryTUlSUOGDLH6XfXnN/e4pm6SAdjZfffdZ4wYMcJczs/PN6pVq2bExMTYsSrcriZOnGgEBwcX2Xbu3DmjTJkyxkcffWSuS05ONiQZO3bsMAzDMNavX284ODgYJ0+eNPssWLDAcHd3N7Kzs21aO24/koxPP/3UXC4oKDC8vLyMf/3rX+a6c+fOGU5OTsYHH3xgGIZhHD582JBk7N692+zz+eefGxaLxfjf//5nGIZhzJ8/3yhfvrzVNTVu3DgjMDDQxkeE28HV15VhGMaAAQOMbt26FbsN1xWu5/Tp04YkY8uWLYZh3Lq/eS+88IJRv359q3317t3bCAsLs/Uhwc6uvqYMwzDatGljjB49uthtuKZuDjPdsKucnBzt3btX7du3N9c5ODioffv22rFjhx0rw+0sJSVF1apVU82aNRUREaG0tDRJ0t69e5Wbm2t1PdWtW1e+vr7m9bRjxw41bNhQVatWNfuEhYUpIyND33///d97ILjtHD9+XCdPnrS6hjw8PNS8eXOra8jT01NNmzY1+7Rv314ODg7atWuX2eeBBx6Qo6Oj2ScsLExHjhzR2bNn/6ajwe0mISFBVapUUWBgoJ555hmdOXPGbOO6wvWcP39eklShQgVJt+5v3o4dO6zGuNKHf4fd/a6+pq5Yvny5KlWqpAYNGmj8+PHKysoy27imbk5pexeAf7bffvtN+fn5Vv/jSlLVqlX1ww8/2Kkq3M6aN2+u+Ph4BQYGKj09XZMnT1br1q116NAhnTx5Uo6OjvL09LTapmrVqjp58qQk6eTJk0Veb1fa8M925Roo6hr58zVUpUoVq/bSpUurQoUKVn38/f0LjXGlrXz58japH7ev8PBw9ezZU/7+/jp27JheeukldezYUTt27FCpUqW4rnBNBQUFioqKUqtWrdSgQQNJumV/84rrk5GRoYsXL6pcuXK2OCTYWVHXlCQ9+eSTqlGjhqpVq6YDBw5o3LhxOnLkiFatWiWJa+pmEboB3FE6duxo/tyoUSM1b95cNWrU0MqVK/+Rv8QB3BmeeOIJ8+eGDRuqUaNGqlWrlhISEvTQQw/ZsTLcCUaMGKFDhw5ZPcME+CuKu6b+/ByJhg0bytvbWw899JCOHTumWrVq/d1l3jW4vRx2ValSJZUqVarQkzZPnTolLy8vO1WFO4mnp6fq1Kmjo0ePysvLSzk5OTp37pxVnz9fT15eXkVeb1fa8M925Rq41u8kLy+vQg96zMvL0++//851hhKrWbOmKlWqpKNHj0riukLxRo4cqXXr1mnz5s265557zPW36m9ecX3c3d15M/suVdw1VZTmzZtLktXvKq6pG0fohl05OjqqSZMm2rRpk7muoKBAmzZtUmhoqB0rw50iMzNTx44dk7e3t5o0aaIyZcpYXU9HjhxRWlqaeT2Fhobq4MGDVv+4/fLLL+Xu7q569er97fXj9uLv7y8vLy+raygjI0O7du2yuobOnTunvXv3mn2+/vprFRQUmP84CQ0N1datW5Wbm2v2+fLLLxUYGMgtwJAk/fzzzzpz5oy8vb0lcV2hMMMwNHLkSH366af6+uuvC3204Fb9zQsNDbUa40of/h1297neNVWUpKQkSbL6XcU1dRPs/SQ3YMWKFYaTk5MRHx9vHD582Hj66acNT09Pq6ciAleMGTPGSEhIMI4fP24kJiYa7du3NypVqmScPn3aMAzDGDZsmOHr62t8/fXXxp49e4zQ0FAjNDTU3D4vL89o0KCB0aFDByMpKcnYsGGDUblyZWP8+PH2OiT8zS5cuGDs27fP2LdvnyHJmDVrlrFv3z7jv//9r2EYhhEbG2t4enoaa9asMQ4cOGB069bN8Pf3Ny5evGiOER4ebjRu3NjYtWuXsX37diMgIMDo06eP2X7u3DmjatWqRr9+/YxDhw4ZK1asMJydnY1Fixb97ceLv8e1rqsLFy4Y0dHRxo4dO4zjx48bX331lRESEmIEBAQYly5dMsfgusKfPfPMM4aHh4eRkJBgpKenm6+srCyzz634m/fTTz8Zzs7OxtixY43k5GRj3rx5RqlSpYwNGzb8rccL27veNXX06FFjypQpxp49e4zjx48ba9asMWrWrGk88MAD5hhcUzeH0I3bwttvv234+voajo6Oxn333Wfs3LnT3iXhNtW7d2/D29vbcHR0NKpXr2707t3bOHr0qNl+8eJFY/jw4Ub58uUNZ2dno0ePHkZ6errVGKmpqUbHjh2NcuXKGZUqVTLGjBlj5Obm/t2HAjvZvHmzIanQa8CAAYZhXP7asFdffdWoWrWq4eTkZDz00EPGkSNHrMY4c+aM0adPH8PV1dVwd3c3Bg4caFy4cMGqz/79+43777/fcHJyMqpXr27Exsb+XYcIO7jWdZWVlWV06NDBqFy5slGmTBmjRo0axpAhQwq9ucx1hT8r6nqSZMTFxZl9btXfvM2bNxv33nuv4ejoaNSsWdNqH7h7XO+aSktLMx544AGjQoUKhpOTk1G7dm1j7Nixxvnz563G4Zq6cRbDMIy/b14dAAAAAIB/Dj7TDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAASiQ1NVUWi0VJSUn2LsX0ww8/qEWLFipbtqzuvfdee5fzt5o0adI/7pgB4E5E6AYA4A4RGRkpi8Wi2NhYq/WrV6+WxWKxU1X2NXHiRLm4uOjIkSPatGlTkX0iIyPVvXv3GxrXYrFo9erVf73AW6SoeqKjo4s9ZgDA7YPQDQDAHaRs2bKaPn26zp49a+9SbpmcnJyb3vbYsWO6//77VaNGDVWsWPEWVnVr5Obm2mxsV1fX2/KYAQDWCN0AANxB2rdvLy8vL8XExBTbp6jbjt988035+fmZy1dmf6dNm6aqVavK09NTU6ZMUV5ensaOHasKFSronnvuUVxcXKHxf/jhB7Vs2VJly5ZVgwYNtGXLFqv2Q4cOqWPHjnJ1dVXVqlXVr18//fbbb2Z727ZtNXLkSEVFRalSpUoKCwsr8jgKCgo0ZcoU3XPPPXJyctK9996rDRs2mO0Wi0V79+7VlClTZLFYNGnSpGucuf+vbdu2GjVqlF544QVVqFBBXl5eVtteOU89evSQxWKxOm9r1qxRSEiIypYtq5o1a2ry5MnKy8uzqmnBggV65JFH5OLiotdff135+fkaNGiQ/P39Va5cOQUGBmrOnDmF6lqyZInq168vJycneXt7a+TIkdes5+r/ztc7X1c+HrBq1Sq1a9dOzs7OCg4O1o4dO8w+//3vf9W1a1eVL19eLi4uql+/vtavX1+i8woAKBqhGwCAO0ipUqU0bdo0vf322/r555//0lhff/21fvnlF23dulWzZs3SxIkT1aVLF5UvX167du3SsGHDNHTo0EL7GTt2rMaMGaN9+/YpNDRUXbt21ZkzZyRJ586d04MPPqjGjRtrz5492rBhg06dOqVevXpZjbF06VI5OjoqMTFRCxcuLLK+OXPmaObMmZoxY4YOHDigsLAwPfLII0pJSZEkpaenq379+hozZozS09MVHR1d4mNfunSpXFxctGvXLr3xxhuaMmWKvvzyS0nS7t27JUlxcXFKT083l7dt26b+/ftr9OjROnz4sBYtWqT4+Hi9/vrrVmNPmjRJPXr00MGDB/XUU0+poKBA99xzjz766CMdPnxYEyZM0EsvvaSVK1ea2yxYsEAjRozQ008/rYMHD2rt2rWqXbv2Neu50fN1xcsvv6zo6GglJSWpTp066tOnj/nGwYgRI5Sdna2tW7fq4MGDmj59ulxdXUt8XgEARTAAAMAdYcCAAUa3bt0MwzCMFi1aGE899ZRhGIbx6aefGn/+kz5x4kQjODjYatvZs2cbNWrUsBqrRo0aRn5+vrkuMDDQaN26tbmcl5dnuLi4GB988IFhGIZx/PhxQ5IRGxtr9snNzTXuueceY/r06YZhGMbUqVONDh06WO37xIkThiTjyJEjhmEYRps2bYzGjRtf93irVatmvP7661brmjVrZgwfPtxcDg4ONiZOnHjNcf583q7s//777y807rhx48xlScann35q1eehhx4ypk2bZrVu2bJlhre3t9V2UVFR16zHMAxjxIgRxqOPPmouV6tWzXj55ZeL7V9UPVf/d77e+bry32/x4sVm+/fff29IMpKTkw3DMIyGDRsakyZNum79AICSK22/uA8AAG7W9OnT9eCDD97Q7O7V6tevLweH/3/TW9WqVdWgQQNzuVSpUqpYsaJOnz5ttV1oaKj5c+nSpdW0aVMlJydLkvbv36/NmzcXOTt67Ngx1alTR5LUpEmTa9aWkZGhX375Ra1atbJa36pVK+3fv7+ER1i8Ro0aWS17e3sXOs6r7d+/X4mJiVYz2/n5+bp06ZKysrLk7OwsSWratGmhbefNm6clS5YoLS1NFy9eVE5Ojnlr+OnTp/XLL7/ooYceuunjuZHz9edj9/b2NmuoW7euRo0apWeeeUZffPGF2rdvr0cffbTQuQIA3BhuLwcA4A70wAMPKCwsTOPHjy/U5uDgIMMwrNYV9UCvMmXKWC1bLJYi1xUUFJS4rszMTHXt2lVJSUlWr5SUFD3wwANmPxcXlxKPaQs3c5yZmZmaPHmy1XEdPHhQKSkpKlu2rNnv6mNbsWKFoqOjNWjQIH3xxRdKSkrSwIEDzQfIlStX7hYdVcn8+divPPX+yrEPHjxYP/30k/r166eDBw+qadOmevvtt//W+gDgbkPoBgDgDhUbG6v//Oc/Vg/CkqTKlSvr5MmTVsH7Vn639s6dO82f8/LytHfvXgUFBUmSQkJC9P3338vPz0+1a9e2et1I0HZ3d1e1atWUmJhotT4xMVH16tW7NQdyDWXKlFF+fr7VupCQEB05cqTQcdWuXdvqjoGrJSYmqmXLlho+fLgaN26s2rVr69ixY2a7m5ub/Pz8rvn1X0XV82e38nz5+Pho2LBhWrVqlcaMGaN33nnnhrYHAFjj9nIAAO5QDRs2VEREhN566y2r9W3bttWvv/6qN954Q4899pg2bNigzz//XO7u7rdkv/PmzVNAQICCgoI0e/ZsnT17Vk899ZSkyw/ieuedd9SnTx/z6eBHjx7VihUrtHjxYpUqVarE+xk7dqwmTpyoWrVq6d5771VcXJySkpK0fPnyW3Ic13IlBLdq1UpOTk4qX768JkyYoC5dusjX11ePPfaYHBwctH//fh06dEivvfZasWMFBATovffe08aNG+Xv769ly5Zp9+7d8vf3N/tMmjRJw4YNU5UqVdSxY0dduHBBiYmJevbZZ4ut52q34nxFRUWpY8eOqlOnjs6ePavNmzebb6gAAG4OM90AANzBpkyZUui26KCgIM2fP1/z5s1TcHCwvv3227/02e+rxcbGKjY2VsHBwdq+fbvWrl2rSpUqSZI525qfn68OHTqoYcOGioqKkqen5zVng4syatQoPf/88xozZowaNmyoDRs2aO3atQoICLhlx1KcmTNn6ssvv5SPj48aN24sSQoLC9O6dev0xRdfqFmzZmrRooVmz56tGjVqXHOsoUOHqmfPnurdu7eaN2+uM2fOaPjw4VZ9BgwYoDfffFPz589X/fr11aVLF6unjhdVz9VuxfnKz8/XiBEjFBQUpPDwcNWpU0fz588v8fYAgMIsxtUf+gIAAAAAALcEM90AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbITQDQAAAACAjRC6AQAAAACwEUI3AAAAAAA2QugGAAAAAMBGCN0AAAAAANgIoRsAAAAAABshdAMAAAAAYCOEbgAAAAAAbOT/Aa3WJBkOXu3dAAAAAElFTkSuQmCC\n"},"metadata":{}}]},{"cell_type":"code","source":["##Pharmcaology df\n","pharmacology_rows = []\n","\n","for drug in drugs:\n","    drug_id = drug.findtext('db:drugbank-id', namespaces=ns)\n","    drug_name = drug.findtext('db:name', namespaces=ns)\n","\n","    # Pharmacological fields\n","    indication = drug.findtext('db:indication', namespaces=ns)\n","    pharmacodynamics = drug.findtext('db:pharmacodynamics', namespaces=ns)\n","    mechanism = drug.findtext('db:mechanism-of-action', namespaces=ns)\n","    toxicity = drug.findtext('db:toxicity', namespaces=ns)\n","    metabolism = drug.findtext('db:metabolism', namespaces=ns)\n","    absorption = drug.findtext('db:absorption', namespaces=ns)\n","    half_life = drug.findtext('db:half-life', namespaces=ns)\n","    route_of_elimination = drug.findtext('db:route-of-elimination', namespaces=ns)\n","    volume_of_distribution = drug.findtext('db:volume-of-distribution', namespaces=ns)\n","    clearance = drug.findtext('db:clearance', namespaces=ns)\n","\n","    pharmacology_rows.append({\n","        'drugbank_id': drug_id,\n","        'name': drug_name,\n","        'indication': indication,\n","        'pharmacodynamics': pharmacodynamics,\n","        'mechanism_of_action': mechanism,\n","        'toxicity': toxicity,\n","        'metabolism': metabolism,\n","        'absorption': absorption,\n","        'half_life': half_life,\n","        'route_of_elimination': route_of_elimination,\n","        'volume_of_distribution': volume_of_distribution,\n","        'clearance': clearance\n","    })\n","\n","pharmacology_df = pd.DataFrame(pharmacology_rows)\n","pharmacology_df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":431},"id":"-EAFw1bAfznJ","executionInfo":{"status":"ok","timestamp":1750006311668,"user_tz":240,"elapsed":781,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"cbcd5180-0a5c-44eb-f2a9-4c182922e5da"},"execution_count":37,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  drugbank_id                 name  \\\n","0     DB00001            Lepirudin   \n","1     DB00002            Cetuximab   \n","2     DB00003         Dornase alfa   \n","3     DB00004  Denileukin diftitox   \n","4     DB00005           Etanercept   \n","\n","                                          indication  \\\n","0  Lepirudin is indicated for anticoagulation in ...   \n","1  Cetuximab indicated for the treatment of local...   \n","2  Used as adjunct therapy in the treatment of cy...   \n","3  Denileukin diftitox was previously indicated f...   \n","4  Etanercept is indicated for the treatment of m...   \n","\n","                                    pharmacodynamics  \\\n","0  Lepirudin is a recombinant hirudin that acts a...   \n","1  Cetuximab is an anticancer agent that works by...   \n","2  Cystic fibrosis (CF) is a disease characterize...   \n","3  Denileukin diftitox is an anticancer drug with...   \n","4  Etanercept binds specifically to tumor necrosi...   \n","\n","                                 mechanism_of_action  \\\n","0  Lepirudin is a direct thrombin inhibitor used ...   \n","1  The epidermal growth factor receptor (EGFR) is...   \n","2  Dornase alfa is a biosynthetic form of human D...   \n","3  Denileukin diftitox is a fusion protein compos...   \n","4  There are two distinct receptors for TNF (TNFR...   \n","\n","                                            toxicity  \\\n","0  The acute toxicity of intravenous lepirudin wa...   \n","1  The intravenous LD<sub>50</sub> is > 300 mg/kg...   \n","2  Adverse reactions occur at a frequency of < 1/...   \n","3  There is limited information regarding the acu...   \n","4                                                      \n","\n","                                          metabolism  \\\n","0  As a polypeptide, lepirudin is expected to be ...   \n","1  Like other monoclonal antibodies, cetuximab is...   \n","2  While no conclusive studies have yet been publ...   \n","3  Denileukin diftitox is expected to be metaboli...   \n","4  As etanercept is a fusion protein antibody, it...   \n","\n","                                          absorption  \\\n","0  Lepirudin administered as a single intravenous...   \n","1  After administration of a 400 mg/m<sup>2</sup>...   \n","2  Studies in rats and monkeys after inhalation o...   \n","3  Following a single dose of denileukin diftitox...   \n","4  Population pharmacokinetic modeling in adults ...   \n","\n","                                           half_life  \\\n","0  Lepirudin has an initial half-life of approxim...   \n","1  After administration of a 400 mg/m<sup>2</sup>...   \n","2                                                      \n","3  The arithmetic mean (CV%) denileukin diftitox ...   \n","4  Etanercept has a mean half-life of elimination...   \n","\n","                                route_of_elimination  \\\n","0  Lepirudin is mostly excreted through urine (48...   \n","1            There is limited information available.   \n","2                                                      \n","3                                                      \n","4                                                      \n","\n","                              volume_of_distribution  \\\n","0  The volume of distribution of lepirudin at ste...   \n","1  The volume of the distribution is about 2-3 L/...   \n","2  In studies in rats and monkeys, the initial vo...   \n","3  The geometric mean (CV%) volume of distributio...   \n","4  Population pharmacokinetic modeling predicts a...   \n","\n","                                           clearance  \n","0  The clearance of lepirudin is proportional to ...  \n","1  In patients with recurrent and/or metastatic s...  \n","2  Studies in rats indicate that, following aeros...  \n","3  The geometric mean (CV%) clearance is 36.5 mL/...  \n","4  Etanercept has a mean apparent clearance of 16...  "],"text/html":["\n","  <div id=\"df-b5b6daf6-32a7-4d44-ac5c-7c4bcdf6e143\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>drugbank_id</th>\n","      <th>name</th>\n","      <th>indication</th>\n","      <th>pharmacodynamics</th>\n","      <th>mechanism_of_action</th>\n","      <th>toxicity</th>\n","      <th>metabolism</th>\n","      <th>absorption</th>\n","      <th>half_life</th>\n","      <th>route_of_elimination</th>\n","      <th>volume_of_distribution</th>\n","      <th>clearance</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>Lepirudin is indicated for anticoagulation in ...</td>\n","      <td>Lepirudin is a recombinant hirudin that acts a...</td>\n","      <td>Lepirudin is a direct thrombin inhibitor used ...</td>\n","      <td>The acute toxicity of intravenous lepirudin wa...</td>\n","      <td>As a polypeptide, lepirudin is expected to be ...</td>\n","      <td>Lepirudin administered as a single intravenous...</td>\n","      <td>Lepirudin has an initial half-life of approxim...</td>\n","      <td>Lepirudin is mostly excreted through urine (48...</td>\n","      <td>The volume of distribution of lepirudin at ste...</td>\n","      <td>The clearance of lepirudin is proportional to ...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>Cetuximab indicated for the treatment of local...</td>\n","      <td>Cetuximab is an anticancer agent that works by...</td>\n","      <td>The epidermal growth factor receptor (EGFR) is...</td>\n","      <td>The intravenous LD&lt;sub&gt;50&lt;/sub&gt; is &gt; 300 mg/kg...</td>\n","      <td>Like other monoclonal antibodies, cetuximab is...</td>\n","      <td>After administration of a 400 mg/m&lt;sup&gt;2&lt;/sup&gt;...</td>\n","      <td>After administration of a 400 mg/m&lt;sup&gt;2&lt;/sup&gt;...</td>\n","      <td>There is limited information available.</td>\n","      <td>The volume of the distribution is about 2-3 L/...</td>\n","      <td>In patients with recurrent and/or metastatic s...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00003</td>\n","      <td>Dornase alfa</td>\n","      <td>Used as adjunct therapy in the treatment of cy...</td>\n","      <td>Cystic fibrosis (CF) is a disease characterize...</td>\n","      <td>Dornase alfa is a biosynthetic form of human D...</td>\n","      <td>Adverse reactions occur at a frequency of &lt; 1/...</td>\n","      <td>While no conclusive studies have yet been publ...</td>\n","      <td>Studies in rats and monkeys after inhalation o...</td>\n","      <td></td>\n","      <td></td>\n","      <td>In studies in rats and monkeys, the initial vo...</td>\n","      <td>Studies in rats indicate that, following aeros...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00004</td>\n","      <td>Denileukin diftitox</td>\n","      <td>Denileukin diftitox was previously indicated f...</td>\n","      <td>Denileukin diftitox is an anticancer drug with...</td>\n","      <td>Denileukin diftitox is a fusion protein compos...</td>\n","      <td>There is limited information regarding the acu...</td>\n","      <td>Denileukin diftitox is expected to be metaboli...</td>\n","      <td>Following a single dose of denileukin diftitox...</td>\n","      <td>The arithmetic mean (CV%) denileukin diftitox ...</td>\n","      <td></td>\n","      <td>The geometric mean (CV%) volume of distributio...</td>\n","      <td>The geometric mean (CV%) clearance is 36.5 mL/...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00005</td>\n","      <td>Etanercept</td>\n","      <td>Etanercept is indicated for the treatment of m...</td>\n","      <td>Etanercept binds specifically to tumor necrosi...</td>\n","      <td>There are two distinct receptors for TNF (TNFR...</td>\n","      <td></td>\n","      <td>As etanercept is a fusion protein antibody, it...</td>\n","      <td>Population pharmacokinetic modeling in adults ...</td>\n","      <td>Etanercept has a mean half-life of elimination...</td>\n","      <td></td>\n","      <td>Population pharmacokinetic modeling predicts a...</td>\n","      <td>Etanercept has a mean apparent clearance of 16...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-b5b6daf6-32a7-4d44-ac5c-7c4bcdf6e143')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-b5b6daf6-32a7-4d44-ac5c-7c4bcdf6e143 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-b5b6daf6-32a7-4d44-ac5c-7c4bcdf6e143');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-5e815483-0c58-4bb9-88df-590100472cb6\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-5e815483-0c58-4bb9-88df-590100472cb6')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-5e815483-0c58-4bb9-88df-590100472cb6 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"pharmacology_df","summary":"{\n  \"name\": \"pharmacology_df\",\n  \"rows\": 17430,\n  \"fields\": [\n    {\n      \"column\": \"drugbank_id\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"DB05423\",\n          \"DB00020\",\n          \"DB08484\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"ORG-34517\",\n          \"Sargramostim\",\n          \"4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"indication\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3813,\n        \"samples\": [\n          \"Inebilizumab is indicated for the treatment of aquaporin-4 (AQP4) immunoglobulin-positive (AQP4-IgG) neuromyelitis optica spectrum disorder (NMOSD) in adult patients.[L14315]\",\n          \"Indicated for the symptomatic relief of digestive disturbances, such as feelings of fullness, slow digestion and flatulence [F114]. \",\n          \"For the topical treatment of recurrent oral-facial herpes simplex episodes (cold sores or fever blisters).\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"pharmacodynamics\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 3127,\n        \"samples\": [\n          \"Levomethadyl acetate (also known as LAAM) is a synthetic synthetic opioid analgesic with multiple actions quantitatively similar to those as morphine, the most prominent of which involve the central nervous system and organs composed of smooth muscle. However, levomethadyl acetate is more active and more toxic than morphine. The principal actions of therapeutic value are analgesia and sedation and detoxification or temporary maintenance in narcotic addiction. In this respect, the drug is similar to Methadone and also has structural similarities to it. The levomethadyl acetate abstinence syndrome, although qualitatively similar to that of morphine, differs in that the onset is slower, the course is more prolonged, and the symptoms are less severe.\",\n          \"Kanamycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.\",\n          \"Data for the pharmacodynamics of butyrfentanyl are not readily available.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"mechanism_of_action\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 4065,\n        \"samples\": [\n          \"TRC093 (MT293) is a recombinant humanized IgG1 monoclonal antibody that inhibits angiogenesis, tumor cell growth and metastasis by binding cleaved collagen, which is predominantly produced in the extracellular matrix of tumors. TRC093 targets collagen found in the basement membrane of tumor blood vessels. Collagen is a essential triple helix of polypeptide chains found in the extracellular matrix which is involved with many cellular processs including cell proliferation, adhesion, migration, and angiogenesis (neovascularization - growth of new blood vessels). Matrix metalloproteinase enzymes (MMPs) remodel and denature collagen during angiogenesis, causing changes in bioactive sites which results in altered proliferation, adhesion and migration of cells. TRC093 specifically binds to mice breast cancer blood vessel tumors, inhibiting tumor growth. It is proposed that TRC093 binds to hydroxyproline residues of GPO sequences (the major platelet-activating motif within collagen and essential for collagen folding) when they are exposed by thermal denaturation or partially proteolytically degraded by MMPs. TRC093 may target many different types of cancer as  a critical component of the TRC093 epitope is a GPOG sequence which are present in high numbers in many different types of collagen. \",\n          \"Respiratory tract infections can be caused by numerous strains of bacteria, requiring careful consideration of treatment and antibiotics effective against a broad spectrum of potential pathogens. Cethromycin, like other macrolide antibiotics, binds to the 23S rRNA of the 50S subunit of the bacterial ribosome. This binding, primarily mediated through regions II and V of the rRNA, occludes the peptide exit tunnel and inhibits bacterial protein synthesis. In addition, cethromycin is capable of binding to ribosomal intermediates during ribosome biogenesis, inhibiting the formation of functional 70S bacterial ribosomes. Due to the sequence and structural similarity of ribosomes between species, cethromycin displays broad-spectrum activity against diverse Gram-positive, Gram-negative, and atypical bacteria.[A203369, A203417, A203417]\",\n          \"Induces peripheral immune activation through the activity of regulatory T-cells that surpress inappropriate Th2 cytokeine activity. \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"toxicity\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2493,\n        \"samples\": [\n          \"Readily available information regarding the pharmacokinetics of isopropyl myristate is not available [L1978, T151].\",\n          \"Reported incidences of agranulocytosis, hyperkalemia, and anaphylaxis. The use of nafamostat has been reported to cause cardiac arrest in patients receiving dialysis due to a sudden change in the patient's condition such as dyspnea. A study suggests that the drug and its metabolites may inhibit the amiloride-sensitive sodium (Na) conductance at the collecting ducts, resulting in an inhibition of K secretion and hyperkalemia [A19240]. Reported LD50 value from intravenous administration in rats is 16.4mg/kg.\",\n          \"Patients experiencing an overdose may present with shock, cyanosis, and coma.[A204053] Treat patients with symptomatic and supportive measures which may include administration of fluids, exchange transfusions, and administration of dopamine.[A204053]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"metabolism\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2207,\n        \"samples\": [\n          \"Samidorphan is primarily metabolized by CYP3A4, with minor contributions from CYP3A5, CYP2C19, and CYP2C8.[L34359] The main metabolism products are RDC-9986 (an N-dealkylated metabolite) and RDC-1066 (an N-oxide metabolite); although both metabolites have a nanomolar affinity for the \\u03bc-, \\u03ba-, and \\u03b4-opioid receptors, neither is thought to contribute to the pharmacological effects of samidorphan.[L34359, L34378]\",\n          \"Once aluminum has entered the body, the mechanism by which it is metabolized is still not fully known [F23]. Conversely, magnesium balance in the body is predominantly managed via a balance between intestinal absorption, exchange with bone, and renal excretion [A32840].\",\n          \"The two main metabolites of bempedoic metabolism are ETC-1002-CoA[A191907] and ESP15228. Bempedoic acid is primarily eliminated via the metabolism of its acyl glucuronide. This drug is reversibly converted to an active metabolite (ESP15228) based on observations during in vitro studies. Both compounds resulting from the metabolism of bempedoic acid are metabolized to become inactive glucuronide conjugates by the enzyme UGT2B7.[L12144]\\r\\n \\r\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"absorption\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2398,\n        \"samples\": [\n          \"Rapid via the digestive tract.\",\n          \"The pharmacokinetic profile of atomoxetine is highly dependent on cytochrome P450 2D6 genetic polymorphisms of the individual.[A175669] A large fraction of the population (up to 10% of Caucasians and 2% of people of African descent and 1% of Asians) are poor metabolizers (PMs) of CYP2D6 metabolized drugs. These individuals have reduced activity in this pathway resulting in 10-fold higher AUCs, 5-fold higher peak plasma concentrations, and slower elimination (plasma half-life of 21.6 hours) of atomoxetine compared with people with normal CYP2D6 activity.\\r\\n\\r\\nAtomoxetine is rapidly absorbed after oral administration, with absolute bioavailability of about 63% in extensive metabolizers (EMs) and 94% in poor metabolizers (PMs). Mean maximal plasma concentrations (Cmax) are reached approximately 1 to 2 hours after dosing with a maximal concentration of 350 ng/ml with an AUC of 2 mcg.h/ml.[A175669]\\r\\n\",\n          \"Immediately following intravascular injection, iopromide reaches peak plasma concentrations and is then rapidly distributed throughout the extracellular fluid compartment. It displays little tendency to bind to serum or plasma proteins.[L46911] Iodinated contrast agents cross a disrupted blood-brain barrier.[L46906]\\r\\n\\r\\n\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"half_life\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2278,\n        \"samples\": [\n          \"2.4 to 4.8 hours.\",\n          \"The half life of testosterone is highly variable, ranging from 10-100 minutes.[L8983,L8935,L8938,L8986,L8989,L8992,L8995]\",\n          \"~6 days\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"route_of_elimination\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1996,\n        \"samples\": [\n          \"Ecallantide undergoes renal elimination [FDA Label].\",\n          \"Following ester cleavage, the nicotinic acid metabolite is expected to enter the endogenous metabolic pool as a part of the vitamin B complex [F12]. The 2-butoxyethanol metabolite is believed to be mainly excreted primarily in the urine and to a certain extent, in exhaled air [F12]. In humans, the urinary elimination of 2-butoxyethanol's metabolite, 2-butoxyacetic acid was also reported [F12].\",\n          \"Studies of distribution, metabolism, and excretion in cats and dogs indicate that rocuronium is eliminated primarily by the liver.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"volume_of_distribution\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1720,\n        \"samples\": [\n          \"* 0.21 L/kg [adult subjects]\\r\\n* 0.5 L/kg [fasting pediatric patients]\",\n          \"The volume of distribution of segesterone acetate is 19.6 L/kg [FDA Label].\",\n          \"* 0.3 to 0.7 L/kg\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"clearance\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1594,\n        \"samples\": [\n          \"During the first 24 hours of technetium Tc-99m oxidronate administration, it is observed a rapid clearance from blood and non-osseous tissues. The dosage gets accumulated in skeleton and urine.[L1142]\",\n          \"Not possible to calculate clearance rate based on plasma concentrations of lifitegrast, but reported to be relatively fast in rat I.V. pharmacokinetics study [A19223]. It is predicted that lifitegrast is cleared via nasal and subsequently gastrointestinal tract [L769].\",\n          \"Tazemetostat has an apparent total clearance of 274L/h.[L11476]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":37}]},{"cell_type":"code","source":["pharmacology_df.to_csv('pharmacology.csv')"],"metadata":{"id":"xux4j2S2gU8N","executionInfo":{"status":"ok","timestamp":1750006347439,"user_tz":240,"elapsed":227,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":38,"outputs":[]},{"cell_type":"code","source":["##Making basic drug table\n","\n","drug_rows = []\n","\n","for drug in drugs:\n","    drug_rows.append({\n","        'drugbank_id': drug.findtext('db:drugbank-id', namespaces=ns),\n","        'name': drug.findtext('db:name', namespaces=ns),\n","        'type': drug.attrib.get('type'),\n","        'created': drug.attrib.get('created'),\n","        'updated': drug.attrib.get('updated'),\n","        'description': drug.findtext('db:description', namespaces=ns),\n","    })\n","\n","drugs_df = pd.DataFrame(drug_rows)\n","\n","drugs_df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"NNvLfK-bcwjj","executionInfo":{"status":"ok","timestamp":1750006770323,"user_tz":240,"elapsed":299,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"6bbf498b-7949-4237-e58d-690be7f899fd"},"execution_count":40,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  drugbank_id                 name     type     created     updated  \\\n","0     DB00001            Lepirudin  biotech  2005-06-13  2024-11-03   \n","1     DB00002            Cetuximab  biotech  2005-06-13  2025-01-02   \n","2     DB00003         Dornase alfa  biotech  2005-06-13  2024-12-14   \n","3     DB00004  Denileukin diftitox  biotech  2005-06-13  2025-01-02   \n","4     DB00005           Etanercept  biotech  2005-06-13  2024-12-03   \n","\n","                                         description  \n","0  Lepirudin is a recombinant hirudin formed by 6...  \n","1  Cetuximab is a recombinant chimeric human/mous...  \n","2  Dornase alfa is a biosynthetic form of human d...  \n","3  Denileukin diftitox is an IL2-receptor-directe...  \n","4  Dimeric fusion protein consisting of the extra...  "],"text/html":["\n","  <div id=\"df-fe312309-dc80-4ecf-a856-50c5cbc43b1c\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>drugbank_id</th>\n","      <th>name</th>\n","      <th>type</th>\n","      <th>created</th>\n","      <th>updated</th>\n","      <th>description</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2024-11-03</td>\n","      <td>Lepirudin is a recombinant hirudin formed by 6...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2025-01-02</td>\n","      <td>Cetuximab is a recombinant chimeric human/mous...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00003</td>\n","      <td>Dornase alfa</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2024-12-14</td>\n","      <td>Dornase alfa is a biosynthetic form of human d...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00004</td>\n","      <td>Denileukin diftitox</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2025-01-02</td>\n","      <td>Denileukin diftitox is an IL2-receptor-directe...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00005</td>\n","      <td>Etanercept</td>\n","      <td>biotech</td>\n","      <td>2005-06-13</td>\n","      <td>2024-12-03</td>\n","      <td>Dimeric fusion protein consisting of the extra...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-fe312309-dc80-4ecf-a856-50c5cbc43b1c')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-fe312309-dc80-4ecf-a856-50c5cbc43b1c button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-fe312309-dc80-4ecf-a856-50c5cbc43b1c');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-dce0252e-1da4-436d-89e6-80aa1ca7e904\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-dce0252e-1da4-436d-89e6-80aa1ca7e904')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-dce0252e-1da4-436d-89e6-80aa1ca7e904 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"drugs_df","summary":"{\n  \"name\": \"drugs_df\",\n  \"rows\": 17430,\n  \"fields\": [\n    {\n      \"column\": \"drugbank_id\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"DB05423\",\n          \"DB00020\",\n          \"DB08484\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 17430,\n        \"samples\": [\n          \"ORG-34517\",\n          \"Sargramostim\",\n          \"4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"type\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"small molecule\",\n          \"biotech\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"created\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"num_unique_values\": 988,\n        \"samples\": [\n          \"2015-10-16\",\n          \"2017-11-27\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"updated\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"num_unique_values\": 501,\n        \"samples\": [\n          \"2024-02-15\",\n          \"2022-02-18\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"description\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 9776,\n        \"samples\": [\n          \"A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.\",\n          \"Sibofimloc is under investigation in clinical trial NCT03943446 (TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)).\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":40}]},{"cell_type":"code","source":["drugs_df.to_csv('basic_drug.csv')"],"metadata":{"id":"wi1JPgTxh7r6","executionInfo":{"status":"ok","timestamp":1750006773770,"user_tz":240,"elapsed":125,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":41,"outputs":[]},{"cell_type":"code","source":["target_rows = []\n","\n","for drug in drugs:\n","    drug_id = drug.findtext('db:drugbank-id', namespaces=ns)\n","    drug_name = drug.findtext('db:name', namespaces=ns)\n","    targets = drug.findall('db:targets/db:target', namespaces=ns)\n","\n","    for t in targets:\n","        polypep = t.find('db:polypeptide', namespaces=ns)\n","        if polypep is not None:\n","            target_rows.append({\n","                'drugbank_id': drug_id,\n","                'drug_name': drug_name,\n","                'target_name': polypep.findtext('db:name', namespaces=ns),\n","                'gene_name': polypep.findtext('db:gene-name', namespaces=ns),\n","                'uniprot_id': polypep.attrib.get('id'),  # This one is still in attribute\n","                'organism': polypep.findtext('db:organism', namespaces=ns)\n","            })\n","\n","targets_df = pd.DataFrame(target_rows)\n","targets_df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"1q0vJMD8dSG2","executionInfo":{"status":"ok","timestamp":1750007198388,"user_tz":240,"elapsed":495,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"5e2d8a3f-2592-4ebd-f5ca-a4968f38cb18"},"execution_count":45,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  drugbank_id  drug_name                                        target_name  \\\n","0     DB00001  Lepirudin                                        Prothrombin   \n","1     DB00002  Cetuximab                   Epidermal growth factor receptor   \n","2     DB00002  Cetuximab  Low affinity immunoglobulin gamma Fc region re...   \n","3     DB00002  Cetuximab              Complement C1q subcomponent subunit A   \n","4     DB00002  Cetuximab              Complement C1q subcomponent subunit B   \n","\n","  gene_name uniprot_id organism  \n","0        F2     P00734   Humans  \n","1      EGFR     P00533   Humans  \n","2    FCGR3B     O75015   Humans  \n","3      C1QA     P02745   Humans  \n","4      C1QB     P02746   Humans  "],"text/html":["\n","  <div id=\"df-8d250506-cf93-4e97-a38a-3cac22f51166\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>drugbank_id</th>\n","      <th>drug_name</th>\n","      <th>target_name</th>\n","      <th>gene_name</th>\n","      <th>uniprot_id</th>\n","      <th>organism</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00001</td>\n","      <td>Lepirudin</td>\n","      <td>Prothrombin</td>\n","      <td>F2</td>\n","      <td>P00734</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>Epidermal growth factor receptor</td>\n","      <td>EGFR</td>\n","      <td>P00533</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>Low affinity immunoglobulin gamma Fc region re...</td>\n","      <td>FCGR3B</td>\n","      <td>O75015</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>Complement C1q subcomponent subunit A</td>\n","      <td>C1QA</td>\n","      <td>P02745</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00002</td>\n","      <td>Cetuximab</td>\n","      <td>Complement C1q subcomponent subunit B</td>\n","      <td>C1QB</td>\n","      <td>P02746</td>\n","      <td>Humans</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-8d250506-cf93-4e97-a38a-3cac22f51166')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-8d250506-cf93-4e97-a38a-3cac22f51166 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-8d250506-cf93-4e97-a38a-3cac22f51166');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-973f8b08-4f39-49be-993f-715dcd6a0863\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-973f8b08-4f39-49be-993f-715dcd6a0863')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-973f8b08-4f39-49be-993f-715dcd6a0863 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"targets_df","summary":"{\n  \"name\": \"targets_df\",\n  \"rows\": 22820,\n  \"fields\": [\n    {\n      \"column\": \"drugbank_id\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 9241,\n        \"samples\": [\n          \"DB06151\",\n          \"DB12713\",\n          \"DB04870\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"drug_name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 9241,\n        \"samples\": [\n          \"Acetylcysteine\",\n          \"Sotagliflozin\",\n          \"Oleoyl-estrone\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"target_name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 4404,\n        \"samples\": [\n          \"Eukaryotic peptide chain release factor GTP-binding subunit ERF3A\",\n          \"Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform\",\n          \"Glutathione S-transferase\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"gene_name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 4187,\n        \"samples\": [\n          \"KCNMA1\",\n          \"BAX\",\n          \"PLA2G2E\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"uniprot_id\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 4917,\n        \"samples\": [\n          \"Q9H228\",\n          \"O75530\",\n          \"P67870\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"organism\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 544,\n        \"samples\": [\n          \"Methylococcus capsulatus (strain ATCC 33009 / NCIMB 11132 / Bath)\",\n          \"RSV-SRA\",\n          \"Vibrio sp. PA-44\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":45}]},{"cell_type":"code","source":["targets_df.to_csv('targets.csv')"],"metadata":{"id":"SS7lqZ0pjuFJ","executionInfo":{"status":"ok","timestamp":1750007219518,"user_tz":240,"elapsed":99,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":47,"outputs":[]},{"cell_type":"code","source":["enzyme_rows = []\n","\n","for drug in drugs:\n","    drug_id = drug.findtext('db:drugbank-id', namespaces=ns)\n","    drug_name = drug.findtext('db:name', namespaces=ns)\n","    enzymes = drug.findall('db:enzymes/db:enzyme', namespaces=ns)\n","\n","    for enz in enzymes:\n","        polypep = enz.find('db:polypeptide', namespaces=ns)\n","        if polypep is not None:\n","            enzyme_rows.append({\n","                'drugbank_id': drug_id,\n","                'drug_name': drug_name,\n","                'enzyme_name': polypep.findtext('db:name', namespaces=ns),\n","                'gene_name': polypep.findtext('db:gene-name', namespaces=ns),\n","                'uniprot_id': polypep.attrib.get('id'),  # Still an attribute\n","                'organism': polypep.findtext('db:organism', namespaces=ns)\n","            })\n","\n","enzymes_df = pd.DataFrame(enzyme_rows)\n","enzymes_df.head()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":206},"id":"gURGYyNPdbO0","executionInfo":{"status":"ok","timestamp":1750007284858,"user_tz":240,"elapsed":383,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"7eec8c4d-7080-4db3-9fac-352191d79245"},"execution_count":50,"outputs":[{"output_type":"execute_result","data":{"text/plain":["  drugbank_id              drug_name                 enzyme_name gene_name  \\\n","0     DB00006            Bivalirudin             Myeloperoxidase       MPO   \n","1     DB00008  Peginterferon alfa-2a         Cytochrome P450 1A2    CYP1A2   \n","2     DB00011     Interferon alfa-n1         Cytochrome P450 1A2    CYP1A2   \n","3     DB00013              Urokinase  Macrophage metalloelastase     MMP12   \n","4     DB00018     Interferon alfa-n3         Cytochrome P450 1A2    CYP1A2   \n","\n","  uniprot_id organism  \n","0     P05164   Humans  \n","1     P05177   Humans  \n","2     P05177   Humans  \n","3     P39900   Humans  \n","4     P05177   Humans  "],"text/html":["\n","  <div id=\"df-07d67520-f855-4a61-98f8-3dc3dabf32ee\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>drugbank_id</th>\n","      <th>drug_name</th>\n","      <th>enzyme_name</th>\n","      <th>gene_name</th>\n","      <th>uniprot_id</th>\n","      <th>organism</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>DB00006</td>\n","      <td>Bivalirudin</td>\n","      <td>Myeloperoxidase</td>\n","      <td>MPO</td>\n","      <td>P05164</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>DB00008</td>\n","      <td>Peginterferon alfa-2a</td>\n","      <td>Cytochrome P450 1A2</td>\n","      <td>CYP1A2</td>\n","      <td>P05177</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>DB00011</td>\n","      <td>Interferon alfa-n1</td>\n","      <td>Cytochrome P450 1A2</td>\n","      <td>CYP1A2</td>\n","      <td>P05177</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>DB00013</td>\n","      <td>Urokinase</td>\n","      <td>Macrophage metalloelastase</td>\n","      <td>MMP12</td>\n","      <td>P39900</td>\n","      <td>Humans</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>DB00018</td>\n","      <td>Interferon alfa-n3</td>\n","      <td>Cytochrome P450 1A2</td>\n","      <td>CYP1A2</td>\n","      <td>P05177</td>\n","      <td>Humans</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-07d67520-f855-4a61-98f8-3dc3dabf32ee')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-07d67520-f855-4a61-98f8-3dc3dabf32ee button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-07d67520-f855-4a61-98f8-3dc3dabf32ee');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-292ca90b-2ff2-4ffd-b65f-ac7eee4985ad\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-292ca90b-2ff2-4ffd-b65f-ac7eee4985ad')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-292ca90b-2ff2-4ffd-b65f-ac7eee4985ad button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"enzymes_df","summary":"{\n  \"name\": \"enzymes_df\",\n  \"rows\": 5927,\n  \"fields\": [\n    {\n      \"column\": \"drugbank_id\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1833,\n        \"samples\": [\n          \"DB05154\",\n          \"DB11942\",\n          \"DB01204\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"drug_name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1833,\n        \"samples\": [\n          \"Pretomanid\",\n          \"Selinexor\",\n          \"Mitoxantrone\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"enzyme_name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 448,\n        \"samples\": [\n          \"Histamine N-methyltransferase\",\n          \"Carbonic anhydrase 1\",\n          \"Glutathione S-transferase omega-1\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"gene_name\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 446,\n        \"samples\": [\n          \"CYP51A1\",\n          \"GPX1\",\n          \"GSTO1\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"uniprot_id\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 457,\n        \"samples\": [\n          \"P14060\",\n          \"O94925\",\n          \"O75173\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"organism\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 34,\n        \"samples\": [\n          \"Bacillus cereus\",\n          \"Klebsiella pneumoniae\",\n          \"Streptococcus mutans\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":50}]},{"cell_type":"code","source":["enzymes_df.to_csv('enzymes.csv')"],"metadata":{"id":"D9f-oSrSkCPk","executionInfo":{"status":"ok","timestamp":1750007298233,"user_tz":240,"elapsed":25,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}}},"execution_count":52,"outputs":[]},{"cell_type":"markdown","source":["# **Import Kaggle dataset**"],"metadata":{"id":"prFVxGRQeC4q"}},{"cell_type":"code","execution_count":null,"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"hRwU_mqFd95Y","executionInfo":{"status":"ok","timestamp":1748789748689,"user_tz":240,"elapsed":3298,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"2fda1d6a-3d74-4429-abd3-d63f770d4977"},"outputs":[{"output_type":"stream","name":"stdout","text":["Downloading from https://www.kaggle.com/api/v1/datasets/download/mghobashy/drug-drug-interactions?dataset_version_number=1...\n"]},{"output_type":"stream","name":"stderr","text":["100%|██████████| 1.83M/1.83M [00:00<00:00, 82.3MB/s]"]},{"output_type":"stream","name":"stdout","text":["Extracting files...\n","Path to dataset files: /root/.cache/kagglehub/datasets/mghobashy/drug-drug-interactions/versions/1\n"]},{"output_type":"stream","name":"stderr","text":["\n"]},{"output_type":"stream","name":"stdout","text":["                Drug 1       Drug 2  \\\n","0           Trioxsalen  Verteporfin   \n","1  Aminolevulinic acid  Verteporfin   \n","2     Titanium dioxide  Verteporfin   \n","3     Tiaprofenic acid  Verteporfin   \n","4          Cyamemazine  Verteporfin   \n","\n","                             Interaction Description  \n","0  Trioxsalen may increase the photosensitizing a...  \n","1  Aminolevulinic acid may increase the photosens...  \n","2  Titanium dioxide may increase the photosensiti...  \n","3  Tiaprofenic acid may increase the photosensiti...  \n","4  Cyamemazine may increase the photosensitizing ...  \n"]}],"source":["##Path for kaggle dataset\n","path = kagglehub.dataset_download(\"mghobashy/drug-drug-interactions\")\n","\n","print(\"Path to dataset files:\", path)\n","\n","kaggle_drug = pd.read_csv(os.path.join(path, \"db_drug_interactions.csv\"))\n","\n","print(kaggle_drug.head())"]},{"cell_type":"markdown","source":["# **National Library of Medicine Data**\n","https://dailymed.nlm.nih.gov/dailymed/spl-resources-all-mapping-files.cfm"],"metadata":{"id":"HjEdxfl3eXHv"}},{"cell_type":"code","source":["##All text files, didnt seem too important, uploaded to the folder in case"],"metadata":{"id":"mgmGFoRceV12"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# **FDA Data**"],"metadata":{"id":"q_A4mocAhtDx"}},{"cell_type":"code","source":["json_path = \"/content/drug-drugsfda-0001-of-0001.json\"\n","with open(json_path, 'r') as f:\n","    data = json.load(f)\n","\n","##Has both resutls and meta data\n","results = data[\"results\"]\n","\n","fda = pd.json_normalize(results)\n","\n","fda"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":999},"id":"E4RWY5OBiExI","executionInfo":{"status":"ok","timestamp":1748789752107,"user_tz":240,"elapsed":3401,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"872f20af-8393-4337-eaf7-f5ecefe69e94"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["                                             submissions application_number  \\\n","0      [{'submission_type': 'ORIG', 'submission_numbe...          NDA000159   \n","1      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076175   \n","2      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","3      [{'submission_type': 'ORIG', 'submission_numbe...         ANDA076202   \n","4      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076236   \n","...                                                  ...                ...   \n","28239  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076135   \n","28240  [{'submission_type': 'ORIG', 'submission_numbe...         ANDA076136   \n","28241  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076138   \n","28242  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076159   \n","28243  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076170   \n","\n","          sponsor_name                                           products  \\\n","0                LILLY  [{'product_number': '001', 'reference_drug': '...   \n","1         CHARTWELL RX  [{'product_number': '001', 'reference_drug': '...   \n","2          WATSON LABS  [{'product_number': '003', 'reference_drug': '...   \n","3         GAVIS PHARMS  [{'product_number': '001', 'reference_drug': '...   \n","4                 BARR  [{'product_number': '001', 'reference_drug': '...   \n","...                ...                                                ...   \n","28239  TEVA PHARMS USA  [{'product_number': '003', 'reference_drug': '...   \n","28240             TEVA  [{'product_number': '002', 'reference_drug': '...   \n","28241     NOSTRUM LABS  [{'product_number': '003', 'reference_drug': '...   \n","28242  ENDO OPERATIONS  [{'product_number': '002', 'reference_drug': '...   \n","28243  HERITAGE PHARMA  [{'product_number': '001', 'reference_drug': '...   \n","\n","      openfda.application_number                    openfda.brand_name  \\\n","0                            NaN                                   NaN   \n","1                   [ANDA076175]            [MEFLOQUINE HYDROCHLORIDE]   \n","2                   [ANDA076194]  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","3                            NaN                                   NaN   \n","4                            NaN                                   NaN   \n","...                          ...                                   ...   \n","28239               [ANDA076135]                            [CLARAVIS]   \n","28240                        NaN                                   NaN   \n","28241                        NaN                                   NaN   \n","28242                        NaN                                   NaN   \n","28243                        NaN                                   NaN   \n","\n","                       openfda.generic_name         openfda.manufacturer_name  \\\n","0                                       NaN                               NaN   \n","1                [MEFLOQUINE HYDROCHLORIDE]               [Chartwell RX, LLC]   \n","2      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]            [Actavis Pharma, Inc.]   \n","3                                       NaN                               NaN   \n","4                                       NaN                               NaN   \n","...                                     ...                               ...   \n","28239                        [ISOTRETINOIN]  [Teva Pharmaceuticals USA, Inc.]   \n","28240                                   NaN                               NaN   \n","28241                                   NaN                               NaN   \n","28242                                   NaN                               NaN   \n","28243                                   NaN                               NaN   \n","\n","                                openfda.product_ndc  \\\n","0                                               NaN   \n","1                                       [62135-973]   \n","2                 [0591-0860, 0591-0861, 0591-0862]   \n","3                                               NaN   \n","4                                               NaN   \n","...                                             ...   \n","28239  [0555-1055, 0555-1054, 0555-1056, 0555-1057]   \n","28240                                           NaN   \n","28241                                           NaN   \n","28242                                           NaN   \n","28243                                           NaN   \n","\n","            openfda.product_type  ...  \\\n","0                            NaN  ...   \n","1      [HUMAN PRESCRIPTION DRUG]  ...   \n","2      [HUMAN PRESCRIPTION DRUG]  ...   \n","3                            NaN  ...   \n","4                            NaN  ...   \n","...                          ...  ...   \n","28239  [HUMAN PRESCRIPTION DRUG]  ...   \n","28240                        NaN  ...   \n","28241                        NaN  ...   \n","28242                        NaN  ...   \n","28243                        NaN  ...   \n","\n","                                           openfda.rxcui  \\\n","0                                                    NaN   \n","1                                               [835913]   \n","2                               [197885, 197886, 197887]   \n","3                                                    NaN   \n","4                                                    NaN   \n","...                                                  ...   \n","28239  [197843, 197844, 197845, 403930, 404059, 40406...   \n","28240                                                NaN   \n","28241                                                NaN   \n","28242                                                NaN   \n","28243                                                NaN   \n","\n","                               openfda.spl_id  \\\n","0                                         NaN   \n","1      [2732839a-191a-570f-e063-6294a90a40a4]   \n","2      [ff5e5610-775f-48a9-a410-e8d8b547b958]   \n","3                                         NaN   \n","4                                         NaN   \n","...                                       ...   \n","28239  [a69dde5d-5585-4313-be43-02d11fec4c9f]   \n","28240                                     NaN   \n","28241                                     NaN   \n","28242                                     NaN   \n","28243                                     NaN   \n","\n","                           openfda.spl_set_id  \\\n","0                                         NaN   \n","1      [b884d22b-aae7-4f14-9a04-ae4029a229f0]   \n","2      [ab5e9ae4-e575-4a63-99f3-2bde36bdd508]   \n","3                                         NaN   \n","4                                         NaN   \n","...                                       ...   \n","28239  [a31fd109-d0fd-4ab9-ba98-a3d64333c18d]   \n","28240                                     NaN   \n","28241                                     NaN   \n","28242                                     NaN   \n","28243                                     NaN   \n","\n","                                     openfda.package_ndc  \\\n","0                                                    NaN   \n","1                           [62135-973-25, 62135-973-11]   \n","2      [0591-0860-01, 0591-0860-05, 0591-0861-01, 059...   \n","3                                                    NaN   \n","4                                                    NaN   \n","...                                                  ...   \n","28239  [0555-1054-60, 0555-1054-86, 0555-1054-56, 055...   \n","28240                                                NaN   \n","28241                                                NaN   \n","28242                                                NaN   \n","28243                                                NaN   \n","\n","                   openfda.unii                           openfda.nui  \\\n","0                           NaN                                   NaN   \n","1                  [5Y9L3636O3]                                   NaN   \n","2      [0J48LPH2TH, E7199S1YWR]  [N0000175359, N0000175419, M0471776]   \n","3                           NaN                                   NaN   \n","4                           NaN                                   NaN   \n","...                         ...                                   ...   \n","28239              [EH28UP18IF]               [N0000175607, M0018962]   \n","28240                       NaN                                   NaN   \n","28241                       NaN                                   NaN   \n","28242                       NaN                                   NaN   \n","28243                       NaN                                   NaN   \n","\n","          openfda.pharm_class_pe    openfda.pharm_class_epc  \\\n","0                            NaN                        NaN   \n","1                            NaN                        NaN   \n","2      [Increased Diuresis [PE]]  [Thiazide Diuretic [EPC]]   \n","3                            NaN                        NaN   \n","4                            NaN                        NaN   \n","...                          ...                        ...   \n","28239                        NaN           [Retinoid [EPC]]   \n","28240                        NaN                        NaN   \n","28241                        NaN                        NaN   \n","28242                        NaN                        NaN   \n","28243                        NaN                        NaN   \n","\n","      openfda.pharm_class_cs openfda.pharm_class_moa  \n","0                        NaN                     NaN  \n","1                        NaN                     NaN  \n","2           [Thiazides [CS]]                     NaN  \n","3                        NaN                     NaN  \n","4                        NaN                     NaN  \n","...                      ...                     ...  \n","28239       [Retinoids [CS]]                     NaN  \n","28240                    NaN                     NaN  \n","28241                    NaN                     NaN  \n","28242                    NaN                     NaN  \n","28243                    NaN                     NaN  \n","\n","[28244 rows x 22 columns]"],"text/html":["\n","  <div id=\"df-eec8630a-bf37-43b0-b56b-21e6d7b3313f\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>submissions</th>\n","      <th>application_number</th>\n","      <th>sponsor_name</th>\n","      <th>products</th>\n","      <th>openfda.application_number</th>\n","      <th>openfda.brand_name</th>\n","      <th>openfda.generic_name</th>\n","      <th>openfda.manufacturer_name</th>\n","      <th>openfda.product_ndc</th>\n","      <th>openfda.product_type</th>\n","      <th>...</th>\n","      <th>openfda.rxcui</th>\n","      <th>openfda.spl_id</th>\n","      <th>openfda.spl_set_id</th>\n","      <th>openfda.package_ndc</th>\n","      <th>openfda.unii</th>\n","      <th>openfda.nui</th>\n","      <th>openfda.pharm_class_pe</th>\n","      <th>openfda.pharm_class_epc</th>\n","      <th>openfda.pharm_class_cs</th>\n","      <th>openfda.pharm_class_moa</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>[{'submission_type': 'ORIG', 'submission_numbe...</td>\n","      <td>NDA000159</td>\n","      <td>LILLY</td>\n","      <td>[{'product_number': '001', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076175</td>\n","      <td>CHARTWELL RX</td>\n","      <td>[{'product_number': '001', 'reference_drug': '...</td>\n","      <td>[ANDA076175]</td>\n","      <td>[MEFLOQUINE HYDROCHLORIDE]</td>\n","      <td>[MEFLOQUINE HYDROCHLORIDE]</td>\n","      <td>[Chartwell RX, LLC]</td>\n","      <td>[62135-973]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>...</td>\n","      <td>[835913]</td>\n","      <td>[2732839a-191a-570f-e063-6294a90a40a4]</td>\n","      <td>[b884d22b-aae7-4f14-9a04-ae4029a229f0]</td>\n","      <td>[62135-973-25, 62135-973-11]</td>\n","      <td>[5Y9L3636O3]</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[{'product_number': '003', 'reference_drug': '...</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>...</td>\n","      <td>[197885, 197886, 197887]</td>\n","      <td>[ff5e5610-775f-48a9-a410-e8d8b547b958]</td>\n","      <td>[ab5e9ae4-e575-4a63-99f3-2bde36bdd508]</td>\n","      <td>[0591-0860-01, 0591-0860-05, 0591-0861-01, 059...</td>\n","      <td>[0J48LPH2TH, E7199S1YWR]</td>\n","      <td>[N0000175359, N0000175419, M0471776]</td>\n","      <td>[Increased Diuresis [PE]]</td>\n","      <td>[Thiazide Diuretic [EPC]]</td>\n","      <td>[Thiazides [CS]]</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>[{'submission_type': 'ORIG', 'submission_numbe...</td>\n","      <td>ANDA076202</td>\n","      <td>GAVIS PHARMS</td>\n","      <td>[{'product_number': '001', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076236</td>\n","      <td>BARR</td>\n","      <td>[{'product_number': '001', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>28239</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076135</td>\n","      <td>TEVA PHARMS USA</td>\n","      <td>[{'product_number': '003', 'reference_drug': '...</td>\n","      <td>[ANDA076135]</td>\n","      <td>[CLARAVIS]</td>\n","      <td>[ISOTRETINOIN]</td>\n","      <td>[Teva Pharmaceuticals USA, Inc.]</td>\n","      <td>[0555-1055, 0555-1054, 0555-1056, 0555-1057]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>...</td>\n","      <td>[197843, 197844, 197845, 403930, 404059, 40406...</td>\n","      <td>[a69dde5d-5585-4313-be43-02d11fec4c9f]</td>\n","      <td>[a31fd109-d0fd-4ab9-ba98-a3d64333c18d]</td>\n","      <td>[0555-1054-60, 0555-1054-86, 0555-1054-56, 055...</td>\n","      <td>[EH28UP18IF]</td>\n","      <td>[N0000175607, M0018962]</td>\n","      <td>NaN</td>\n","      <td>[Retinoid [EPC]]</td>\n","      <td>[Retinoids [CS]]</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>28240</th>\n","      <td>[{'submission_type': 'ORIG', 'submission_numbe...</td>\n","      <td>ANDA076136</td>\n","      <td>TEVA</td>\n","      <td>[{'product_number': '002', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>28241</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076138</td>\n","      <td>NOSTRUM LABS</td>\n","      <td>[{'product_number': '003', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>28242</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076159</td>\n","      <td>ENDO OPERATIONS</td>\n","      <td>[{'product_number': '002', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>28243</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076170</td>\n","      <td>HERITAGE PHARMA</td>\n","      <td>[{'product_number': '001', 'reference_drug': '...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>28244 rows × 22 columns</p>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-eec8630a-bf37-43b0-b56b-21e6d7b3313f')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-eec8630a-bf37-43b0-b56b-21e6d7b3313f button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-eec8630a-bf37-43b0-b56b-21e6d7b3313f');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-495b9a8b-5dcd-42c2-b79f-29befb679a3c\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-495b9a8b-5dcd-42c2-b79f-29befb679a3c')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-495b9a8b-5dcd-42c2-b79f-29befb679a3c button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","  <div id=\"id_521173f6-7041-4aea-9913-03c9e58b11ba\">\n","    <style>\n","      .colab-df-generate {\n","        background-color: #E8F0FE;\n","        border: none;\n","        border-radius: 50%;\n","        cursor: pointer;\n","        display: none;\n","        fill: #1967D2;\n","        height: 32px;\n","        padding: 0 0 0 0;\n","        width: 32px;\n","      }\n","\n","      .colab-df-generate:hover {\n","        background-color: #E2EBFA;\n","        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","        fill: #174EA6;\n","      }\n","\n","      [theme=dark] .colab-df-generate {\n","        background-color: #3B4455;\n","        fill: #D2E3FC;\n","      }\n","\n","      [theme=dark] .colab-df-generate:hover {\n","        background-color: #434B5C;\n","        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","        fill: #FFFFFF;\n","      }\n","    </style>\n","    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('fda')\"\n","            title=\"Generate code using this dataframe.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","       width=\"24px\">\n","    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n","  </svg>\n","    </button>\n","    <script>\n","      (() => {\n","      const buttonEl =\n","        document.querySelector('#id_521173f6-7041-4aea-9913-03c9e58b11ba button.colab-df-generate');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      buttonEl.onclick = () => {\n","        google.colab.notebook.generateWithVariable('fda');\n","      }\n","      })();\n","    </script>\n","  </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"fda"}},"metadata":{},"execution_count":4}]},{"cell_type":"code","source":["##exploding products\n","df_exploded = fda.explode(\"products\")\n","\n","products_df = pd.json_normalize(df_exploded[\"products\"])\n","\n","##combine\n","df_combined = pd.concat([df_exploded.drop(columns=[\"products\"]).reset_index(drop=True),\n","                         products_df.reset_index(drop=True)], axis=1)\n","\n","df_combined\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":791},"id":"qIu2fLbykAO2","executionInfo":{"status":"ok","timestamp":1748789753764,"user_tz":240,"elapsed":1649,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"f99fe6fb-e4c7-4ec9-b675-0c971ca83dd1"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["                                             submissions application_number  \\\n","0      [{'submission_type': 'ORIG', 'submission_numbe...          NDA000159   \n","1      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076175   \n","2      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","3      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","4      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","...                                                  ...                ...   \n","49753  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076138   \n","49754  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076138   \n","49755  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076159   \n","49756  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076159   \n","49757  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076170   \n","\n","          sponsor_name openfda.application_number  \\\n","0                LILLY                        NaN   \n","1         CHARTWELL RX               [ANDA076175]   \n","2          WATSON LABS               [ANDA076194]   \n","3          WATSON LABS               [ANDA076194]   \n","4          WATSON LABS               [ANDA076194]   \n","...                ...                        ...   \n","49753     NOSTRUM LABS                        NaN   \n","49754     NOSTRUM LABS                        NaN   \n","49755  ENDO OPERATIONS                        NaN   \n","49756  ENDO OPERATIONS                        NaN   \n","49757  HERITAGE PHARMA                        NaN   \n","\n","                         openfda.brand_name  \\\n","0                                       NaN   \n","1                [MEFLOQUINE HYDROCHLORIDE]   \n","2      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","3      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","4      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","...                                     ...   \n","49753                                   NaN   \n","49754                                   NaN   \n","49755                                   NaN   \n","49756                                   NaN   \n","49757                                   NaN   \n","\n","                       openfda.generic_name openfda.manufacturer_name  \\\n","0                                       NaN                       NaN   \n","1                [MEFLOQUINE HYDROCHLORIDE]       [Chartwell RX, LLC]   \n","2      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]    [Actavis Pharma, Inc.]   \n","3      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]    [Actavis Pharma, Inc.]   \n","4      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]    [Actavis Pharma, Inc.]   \n","...                                     ...                       ...   \n","49753                                   NaN                       NaN   \n","49754                                   NaN                       NaN   \n","49755                                   NaN                       NaN   \n","49756                                   NaN                       NaN   \n","49757                                   NaN                       NaN   \n","\n","                     openfda.product_ndc       openfda.product_type  \\\n","0                                    NaN                        NaN   \n","1                            [62135-973]  [HUMAN PRESCRIPTION DRUG]   \n","2      [0591-0860, 0591-0861, 0591-0862]  [HUMAN PRESCRIPTION DRUG]   \n","3      [0591-0860, 0591-0861, 0591-0862]  [HUMAN PRESCRIPTION DRUG]   \n","4      [0591-0860, 0591-0861, 0591-0862]  [HUMAN PRESCRIPTION DRUG]   \n","...                                  ...                        ...   \n","49753                                NaN                        NaN   \n","49754                                NaN                        NaN   \n","49755                                NaN                        NaN   \n","49756                                NaN                        NaN   \n","49757                                NaN                        NaN   \n","\n","      openfda.route  ... openfda.pharm_class_moa product_number  \\\n","0               NaN  ...                     NaN            001   \n","1            [ORAL]  ...                     NaN            001   \n","2            [ORAL]  ...                     NaN            003   \n","3            [ORAL]  ...                     NaN            001   \n","4            [ORAL]  ...                     NaN            002   \n","...             ...  ...                     ...            ...   \n","49753           NaN  ...                     NaN            001   \n","49754           NaN  ...                     NaN            002   \n","49755           NaN  ...                     NaN            002   \n","49756           NaN  ...                     NaN            001   \n","49757           NaN  ...                     NaN            001   \n","\n","      reference_drug                          brand_name  \\\n","0                 No                       SULFAPYRIDINE   \n","1                 No            MEFLOQUINE HYDROCHLORIDE   \n","2                 No  LISINOPRIL AND HYDROCHLOROTHIAZIDE   \n","3                 No  LISINOPRIL AND HYDROCHLOROTHIAZIDE   \n","4                 No  LISINOPRIL AND HYDROCHLOROTHIAZIDE   \n","...              ...                                 ...   \n","49753             No         CIPROFLOXACIN HYDROCHLORIDE   \n","49754             No         CIPROFLOXACIN HYDROCHLORIDE   \n","49755             No                           GLIPIZIDE   \n","49756             No                           GLIPIZIDE   \n","49757             No                   LITHIUM CARBONATE   \n","\n","                                      active_ingredients reference_standard  \\\n","0       [{'name': 'SULFAPYRIDINE', 'strength': '500MG'}]                 No   \n","1      [{'name': 'MEFLOQUINE HYDROCHLORIDE', 'strengt...                 No   \n","2      [{'name': 'HYDROCHLOROTHIAZIDE', 'strength': '...                 No   \n","3      [{'name': 'HYDROCHLOROTHIAZIDE', 'strength': '...                 No   \n","4      [{'name': 'HYDROCHLOROTHIAZIDE', 'strength': '...                 No   \n","...                                                  ...                ...   \n","49753  [{'name': 'CIPROFLOXACIN HYDROCHLORIDE', 'stre...                 No   \n","49754  [{'name': 'CIPROFLOXACIN HYDROCHLORIDE', 'stre...                 No   \n","49755         [{'name': 'GLIPIZIDE', 'strength': '5MG'}]                 No   \n","49756        [{'name': 'GLIPIZIDE', 'strength': '10MG'}]                 No   \n","49757  [{'name': 'LITHIUM CARBONATE', 'strength': '30...                 No   \n","\n","                    dosage_form route marketing_status te_code  \n","0                        TABLET  ORAL     Discontinued     NaN  \n","1                        TABLET  ORAL     Discontinued     NaN  \n","2                        TABLET  ORAL     Prescription      AB  \n","3                        TABLET  ORAL     Prescription      AB  \n","4                        TABLET  ORAL     Prescription      AB  \n","...                         ...   ...              ...     ...  \n","49753                    TABLET  ORAL     Discontinued     NaN  \n","49754                    TABLET  ORAL     Discontinued     NaN  \n","49755  TABLET, EXTENDED RELEASE  ORAL     Discontinued     NaN  \n","49756  TABLET, EXTENDED RELEASE  ORAL     Discontinued     NaN  \n","49757  TABLET, EXTENDED RELEASE  ORAL     Discontinued     NaN  \n","\n","[49758 rows x 30 columns]"],"text/html":["\n","  <div id=\"df-2fa0c26d-3f7a-4a49-9775-be7ad5a3b137\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>submissions</th>\n","      <th>application_number</th>\n","      <th>sponsor_name</th>\n","      <th>openfda.application_number</th>\n","      <th>openfda.brand_name</th>\n","      <th>openfda.generic_name</th>\n","      <th>openfda.manufacturer_name</th>\n","      <th>openfda.product_ndc</th>\n","      <th>openfda.product_type</th>\n","      <th>openfda.route</th>\n","      <th>...</th>\n","      <th>openfda.pharm_class_moa</th>\n","      <th>product_number</th>\n","      <th>reference_drug</th>\n","      <th>brand_name</th>\n","      <th>active_ingredients</th>\n","      <th>reference_standard</th>\n","      <th>dosage_form</th>\n","      <th>route</th>\n","      <th>marketing_status</th>\n","      <th>te_code</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>[{'submission_type': 'ORIG', 'submission_numbe...</td>\n","      <td>NDA000159</td>\n","      <td>LILLY</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>SULFAPYRIDINE</td>\n","      <td>[{'name': 'SULFAPYRIDINE', 'strength': '500MG'}]</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076175</td>\n","      <td>CHARTWELL RX</td>\n","      <td>[ANDA076175]</td>\n","      <td>[MEFLOQUINE HYDROCHLORIDE]</td>\n","      <td>[MEFLOQUINE HYDROCHLORIDE]</td>\n","      <td>[Chartwell RX, LLC]</td>\n","      <td>[62135-973]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>MEFLOQUINE HYDROCHLORIDE</td>\n","      <td>[{'name': 'MEFLOQUINE HYDROCHLORIDE', 'strengt...</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>003</td>\n","      <td>No</td>\n","      <td>LISINOPRIL AND HYDROCHLOROTHIAZIDE</td>\n","      <td>[{'name': 'HYDROCHLOROTHIAZIDE', 'strength': '...</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Prescription</td>\n","      <td>AB</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>LISINOPRIL AND HYDROCHLOROTHIAZIDE</td>\n","      <td>[{'name': 'HYDROCHLOROTHIAZIDE', 'strength': '...</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Prescription</td>\n","      <td>AB</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>002</td>\n","      <td>No</td>\n","      <td>LISINOPRIL AND HYDROCHLOROTHIAZIDE</td>\n","      <td>[{'name': 'HYDROCHLOROTHIAZIDE', 'strength': '...</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Prescription</td>\n","      <td>AB</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>49753</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076138</td>\n","      <td>NOSTRUM LABS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>CIPROFLOXACIN HYDROCHLORIDE</td>\n","      <td>[{'name': 'CIPROFLOXACIN HYDROCHLORIDE', 'stre...</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>49754</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076138</td>\n","      <td>NOSTRUM LABS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>002</td>\n","      <td>No</td>\n","      <td>CIPROFLOXACIN HYDROCHLORIDE</td>\n","      <td>[{'name': 'CIPROFLOXACIN HYDROCHLORIDE', 'stre...</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>49755</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076159</td>\n","      <td>ENDO OPERATIONS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>002</td>\n","      <td>No</td>\n","      <td>GLIPIZIDE</td>\n","      <td>[{'name': 'GLIPIZIDE', 'strength': '5MG'}]</td>\n","      <td>No</td>\n","      <td>TABLET, EXTENDED RELEASE</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>49756</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076159</td>\n","      <td>ENDO OPERATIONS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>GLIPIZIDE</td>\n","      <td>[{'name': 'GLIPIZIDE', 'strength': '10MG'}]</td>\n","      <td>No</td>\n","      <td>TABLET, EXTENDED RELEASE</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","    <tr>\n","      <th>49757</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076170</td>\n","      <td>HERITAGE PHARMA</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>NaN</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>LITHIUM CARBONATE</td>\n","      <td>[{'name': 'LITHIUM CARBONATE', 'strength': '30...</td>\n","      <td>No</td>\n","      <td>TABLET, EXTENDED RELEASE</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>49758 rows × 30 columns</p>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2fa0c26d-3f7a-4a49-9775-be7ad5a3b137')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-2fa0c26d-3f7a-4a49-9775-be7ad5a3b137 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-2fa0c26d-3f7a-4a49-9775-be7ad5a3b137');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-3a270f08-626a-413d-84d7-872178e68a3e\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-3a270f08-626a-413d-84d7-872178e68a3e')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-3a270f08-626a-413d-84d7-872178e68a3e button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","  <div id=\"id_3bf7c4e5-128a-469a-b230-c4b15e661f09\">\n","    <style>\n","      .colab-df-generate {\n","        background-color: #E8F0FE;\n","        border: none;\n","        border-radius: 50%;\n","        cursor: pointer;\n","        display: none;\n","        fill: #1967D2;\n","        height: 32px;\n","        padding: 0 0 0 0;\n","        width: 32px;\n","      }\n","\n","      .colab-df-generate:hover {\n","        background-color: #E2EBFA;\n","        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","        fill: #174EA6;\n","      }\n","\n","      [theme=dark] .colab-df-generate {\n","        background-color: #3B4455;\n","        fill: #D2E3FC;\n","      }\n","\n","      [theme=dark] .colab-df-generate:hover {\n","        background-color: #434B5C;\n","        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","        fill: #FFFFFF;\n","      }\n","    </style>\n","    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df_combined')\"\n","            title=\"Generate code using this dataframe.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","       width=\"24px\">\n","    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n","  </svg>\n","    </button>\n","    <script>\n","      (() => {\n","      const buttonEl =\n","        document.querySelector('#id_3bf7c4e5-128a-469a-b230-c4b15e661f09 button.colab-df-generate');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      buttonEl.onclick = () => {\n","        google.colab.notebook.generateWithVariable('df_combined');\n","      }\n","      })();\n","    </script>\n","  </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df_combined"}},"metadata":{},"execution_count":5}]},{"cell_type":"code","source":["##Now exploding active ingrediants\n","df_ingredients_exploded = df_combined.explode(\"active_ingredients\")\n","\n","ingredients_df = pd.json_normalize(df_ingredients_exploded[\"active_ingredients\"])\n","\n","##combine\n","df_final_fda = pd.concat([df_ingredients_exploded.drop(columns=[\"active_ingredients\"]).reset_index(drop=True),\n","                      ingredients_df.reset_index(drop=True)], axis=1)\n","\n","##final from fda\n","print(df_final_fda.head())\n","\n","df_final_fda\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":1000},"id":"CzrHUfb3lR0C","executionInfo":{"status":"ok","timestamp":1748789754889,"user_tz":240,"elapsed":1086,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"10702a30-e3b3-442e-d17a-420601a3473b"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["                                         submissions application_number  \\\n","0  [{'submission_type': 'ORIG', 'submission_numbe...          NDA000159   \n","1  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076175   \n","2  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","3  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","4  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","\n","   sponsor_name openfda.application_number  \\\n","0         LILLY                        NaN   \n","1  CHARTWELL RX               [ANDA076175]   \n","2   WATSON LABS               [ANDA076194]   \n","3   WATSON LABS               [ANDA076194]   \n","4   WATSON LABS               [ANDA076194]   \n","\n","                     openfda.brand_name                  openfda.generic_name  \\\n","0                                   NaN                                   NaN   \n","1            [MEFLOQUINE HYDROCHLORIDE]            [MEFLOQUINE HYDROCHLORIDE]   \n","2  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","3  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","4  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]  [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","\n","  openfda.manufacturer_name                openfda.product_ndc  \\\n","0                       NaN                                NaN   \n","1       [Chartwell RX, LLC]                        [62135-973]   \n","2    [Actavis Pharma, Inc.]  [0591-0860, 0591-0861, 0591-0862]   \n","3    [Actavis Pharma, Inc.]  [0591-0860, 0591-0861, 0591-0862]   \n","4    [Actavis Pharma, Inc.]  [0591-0860, 0591-0861, 0591-0862]   \n","\n","        openfda.product_type openfda.route  ... product_number reference_drug  \\\n","0                        NaN           NaN  ...            001             No   \n","1  [HUMAN PRESCRIPTION DRUG]        [ORAL]  ...            001             No   \n","2  [HUMAN PRESCRIPTION DRUG]        [ORAL]  ...            003             No   \n","3  [HUMAN PRESCRIPTION DRUG]        [ORAL]  ...            003             No   \n","4  [HUMAN PRESCRIPTION DRUG]        [ORAL]  ...            001             No   \n","\n","                           brand_name reference_standard dosage_form route  \\\n","0                       SULFAPYRIDINE                 No      TABLET  ORAL   \n","1            MEFLOQUINE HYDROCHLORIDE                 No      TABLET  ORAL   \n","2  LISINOPRIL AND HYDROCHLOROTHIAZIDE                 No      TABLET  ORAL   \n","3  LISINOPRIL AND HYDROCHLOROTHIAZIDE                 No      TABLET  ORAL   \n","4  LISINOPRIL AND HYDROCHLOROTHIAZIDE                 No      TABLET  ORAL   \n","\n","  marketing_status te_code                      name strength  \n","0     Discontinued     NaN             SULFAPYRIDINE    500MG  \n","1     Discontinued     NaN  MEFLOQUINE HYDROCHLORIDE    250MG  \n","2     Prescription      AB       HYDROCHLOROTHIAZIDE   12.5MG  \n","3     Prescription      AB                LISINOPRIL     10MG  \n","4     Prescription      AB       HYDROCHLOROTHIAZIDE   12.5MG  \n","\n","[5 rows x 31 columns]\n"]},{"output_type":"execute_result","data":{"text/plain":["                                             submissions application_number  \\\n","0      [{'submission_type': 'ORIG', 'submission_numbe...          NDA000159   \n","1      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076175   \n","2      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","3      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","4      [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076194   \n","...                                                  ...                ...   \n","58019  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076138   \n","58020  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076138   \n","58021  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076159   \n","58022  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076159   \n","58023  [{'submission_type': 'SUPPL', 'submission_numb...         ANDA076170   \n","\n","          sponsor_name openfda.application_number  \\\n","0                LILLY                        NaN   \n","1         CHARTWELL RX               [ANDA076175]   \n","2          WATSON LABS               [ANDA076194]   \n","3          WATSON LABS               [ANDA076194]   \n","4          WATSON LABS               [ANDA076194]   \n","...                ...                        ...   \n","58019     NOSTRUM LABS                        NaN   \n","58020     NOSTRUM LABS                        NaN   \n","58021  ENDO OPERATIONS                        NaN   \n","58022  ENDO OPERATIONS                        NaN   \n","58023  HERITAGE PHARMA                        NaN   \n","\n","                         openfda.brand_name  \\\n","0                                       NaN   \n","1                [MEFLOQUINE HYDROCHLORIDE]   \n","2      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","3      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","4      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]   \n","...                                     ...   \n","58019                                   NaN   \n","58020                                   NaN   \n","58021                                   NaN   \n","58022                                   NaN   \n","58023                                   NaN   \n","\n","                       openfda.generic_name openfda.manufacturer_name  \\\n","0                                       NaN                       NaN   \n","1                [MEFLOQUINE HYDROCHLORIDE]       [Chartwell RX, LLC]   \n","2      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]    [Actavis Pharma, Inc.]   \n","3      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]    [Actavis Pharma, Inc.]   \n","4      [LISINOPRIL AND HYDROCHLOROTHIAZIDE]    [Actavis Pharma, Inc.]   \n","...                                     ...                       ...   \n","58019                                   NaN                       NaN   \n","58020                                   NaN                       NaN   \n","58021                                   NaN                       NaN   \n","58022                                   NaN                       NaN   \n","58023                                   NaN                       NaN   \n","\n","                     openfda.product_ndc       openfda.product_type  \\\n","0                                    NaN                        NaN   \n","1                            [62135-973]  [HUMAN PRESCRIPTION DRUG]   \n","2      [0591-0860, 0591-0861, 0591-0862]  [HUMAN PRESCRIPTION DRUG]   \n","3      [0591-0860, 0591-0861, 0591-0862]  [HUMAN PRESCRIPTION DRUG]   \n","4      [0591-0860, 0591-0861, 0591-0862]  [HUMAN PRESCRIPTION DRUG]   \n","...                                  ...                        ...   \n","58019                                NaN                        NaN   \n","58020                                NaN                        NaN   \n","58021                                NaN                        NaN   \n","58022                                NaN                        NaN   \n","58023                                NaN                        NaN   \n","\n","      openfda.route  ... product_number reference_drug  \\\n","0               NaN  ...            001             No   \n","1            [ORAL]  ...            001             No   \n","2            [ORAL]  ...            003             No   \n","3            [ORAL]  ...            003             No   \n","4            [ORAL]  ...            001             No   \n","...             ...  ...            ...            ...   \n","58019           NaN  ...            001             No   \n","58020           NaN  ...            002             No   \n","58021           NaN  ...            002             No   \n","58022           NaN  ...            001             No   \n","58023           NaN  ...            001             No   \n","\n","                               brand_name reference_standard  \\\n","0                           SULFAPYRIDINE                 No   \n","1                MEFLOQUINE HYDROCHLORIDE                 No   \n","2      LISINOPRIL AND HYDROCHLOROTHIAZIDE                 No   \n","3      LISINOPRIL AND HYDROCHLOROTHIAZIDE                 No   \n","4      LISINOPRIL AND HYDROCHLOROTHIAZIDE                 No   \n","...                                   ...                ...   \n","58019         CIPROFLOXACIN HYDROCHLORIDE                 No   \n","58020         CIPROFLOXACIN HYDROCHLORIDE                 No   \n","58021                           GLIPIZIDE                 No   \n","58022                           GLIPIZIDE                 No   \n","58023                   LITHIUM CARBONATE                 No   \n","\n","                    dosage_form route marketing_status te_code  \\\n","0                        TABLET  ORAL     Discontinued     NaN   \n","1                        TABLET  ORAL     Discontinued     NaN   \n","2                        TABLET  ORAL     Prescription      AB   \n","3                        TABLET  ORAL     Prescription      AB   \n","4                        TABLET  ORAL     Prescription      AB   \n","...                         ...   ...              ...     ...   \n","58019                    TABLET  ORAL     Discontinued     NaN   \n","58020                    TABLET  ORAL     Discontinued     NaN   \n","58021  TABLET, EXTENDED RELEASE  ORAL     Discontinued     NaN   \n","58022  TABLET, EXTENDED RELEASE  ORAL     Discontinued     NaN   \n","58023  TABLET, EXTENDED RELEASE  ORAL     Discontinued     NaN   \n","\n","                              name       strength  \n","0                    SULFAPYRIDINE          500MG  \n","1         MEFLOQUINE HYDROCHLORIDE          250MG  \n","2              HYDROCHLOROTHIAZIDE         12.5MG  \n","3                       LISINOPRIL           10MG  \n","4              HYDROCHLOROTHIAZIDE         12.5MG  \n","...                            ...            ...  \n","58019  CIPROFLOXACIN HYDROCHLORIDE  EQ 250MG BASE  \n","58020  CIPROFLOXACIN HYDROCHLORIDE  EQ 500MG BASE  \n","58021                    GLIPIZIDE            5MG  \n","58022                    GLIPIZIDE           10MG  \n","58023            LITHIUM CARBONATE          300MG  \n","\n","[58024 rows x 31 columns]"],"text/html":["\n","  <div id=\"df-c1365956-a9f6-40ad-b35c-48cfedde4441\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>submissions</th>\n","      <th>application_number</th>\n","      <th>sponsor_name</th>\n","      <th>openfda.application_number</th>\n","      <th>openfda.brand_name</th>\n","      <th>openfda.generic_name</th>\n","      <th>openfda.manufacturer_name</th>\n","      <th>openfda.product_ndc</th>\n","      <th>openfda.product_type</th>\n","      <th>openfda.route</th>\n","      <th>...</th>\n","      <th>product_number</th>\n","      <th>reference_drug</th>\n","      <th>brand_name</th>\n","      <th>reference_standard</th>\n","      <th>dosage_form</th>\n","      <th>route</th>\n","      <th>marketing_status</th>\n","      <th>te_code</th>\n","      <th>name</th>\n","      <th>strength</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>[{'submission_type': 'ORIG', 'submission_numbe...</td>\n","      <td>NDA000159</td>\n","      <td>LILLY</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>SULFAPYRIDINE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>SULFAPYRIDINE</td>\n","      <td>500MG</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076175</td>\n","      <td>CHARTWELL RX</td>\n","      <td>[ANDA076175]</td>\n","      <td>[MEFLOQUINE HYDROCHLORIDE]</td>\n","      <td>[MEFLOQUINE HYDROCHLORIDE]</td>\n","      <td>[Chartwell RX, LLC]</td>\n","      <td>[62135-973]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>MEFLOQUINE HYDROCHLORIDE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>MEFLOQUINE HYDROCHLORIDE</td>\n","      <td>250MG</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>003</td>\n","      <td>No</td>\n","      <td>LISINOPRIL AND HYDROCHLOROTHIAZIDE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Prescription</td>\n","      <td>AB</td>\n","      <td>HYDROCHLOROTHIAZIDE</td>\n","      <td>12.5MG</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>003</td>\n","      <td>No</td>\n","      <td>LISINOPRIL AND HYDROCHLOROTHIAZIDE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Prescription</td>\n","      <td>AB</td>\n","      <td>LISINOPRIL</td>\n","      <td>10MG</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076194</td>\n","      <td>WATSON LABS</td>\n","      <td>[ANDA076194]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[LISINOPRIL AND HYDROCHLOROTHIAZIDE]</td>\n","      <td>[Actavis Pharma, Inc.]</td>\n","      <td>[0591-0860, 0591-0861, 0591-0862]</td>\n","      <td>[HUMAN PRESCRIPTION DRUG]</td>\n","      <td>[ORAL]</td>\n","      <td>...</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>LISINOPRIL AND HYDROCHLOROTHIAZIDE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Prescription</td>\n","      <td>AB</td>\n","      <td>HYDROCHLOROTHIAZIDE</td>\n","      <td>12.5MG</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>58019</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076138</td>\n","      <td>NOSTRUM LABS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>CIPROFLOXACIN HYDROCHLORIDE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>CIPROFLOXACIN HYDROCHLORIDE</td>\n","      <td>EQ 250MG BASE</td>\n","    </tr>\n","    <tr>\n","      <th>58020</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076138</td>\n","      <td>NOSTRUM LABS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>002</td>\n","      <td>No</td>\n","      <td>CIPROFLOXACIN HYDROCHLORIDE</td>\n","      <td>No</td>\n","      <td>TABLET</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>CIPROFLOXACIN HYDROCHLORIDE</td>\n","      <td>EQ 500MG BASE</td>\n","    </tr>\n","    <tr>\n","      <th>58021</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076159</td>\n","      <td>ENDO OPERATIONS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>002</td>\n","      <td>No</td>\n","      <td>GLIPIZIDE</td>\n","      <td>No</td>\n","      <td>TABLET, EXTENDED RELEASE</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>GLIPIZIDE</td>\n","      <td>5MG</td>\n","    </tr>\n","    <tr>\n","      <th>58022</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076159</td>\n","      <td>ENDO OPERATIONS</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>GLIPIZIDE</td>\n","      <td>No</td>\n","      <td>TABLET, EXTENDED RELEASE</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>GLIPIZIDE</td>\n","      <td>10MG</td>\n","    </tr>\n","    <tr>\n","      <th>58023</th>\n","      <td>[{'submission_type': 'SUPPL', 'submission_numb...</td>\n","      <td>ANDA076170</td>\n","      <td>HERITAGE PHARMA</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>NaN</td>\n","      <td>...</td>\n","      <td>001</td>\n","      <td>No</td>\n","      <td>LITHIUM CARBONATE</td>\n","      <td>No</td>\n","      <td>TABLET, EXTENDED RELEASE</td>\n","      <td>ORAL</td>\n","      <td>Discontinued</td>\n","      <td>NaN</td>\n","      <td>LITHIUM CARBONATE</td>\n","      <td>300MG</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>58024 rows × 31 columns</p>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-c1365956-a9f6-40ad-b35c-48cfedde4441')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-c1365956-a9f6-40ad-b35c-48cfedde4441 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-c1365956-a9f6-40ad-b35c-48cfedde4441');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-8e7d1752-f59c-416a-9a5a-d2361b0f4929\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-8e7d1752-f59c-416a-9a5a-d2361b0f4929')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-8e7d1752-f59c-416a-9a5a-d2361b0f4929 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","  <div id=\"id_03aec803-4073-4cfd-893d-6110e72ed690\">\n","    <style>\n","      .colab-df-generate {\n","        background-color: #E8F0FE;\n","        border: none;\n","        border-radius: 50%;\n","        cursor: pointer;\n","        display: none;\n","        fill: #1967D2;\n","        height: 32px;\n","        padding: 0 0 0 0;\n","        width: 32px;\n","      }\n","\n","      .colab-df-generate:hover {\n","        background-color: #E2EBFA;\n","        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","        fill: #174EA6;\n","      }\n","\n","      [theme=dark] .colab-df-generate {\n","        background-color: #3B4455;\n","        fill: #D2E3FC;\n","      }\n","\n","      [theme=dark] .colab-df-generate:hover {\n","        background-color: #434B5C;\n","        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","        fill: #FFFFFF;\n","      }\n","    </style>\n","    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('df_final_fda')\"\n","            title=\"Generate code using this dataframe.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","       width=\"24px\">\n","    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n","  </svg>\n","    </button>\n","    <script>\n","      (() => {\n","      const buttonEl =\n","        document.querySelector('#id_03aec803-4073-4cfd-893d-6110e72ed690 button.colab-df-generate');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      buttonEl.onclick = () => {\n","        google.colab.notebook.generateWithVariable('df_final_fda');\n","      }\n","      })();\n","    </script>\n","  </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"df_final_fda"}},"metadata":{},"execution_count":6}]},{"cell_type":"markdown","source":["# **Hugging Face Dataset**"],"metadata":{"id":"awYR1wJ5mcg7"}},{"cell_type":"code","source":["clinical_notes= pd.read_json(\"hf://datasets/AGBonnet/augmented-clinical-notes/augmented_notes_30K.jsonl\", lines=True)"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":141},"id":"15K7-PdemcFR","executionInfo":{"status":"error","timestamp":1750290253180,"user_tz":240,"elapsed":72,"user":{"displayName":"Kelsey Ryan","userId":"08186164734755456613"}},"outputId":"e79771a2-1f21-4084-d3a4-6e02c7c55fa8"},"execution_count":1,"outputs":[{"output_type":"error","ename":"NameError","evalue":"name 'pd' is not defined","traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)","\u001b[0;32m/tmp/ipython-input-1-2674814373.py\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mclinical_notes\u001b[0m\u001b[0;34m=\u001b[0m \u001b[0mpd\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mread_json\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"hf://datasets/AGBonnet/augmented-clinical-notes/augmented_notes_30K.jsonl\"\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlines\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;32mTrue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m","\u001b[0;31mNameError\u001b[0m: name 'pd' is not defined"]}]},{"cell_type":"code","source":["clinical_notes"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":597},"id":"BLB3rAHmoPUB","executionInfo":{"status":"ok","timestamp":1748789763818,"user_tz":240,"elapsed":3124,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"7b3fdec7-1b2f-4556-8e63-18a16653f6d8"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["                                                    note  \\\n","0      A a sixteen year-old girl, presented to our Ou...   \n","1      This is the case of a 56-year-old man that was...   \n","2      A 36-year old female patient visited our hospi...   \n","3      A 49-year-old male presented with a complaint ...   \n","4      A 47-year-old male patient was referred to the...   \n","...                                                  ...   \n","29995  A 28-year-old male was admitted to the emergen...   \n","29996  An 82-year-old man (64.5 kg, 175 cm) diagnosed...   \n","29997  A 54 year-old man with no past medical history...   \n","29998  A 49-year-old woman visited the clinic due to ...   \n","29999  A 31-year-old male with no significant past me...   \n","\n","                                            conversation     idx  \\\n","0      Doctor: Good morning, what brings you to the O...  155216   \n","1      Doctor: Hi, how are you feeling today?\\nPatien...   77465   \n","2      Doctor: Hello, what brings you to the hospital...  133948   \n","3      Doctor: Good morning, Mr. [Patient's Name]. I'...   80176   \n","4      Doctor: Good morning, how are you feeling toda...   72232   \n","...                                                  ...     ...   \n","29995  Doctor: Good morning, sir. Can you tell me wha...   39279   \n","29996  Doctor: Good morning, sir. I am Dr. John. How ...  137017   \n","29997  Doctor: Good morning, how are you feeling toda...   98004   \n","29998  Doctor: Good morning, how can I help you today...  133320   \n","29999  Doctor: Good morning, what brings you to the e...   97973   \n","\n","                                                 summary  \\\n","0      {\\n\"visit motivation\": \"Discomfort in the neck...   \n","1      {\\n\"visit motivation\": \"Complaints of a dull p...   \n","2      {\\n\"visit motivation\": \"Pain and restricted ra...   \n","3      {\\n\"visit motivation\": \"Pain in the left proxi...   \n","4      {\\n\"visit motivation\": \"Recurrent attacks of p...   \n","...                                                  ...   \n","29995  {\\n\"visit motivation\": \"Stab wound under left ...   \n","29996  {\\n\"visit motivation\": \"Diagnosed with falcine...   \n","29997  {\\n\"visit motivation\": \"Cardiac sounding chest...   \n","29998  {\\n\"visit motivation\": \"Mass in her right thig...   \n","29999  {\\n\"visit motivation\": \"Acute onset crushing s...   \n","\n","                                               full_note  \n","0      A a sixteen year-old girl, presented to our Ou...  \n","1      This is the case of a 56-year-old man that was...  \n","2      A 36-year old female patient visited our hospi...  \n","3      A 49-year-old male presented with a complaint ...  \n","4      A 47-year-old male patient was referred to the...  \n","...                                                  ...  \n","29995  A 28-year-old male was admitted to the emergen...  \n","29996  An 82-year-old man (64.5 kg, 175 cm) diagnosed...  \n","29997  A 54 year-old man with no past medical history...  \n","29998  A 49-year-old woman visited the clinic due to ...  \n","29999  A 31-year-old male with no significant past me...  \n","\n","[30000 rows x 5 columns]"],"text/html":["\n","  <div id=\"df-18d8ce54-a1a3-434e-84a3-73298def3094\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>note</th>\n","      <th>conversation</th>\n","      <th>idx</th>\n","      <th>summary</th>\n","      <th>full_note</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>A a sixteen year-old girl, presented to our Ou...</td>\n","      <td>Doctor: Good morning, what brings you to the O...</td>\n","      <td>155216</td>\n","      <td>{\\n\"visit motivation\": \"Discomfort in the neck...</td>\n","      <td>A a sixteen year-old girl, presented to our Ou...</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>This is the case of a 56-year-old man that was...</td>\n","      <td>Doctor: Hi, how are you feeling today?\\nPatien...</td>\n","      <td>77465</td>\n","      <td>{\\n\"visit motivation\": \"Complaints of a dull p...</td>\n","      <td>This is the case of a 56-year-old man that was...</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>A 36-year old female patient visited our hospi...</td>\n","      <td>Doctor: Hello, what brings you to the hospital...</td>\n","      <td>133948</td>\n","      <td>{\\n\"visit motivation\": \"Pain and restricted ra...</td>\n","      <td>A 36-year old female patient visited our hospi...</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>A 49-year-old male presented with a complaint ...</td>\n","      <td>Doctor: Good morning, Mr. [Patient's Name]. I'...</td>\n","      <td>80176</td>\n","      <td>{\\n\"visit motivation\": \"Pain in the left proxi...</td>\n","      <td>A 49-year-old male presented with a complaint ...</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>A 47-year-old male patient was referred to the...</td>\n","      <td>Doctor: Good morning, how are you feeling toda...</td>\n","      <td>72232</td>\n","      <td>{\\n\"visit motivation\": \"Recurrent attacks of p...</td>\n","      <td>A 47-year-old male patient was referred to the...</td>\n","    </tr>\n","    <tr>\n","      <th>...</th>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","      <td>...</td>\n","    </tr>\n","    <tr>\n","      <th>29995</th>\n","      <td>A 28-year-old male was admitted to the emergen...</td>\n","      <td>Doctor: Good morning, sir. Can you tell me wha...</td>\n","      <td>39279</td>\n","      <td>{\\n\"visit motivation\": \"Stab wound under left ...</td>\n","      <td>A 28-year-old male was admitted to the emergen...</td>\n","    </tr>\n","    <tr>\n","      <th>29996</th>\n","      <td>An 82-year-old man (64.5 kg, 175 cm) diagnosed...</td>\n","      <td>Doctor: Good morning, sir. I am Dr. John. How ...</td>\n","      <td>137017</td>\n","      <td>{\\n\"visit motivation\": \"Diagnosed with falcine...</td>\n","      <td>An 82-year-old man (64.5 kg, 175 cm) diagnosed...</td>\n","    </tr>\n","    <tr>\n","      <th>29997</th>\n","      <td>A 54 year-old man with no past medical history...</td>\n","      <td>Doctor: Good morning, how are you feeling toda...</td>\n","      <td>98004</td>\n","      <td>{\\n\"visit motivation\": \"Cardiac sounding chest...</td>\n","      <td>A 54 year-old man with no past medical history...</td>\n","    </tr>\n","    <tr>\n","      <th>29998</th>\n","      <td>A 49-year-old woman visited the clinic due to ...</td>\n","      <td>Doctor: Good morning, how can I help you today...</td>\n","      <td>133320</td>\n","      <td>{\\n\"visit motivation\": \"Mass in her right thig...</td>\n","      <td>A 49-year-old woman visited the clinic due to ...</td>\n","    </tr>\n","    <tr>\n","      <th>29999</th>\n","      <td>A 31-year-old male with no significant past me...</td>\n","      <td>Doctor: Good morning, what brings you to the e...</td>\n","      <td>97973</td>\n","      <td>{\\n\"visit motivation\": \"Acute onset crushing s...</td>\n","      <td>A 31-year-old male with no significant past me...</td>\n","    </tr>\n","  </tbody>\n","</table>\n","<p>30000 rows × 5 columns</p>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-18d8ce54-a1a3-434e-84a3-73298def3094')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-18d8ce54-a1a3-434e-84a3-73298def3094 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-18d8ce54-a1a3-434e-84a3-73298def3094');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-c549fa65-0d87-46db-b748-9e56716bf550\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-c549fa65-0d87-46db-b748-9e56716bf550')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-c549fa65-0d87-46db-b748-9e56716bf550 button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","  <div id=\"id_f7f3ff3c-7b3e-400c-a213-aab57cae3acc\">\n","    <style>\n","      .colab-df-generate {\n","        background-color: #E8F0FE;\n","        border: none;\n","        border-radius: 50%;\n","        cursor: pointer;\n","        display: none;\n","        fill: #1967D2;\n","        height: 32px;\n","        padding: 0 0 0 0;\n","        width: 32px;\n","      }\n","\n","      .colab-df-generate:hover {\n","        background-color: #E2EBFA;\n","        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","        fill: #174EA6;\n","      }\n","\n","      [theme=dark] .colab-df-generate {\n","        background-color: #3B4455;\n","        fill: #D2E3FC;\n","      }\n","\n","      [theme=dark] .colab-df-generate:hover {\n","        background-color: #434B5C;\n","        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","        fill: #FFFFFF;\n","      }\n","    </style>\n","    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('clinical_notes')\"\n","            title=\"Generate code using this dataframe.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","       width=\"24px\">\n","    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n","  </svg>\n","    </button>\n","    <script>\n","      (() => {\n","      const buttonEl =\n","        document.querySelector('#id_f7f3ff3c-7b3e-400c-a213-aab57cae3acc button.colab-df-generate');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      buttonEl.onclick = () => {\n","        google.colab.notebook.generateWithVariable('clinical_notes');\n","      }\n","      })();\n","    </script>\n","  </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"clinical_notes","summary":"{\n  \"name\": \"clinical_notes\",\n  \"rows\": 30000,\n  \"fields\": [\n    {\n      \"column\": \"note\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 24348,\n        \"samples\": [\n          \"We herein present a case that was recently managed at our institution, the Department of Surgery of the San Camillo Forlanini Hospital of Rome, Italy.\\nA 53-year-old man with previous history of alcohol-related liver cirrhosis presents to our department for routine follow-up. His comorbidities include hypertension managed with oral antihypertensive drugs and diabetes mellitus type 2. He has no significant allergies and never underwent any surgical procedure. He brings an ultrasound, which shows a 4 cm heterogenous mass in segment 8. His alfafetoprotein level is elevated to 76 ng/mL. He has no symptoms and looks in good performance status. We scheduled him for a triphasic CT scan, which shows a lesion of 4.3 cm with brisk arterial contrast and venous washout. According to the LIRADS classification, this lesion could be considered a class 5 with diagnostic features of hepatocellular carcinoma. The patient was discussed in our multidisciplinary tumor board including hepatobiliary and transplant surgeons, hepatologists, radiologists, pathologists, oncologists, and interventional radiologists. The plan was to submit the patient to curative intent treatments given his early presentation according to the Barcelona Clinic Liver Cancer Staging System (BCLC), namely surgical resection or liver transplantation; radiofrequency ablation was excluded given the tumor\\u2019s dimensions. Given the good performance status, the position of the lesion (which was right below the Glissonian capsule) and the liver function of the patients, the MDT decided to schedule the patient for surgery. We therefore saw the patient in clinic and discussed the procedure. Informed consent was signed, and liver function was tested using ICG retention rate. We used 0.5 mg/Kg corresponding to 40 mg in this 80 kg patient. The DICOM data of the CT scan of the patient were then submitted to our radiologist who performed a 3D reconstruction of the patient\\u2019s anatomy and the relationship of the lesion with the major vessels. Furthermore, the exact dimensions of the portal territories\",\n          \"The patient was a 64-year-old woman with seven children brought to the hospital with severe vomiting and a history of solid dysphagia; she had the symptoms for three months and was referred to different physicians, left without definite diagnosis before admission to our center.. Patient\\u2019s past medical history was unremarkable. Post-contrast computed tomography (CT) of the neck showed two lesions (kissing tumors) in the upper esophagus, causing the tracheal shift to the right side with no lymph node enlargement (Fig. ). Physical examination revealed no abnormalities, and the results of laboratory examinations were within the normal range. CT-guided fine-needle aspiration biopsy evaluation of the mass showed a few pleomorphic spindle malignant cells among inflammatory cells in a bloody background. Additional endoscopy of the esophagus, stomach, and duodenum was performed for the patient, which showed a large tumor in the cricopharyngeus causing stricture, while the stomach and duodenum were normal. (Fig. ).\\nThe patient was scheduled for exploratory laparotomy with the exploration of cervical organs, resection of the pharynx, thyroid (partial), and esophagus and gastric pull up along with the insertion of a tracheostomy and bilateral chest tube, and cervical penrose.\\nThe patient was laid in a supine position. After preparation and sterilization, the abdomen was opened by a high midline incision. The surgeon inserted his finger into the mediastinum to assess the presence of any tumors. Stomach was mobilized by harmonic ligasure, lesser sac was opened, short gastric and left gastric arteries were ligated, and gastric pedicle was made on the right gastroepiploic arteries and epigastric area. Then, the esophagus was dissected bluntly by the finger in the mediastinum through the hiatus's opening and continued upward. Adhesion to the carina was found and released meticulously. Next, the collar incision was made on the neck. Then, subtotal thyroidectomy was done, and the specimen was sent for pathologic evaluation. Trocar was\",\n          \"A 38-year-old woman from Elazig, Turkey with atrial septal defect was admitted for exertional dyspnea and fatigue. She had a general tendency and swelling both of the lower limbs at term (38-40 weeks\\u2019 gestation). Echocardiography had documented atrial septal defect () and she had three children in alive. She had an intrauterine death at 28 weeks\\u2019 gestation.\\nOn physical examination, she presented in both lower limbs swelling. A venous color flow Doppler ultrasonography of the both lower-extremity were requested, showing bilateral venous insufficiency, but there were not peripheral venous thrombosis. On auscultation, fixed split of second heart sound and pansystolic murmur on the left side of sternal border were heard. ECG was NSR. A chest X-ray showed mild heart enlargement. Echocardiography documented enlargement of the right ventricle and both atria with atrial septal defect (approximately 33 \\u00d7 38 mm) and normal function of both ventricles (). Right-sided pulmonary veins were not identified. Multidetector Computerized Tomography (CT) angiography confirmed atrial septal defect and abnormal return of right-sided pulmonary veins into the right atrium () and showed inferior vena cava on the right side of spine and showed total interruption of IVC below the hepatic veins (). Multidetector CT angiography provided full description of a complex anomaly documenting right inferior vena cava with azygous continuation, draining into the superior vena cava (, ) and hepatic veins were draining directly into the right atrium (). Ultrasound revealed polysplenia (), 0.5 cm nodule in the left thyroid lobe and 1 cm cystic mass in the right over.\\nA standard median sternotomy was performed. The pericardial cavity was opened and the heart was exposed. SVC was dissected out to the bridging vein, exposing the azygos vein and anomalous pulmonary veins. Cardiopulmonary bypass was established with cannulation to the ascending aorta and SVC was cannulated by L-shaped catheter, because of absence the IVC. The\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"conversation\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 25761,\n        \"samples\": [\n          \"Doctor: Good morning, what brings you here today?\\nPatient: I was referred to your department with a 1-month history of DHS.\\nDoctor: I see. Can you tell me more about your history?\\nPatient: Yes, I have suffered from severe right foot pain because of limb ischemia related to systemic sclerosis.\\nDoctor: I see. When were you diagnosed with systemic sclerosis?\\nPatient: It was diagnosed 30 years ago and was classified as having limited cutaneous systemic sclerosis.\\nDoctor: Hmm, okay. And what about the fibrosis?\\nPatient: It was limited to my hands without involvement of my head or neck.\\nDoctor: I see. Is there any family history of any neuromuscular disease?\\nPatient: No, there isn't.\\nDoctor: Alright. Can you tell me more about your right foot pain?\\nPatient: One month before visiting your hospital, I developed right foot gangrene. Although I had Raynaud's phenomenon and ulcerations in my fingers, I had no symptom in my foot before I had gangrene. The pain was so severe that I used tramadol and NSAIDs as painkillers.\\nDoctor: I see. And when did you start to complain about DHS?\\nPatient: It was when my foot pain worsened. I had difficulty in keeping my head straight and my gaze forward.\\nDoctor: I see. Can you describe your neck deformity?\\nPatient: Clinical examination revealed severe weakness of my neck extensor muscles. My neck deformity was flexible and easily corrected passively.\\nDoctor: I see. And were there any neurological abnormalities including sensory disturbance or muscle weakness in your extremities?\\nPatient: No, there weren't.\\nDoctor: Alright. And what did the radiographs of your cervical spine reveal?\\nPatient: They revealed only mild degenerative changes and severe cervical kyphosis.\\nDoctor: I see. And what about your cervical magnetic resonance imaging?\\nPatient: It showed no spinal canal stenosis and no abnormal signal change in the cervical paraspinal muscles.\\nDoctor: I see. And what did the computed tomographic angiography show?\\nPatient: It showed occlusion of bilateral anterior tibial arteries and peroneal arteries, and development of collaterals.\\nDoctor: I see. Despite intensive conservative therapy including alprostadil, argatroban, and sarpogrelate, lower extremity ischemia progressed, right?\\nPatient: Yes, that's correct.\\nDoctor: Alright. So, we decided to amputate your leg below the knee under general anesthesia, correct?\\nPatient: Yes.\\nDoctor: And your postoperative course was uneventful, right?\\nPatient: Yes, it was.\\nDoctor: Good. And your severe foot pain was resolved after the surgery, correct?\\nPatient: Yes, it was.\\nDoctor: And at the postoperative follow-up visit 3 weeks after surgery, your DHS was significantly attenuated, right?\\nPatient: Yes, it was. My forward vision and neck pain were also improved.\\nDoctor: That's great to hear. The feature of the present patient was attenuation of her DHS after pain relief by amputation of her severely ischemic limb.\\nPatient: Yes, that's correct.\\n[Conversation ends]\\n[Conversation Starts]\\nDoctor: Good morning, what brings you here today?\\nPatient's family: Our mother was referred to your department with a 1-month history of DHS.\\nDoctor: I see. Can you tell me more about her history?\\nPatient's family: Yes, she has suffered from severe right foot pain because of limb ischemia related to systemic sclerosis.\\nDoctor: I see. When was she diagnosed with systemic sclerosis?\\nPatient's family: It was diagnosed 30 years ago and was classified as having limited cutaneous systemic sclerosis.\\nDoctor: Hmm, okay. And what about the fibrosis?\\nPatient's family: It was limited to her hands without involvement of her head or neck.\\nDoctor: I see. Is there any family history of any neuromuscular disease?\\nPatient's family: No, there isn't.\\nDoctor: Alright. Can you tell me more about her right foot pain?\\nPatient's family: One month before visiting your hospital, she developed right foot gangrene. Although she had Raynaud's phenomenon and ulcerations in her fingers, she had no symptom in her foot before she had gangrene. The pain was so severe that she used tramadol and NSAIDs as painkillers.\\nDoctor: I see. And when did she start to complain about DHS?\\nPatient's family: It was when her foot pain worsened. She had difficulty in keeping her head straight and her gaze forward.\\nDoctor: I see. Can you describe her neck deformity?\\nPatient's family: Clinical examination revealed severe weakness of her neck extensor muscles. Her neck deformity was flexible and easily corrected passively.\\nDoctor: I see. And were there any neurological abnormalities including sensory disturbance or muscle weakness in her extremities?\\nPatient's family: No, there weren't.\\nDoctor: Alright. And what did the radiographs of her cervical spine reveal?\\nPatient's family: They revealed only mild degenerative changes and severe cervical kyphosis.\\nDoctor: I see. And what about her cervical magnetic resonance imaging?\\nPatient's family: It showed no spinal canal stenosis and no abnormal signal change in the cervical paraspinal muscles.\\nDoctor: I see. And what did the computed tomographic angiography show?\\nPatient's family: It showed occlusion of bilateral anterior tibial arteries and peroneal arteries, and development of collaterals.\\nDoctor: I see. Despite intensive conservative therapy including alprostadil, argatroban, and sarpogrelate, lower extremity ischemia progressed, right?\\nPatient's family: Yes, that's correct.\\nDoctor: Alright. So, we decided to amputate her leg below the knee under general anesthesia, correct?\\nPatient's family: Yes.\\nDoctor: And her postoperative course was uneventful, right?\\nPatient's family: Yes, it was.\\nDoctor: Good. And her severe foot pain was resolved after the surgery, correct?\\nPatient's family: Yes, it was.\\nDoctor: And at the postoperative follow-up visit 3 weeks after surgery, her DHS was significantly attenuated, right?\\nPatient's family: Yes, it was. Her forward vision and neck pain were also improved.\\nDoctor: That's great to hear. The feature of the present patient was attenuation of her DHS after pain relief by amputation of her severely ischemic limb.\\nPatient's family: Yes, that's correct.\\n[Conversation ends]\\n[Note: The patient eventually died.]\\n[Conversation Starts]\\nDoctor: Good morning, what brings you here today?\\nPatient's family: Our mother was referred to your department with a 1-month history of DHS.\\nDoctor: I see. Can you tell me more about her history?\\nPatient's family: Yes, she suffered from severe right foot pain because of limb ischemia related to systemic sclerosis.\\nDoctor: I see. When was she diagnosed with systemic sclerosis?\\nPatient's family: It was diagnosed 30 years ago and was classified as having limited cutaneous systemic sclerosis.\\nDoctor: Hmm, okay. And what about the fibrosis?\\nPatient's family: It was limited to her hands without involvement of her head or neck.\\nDoctor: I see. Is there any family history of any neuromuscular disease?\\nPatient's family: No, there wasn't.\\nDoctor: Alright. Can you tell me more about her right foot pain?\\nPatient's family: One month before visiting your hospital, she developed right foot gangrene. Although she had Raynaud's phenomenon and ulcerations in her fingers, she had no symptom in her foot before she had gangrene. The pain was so severe that she used tramadol and NSAIDs as painkillers.\\nDoctor: I see. And when did she start to complain about DHS?\\nPatient's family: It was when her foot pain worsened. She had difficulty in keeping her head straight and her gaze forward.\\nDoctor: I see. Can you describe her neck deformity?\\nPatient's family: Clinical examination revealed severe weakness of her neck extensor muscles. Her neck deformity was flexible and easily corrected passively.\\nDoctor: I see. And were there any neurological abnormalities including sensory disturbance or muscle weakness in her extremities?\\nPatient's family: No, there weren't.\\nDoctor: Alright. And what did the radiographs of her cervical spine reveal?\\nPatient's family: They revealed only mild degenerative changes and severe cervical kyphosis.\\nDoctor: I see. And what about her cervical magnetic resonance imaging?\\nPatient's family: It showed no spinal canal stenosis and no abnormal signal change in the cervical paraspinal muscles.\\nDoctor: I see. And what did the computed tomographic angiography show?\\nPatient's family: It showed occlusion of bilateral anterior tibial arteries and peroneal arteries, and development of collaterals.\\nDoctor: I see. Despite intensive conservative therapy including alprostadil, argatroban, and sarpogrelate, lower extremity ischemia progressed, right?\\nPatient's family: Yes, that's correct.\\nDoctor: Alright. So, we decided to amputate her leg below the knee under general anesthesia, correct?\\nPatient's family: Yes.\\nDoctor: And her postoperative course was uneventful, right?\\nPatient's family: Yes, it was.\\nDoctor: Good. And her severe foot pain was resolved after the surgery, correct?\\nPatient's family: Yes, it was.\\nDoctor: And at the postoperative follow-up visit 3 weeks after surgery, her DHS was significantly attenuated, right?\\nPatient's family: Yes, it was. Her forward vision and neck pain were also improved.\\nDoctor: That's great to hear. The feature of the present patient was attenuation of her DHS after pain relief by amputation of her severely ischemic limb.\\nPatient's family: Yes, that's correct.\\nDoctor: I'm sorry to inform you that your mother eventually passed away.\\nPatient's family: Thank you for your help, doctor.\\n[Conversation ends]\\n[Note: The patient eventually died.]\\n[Conversation Starts]\\nDoctor: Good morning, what brings you here today?\\nPatient's family: Our mother was referred to your department with a 1-month history of DHS.\\nDoctor: I see. Can you tell me more about her history?\\nPatient's family: Yes, she had suffered from severe right foot pain because of limb ischemia related to systemic sclerosis.\\nDoctor: I see. When was she diagnosed with systemic sclerosis?\\nPatient's family: It was diagnosed 30 years ago and was classified as having limited cutaneous systemic sclerosis.\\nDoctor: Hmm, okay. And what about the fibrosis?\\nPatient's family: It was limited to her hands without involvement of her head or neck.\\nDoctor: I see. Is there any family history of any neuromuscular disease?\\nPatient's family: No, there wasn't.\\nDoctor: Alright. Can you tell me more about her right foot pain?\\nPatient's family: One month before visiting your hospital, she had developed right foot gangrene. Although she had Raynaud's phenomenon and ulcerations in her fingers, she had no symptom in her foot before she had gangrene. The pain was so severe that she used tramadol and NSAIDs as painkillers.\\nDoctor: I see. And when did she start to complain about DHS?\\nPatient's family: It was when her foot pain worsened. She had difficulty in keeping her head straight and her gaze forward.\\nDoctor: I see. Can you describe her neck deformity?\\nPatient's family: Clinical examination revealed severe weakness of her neck extensor muscles. Her neck deformity was flexible and easily corrected passively.\\nDoctor: I see. And were there any neurological abnormalities including sensory disturbance or muscle weakness in her extremities?\\nPatient's family: No, there weren't.\\nDoctor: Alright. And what did the radiographs of her cervical spine reveal?\\nPatient's family: They revealed only mild degenerative changes and severe cervical kyphosis.\\nDoctor: I see. And what about her cervical magnetic resonance imaging?\\nPatient's family: It showed no spinal canal stenosis and no abnormal signal change in the cervical paraspinal muscles.\\nDoctor: I see. And what did the computed tomographic angiography show?\\nPatient's family: It showed occlusion of bilateral anterior tibial arteries and peroneal arteries, and development of collaterals.\\nDoctor: I see. Despite intensive conservative therapy including alprostadil, argatroban, and sarpogrelate, lower extremity ischemia progressed, right?\\nPatient's family: Yes, that's correct.\\nDoctor: Alright. So, we decided to amputate her leg below the knee under general anesthesia, correct?\\nPatient's family: Yes.\\nDoctor: And her postoperative course was uneventful, right?\\nPatient's family: Yes, it was.\\nDoctor: Good. And her severe foot pain was resolved after the surgery, correct?\\nPatient's family: Yes, it was.\\nDoctor: And at the postoperative follow-up visit 3 weeks after surgery, her DHS was significantly attenuated, right?\\nPatient's family: Yes, it was. Her forward vision and neck pain were also improved.\\nDoctor: That's great to hear. The feature of the present patient was attenuation of her DHS after pain relief by amputation of her severely ischemic limb.\\nPatient's family: Yes, that's correct.\\nDoctor: I'm sorry to inform you that your mother eventually passed away.\\nPatient's family: Thank you for your help, doctor.\\n[Conversation ends]\\n[Note: The patient eventually died.]\\n[Conversation Starts]\\nDoctor: Good morning, what brings you here today?\\nPatient's family: Our mother was referred to your department with a 1-month history of DHS.\\nDoctor: I see. Can you tell me more about her history?\\nPatient's family: Yes, she had suffered from severe right foot pain because of limb ischemia related to systemic sclerosis.\\nDoctor: I see. When was she diagnosed with systemic sclerosis?\\nPatient's family: It was diagnosed 30 years ago and was classified as having limited cutaneous systemic sclerosis.\\nDoctor: Hmm, okay. And what about the fibrosis?\\nPatient's family: It was limited to her hands without involvement of her head or neck.\\nDoctor: I see. Is there any family history of any neuromuscular disease?\\nPatient's family: No, there wasn't.\\nDoctor: Alright. Can you tell me more about her right foot pain?\\nPatient's family: One month before visiting your hospital, she had developed right foot gangrene. Although she had Raynaud's phenomenon and ulcerations in her fingers, she had no symptom in her foot before she had gangrene. The pain was so severe that she used tramadol and NSAIDs as painkillers.\\nDoctor: I see. And when did she start to complain about DHS?\\nPatient's family: It was when her foot pain worsened. She had difficulty in keeping her head straight and her gaze forward.\\nDoctor: I see. Can you describe her neck deformity?\\nPatient's family: Clinical examination revealed severe weakness of her neck extensor muscles. Her neck deformity was flexible and easily corrected passively.\\nDoctor: I see. And were there any neurological abnormalities including sensory disturbance or muscle weakness in her extremities?\\nPatient's family: No, there weren't.\\nDoctor: Alright. And what did the radiographs of her cervical spine reveal?\\nPatient's family: They revealed only mild degenerative changes and severe cervical kyphosis.\\nDoctor: I see. And what about her cervical magnetic resonance imaging?\\nPatient's family: It showed no spinal canal stenosis and no abnormal signal change in the cervical paraspinal muscles.\\nDoctor: I see. And what did the computed tomographic angiography show?\\nPatient's family: It showed occlusion of bilateral anterior tibial arteries and peroneal arteries, and development of collaterals.\\nDoctor: I see. Despite intensive conservative therapy including alprostadil, argatroban, and sarpogrelate, lower extremity ischemia progressed, right?\\nPatient's family: Yes, that's correct.\\nDoctor: Alright. So, we decided to amputate her leg below the knee under general anesthesia, correct?\\nPatient's family: Yes.\\nDoctor: And her postoperative course was uneventful, right?\\nPatient's family: Yes, it was.\\nDoctor: Good. And her severe foot pain was resolved after the surgery, correct?\\nPatient's family: Yes, it was.\\nDoctor: And at the postoperative follow-up visit 3 weeks after surgery, her DHS was significantly attenuated, right?\\nPatient's family: Yes, it was. Her forward vision and neck pain were also improved.\\nDoctor: That's great to hear. The feature of the present patient was attenuation of her DHS after pain relief by amputation of her severely ischemic limb.\\nPatient's family: Yes, that's correct.\\nDoctor: I'm sorry to inform you that your mother eventually passed away.\\nPatient's family: Thank you for your help, doctor.\\n[Conversation ends]\\n[Note: The patient eventually died.]\\n[Conversation Starts]\\nDoctor: Good morning, what brings you here today?\\nPatient's family: Our mother was referred to your department with a 1-month history of DHS.\\nDoctor: I see. Can you tell me more about her history?\\nPatient's family: Yes, she had suffered from severe right foot pain because of limb ischemia related to systemic sclerosis.\\nDoctor: I see. When was she diagnosed with systemic sclerosis?\\nPatient's family: It was diagnosed 30 years ago and was classified as having limited cutaneous systemic sclerosis.\\nDoctor: Hmm, okay. And what about the fibrosis?\\nPatient's\",\n          \"Doctor: Hi, I'm Dr. Smith. What brings you to the ED today?\\nPatient: I was in a road traffic accident and I have severe pain in my right hip and right thigh.\\nDoctor: I see. Can you walk?\\nPatient: No, I can't.\\nDoctor: Okay. Let me have a look. Can you describe the pain you're feeling?\\nPatient: It's really bad. I can't move my right hip and thigh.\\nDoctor: Hmm, I understand. During our clinical examination, we found that you have a deformity of your right hip and thigh. Is that correct?\\nPatient: Yes, that's correct.\\nDoctor: And it seems that your leg and foot are showing external rotation and abduction, is that correct?\\nPatient: Yes, that's correct.\\nDoctor: There is also tenderness and abnormal mobility at your right thigh, correct?\\nPatient: Yes, that's correct.\\nDoctor: And is there tenderness at your right hip joint as well?\\nPatient: Yes, there is.\\nDoctor: Okay, I understand. We also found that the range of movements at your right hip is restricted and painful, correct?\\nPatient: Yes, that's correct.\\nDoctor: Great. And we didn't find any distal neurovascular de\\ufb01cit, correct?\\nPatient: Yes, that's correct.\\nDoctor: After providing advanced trauma life support, we sent you for radiography, including X-rays of your pelvis with both hips and of your right thigh with hip and knee. And we also did a CT scan of your hip and pelvis to exclude acetabulum fractures.\\nPatient: Okay.\\nDoctor: And after reviewing the radiographs, we confirmed that there was a fracture in the shaft of your femur and a posterior dislocation in your hip.\\nPatient: Oh no.\\nDoctor: Yes, I'm afraid so. We took you to an emergency OT and subjected you to closed manipulation of your hip joint. But as there was a fracture in the shaft of your femur, we were unable to reduce the hip dislocation.\\nPatient: What does that mean?\\nDoctor: It means that we had two options: open reduction and external \\ufb01xation, and closed manipulation of the dislocation of your hip joint. In the end, we placed a temporary external \\ufb01xator in your femur under anesthesia and performed closed manipulation and reduction of the dislocation of your hip using the Allis method.\\nPatient: Okay.\\nDoctor: And the day after, we subjected you to final \\ufb01xation of your femur shaft fracture in an elective OT. We fixed the fracture with a closed reduction and an internal \\ufb01xation.\\nPatient: Okay, I understand.\\nDoctor: Great. You'll need to come back for follow-up appointments to monitor your progress. And you should avoid putting weight on your right leg for the time being.\\nPatient: Okay, got it.\",\n          \"Doctor: Hi, how are you feeling today?\\nPatient: Not so good, doctor. I have been experiencing some pain and swelling in my wrist and ankle joints for the past two weeks.\\nDoctor: I see. Can you tell me more about your symptoms?\\nPatient: Sure, I have been experiencing some joint pain, swelling, and stiffness in both my wrist and ankle joints.\\nDoctor: Hmm, okay. Can you tell me a little bit about your medical history?\\nPatient: Yes, I was diagnosed with lepromatous leprosy about a year ago and have been on multidrug therapy since then.\\nDoctor: I see. And you're saying that you've been experiencing these joint symptoms for the past two weeks?\\nPatient: Yes, that's correct.\\nDoctor: Alright, let me take a look. [Examines patient's joint]\\nDoctor: I can see some thickening and tenderness in your tendons. But there doesn't seem to be any joint deformity.\\nPatient: Yes, I have a history of recurrent crops of tender nodular lesions during and after my therapy.\\nDoctor: I see. We did a magnetic resonance imaging on your right ankle joint to evaluate the tenosynovitis and it showed some small focal peritendinous fluid collections along the flexor digitorium longus tendon and minimal fluid around the ankle joint.\\nPatient: Yes, I remember that.\\nDoctor: We also did a fine-needle aspiration cytology from the affected nerve and it revealed the presence of foamy macrophages and acid-fast bacilli.\\nPatient: Yes, I remember that as well.\\nDoctor: The PCR from the isolates confirmed the presence of Mycobacterium leprae. So, we diagnosed you with leprosy presenting with tenosynovitis and erythema nodosum leprosum.\\nPatient: Yes, I remember that.\\nDoctor: We started you on the standard WHO multidrug therapy for leprosy, but you didn't respond well to it. So, we gave you a combination therapy of thalidomide 200 mg per day and prednisone 50 mg per day. But even that didn't help.\\nPatient: Yes, I remember that.\\nDoctor: That's why we started you on infliximab after doing a pre-biologic workup including chest X-Ray and viral serologies.\\nPatient: Yes, I remember that too.\\nDoctor: Infliximab was given at a dose of 250 mg diluted in normal saline with dosing schedule at baseline and weeks 2 and 6. The treatment was well-tolerated and you showed good improvement in your symptoms.\\nPatient: Yes, I did feel better after taking infliximab.\\nDoctor: Great. We followed you up for 6 months and there was no recurrence of erythema nodosum leprosum.\\nPatient: That's good to hear. Thank you, doctor.\\nDoctor: No problem. Just keep taking your medication and come back to see me if you experience any more symptoms.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"idx\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 59105,\n        \"min\": 14,\n        \"max\": 206996,\n        \"num_unique_values\": 30000,\n        \"samples\": [\n          127042,\n          131562,\n          141471\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"summary\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 29992,\n        \"samples\": [\n          \"{\\n\\\"visit motivation\\\": \\\"Right lower quadrant pain, nausea, and a single episode of vomiting after jumping off the back of a pickup truck\\\",\\n\\\"admission\\\": [\\n{\\n\\\"reason\\\": \\\"Repeated episodes of right lower quadrant pain and nausea\\\",\\n\\\"date\\\": \\\"A week after the initial incident\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"care center details\\\": \\\"Local emergency room\\\"\\n}\\n],\\n\\\"patient information\\\": {\\n\\\"age\\\": \\\"21\\\",\\n\\\"sex\\\": \\\"Male\\\",\\n\\\"ethnicity\\\": \\\"None\\\",\\n\\\"weight\\\": \\\"None\\\",\\n\\\"height\\\": \\\"None\\\",\\n\\\"family medical history\\\": \\\"None\\\",\\n\\\"recent travels\\\": \\\"None\\\",\\n\\\"socio economic context\\\": \\\"None\\\",\\n\\\"occupation\\\": \\\"None\\\"\\n},\\n\\\"patient medical history\\\": {\\n\\\"physiological context\\\": \\\"No prior abdominal surgeries, unremarkable medical history\\\",\\n\\\"psychological context\\\": \\\"None\\\",\\n\\\"vaccination history\\\": \\\"None\\\",\\n\\\"allergies\\\": \\\"None\\\",\\n\\\"exercise frequency\\\": \\\"None\\\",\\n\\\"nutrition\\\": \\\"None\\\",\\n\\\"sexual history\\\": \\\"None\\\",\\n\\\"alcohol consumption\\\": \\\"None\\\",\\n\\\"drug usage\\\": \\\"None\\\",\\n\\\"smoking status\\\": \\\"None\\\"\\n},\\n\\\"surgeries\\\": [\\n{\\n\\\"reason\\\": \\\"Indirect inguinal hernia sac and communicating inguinal hydrocele\\\",\\n\\\"Type\\\": \\\"Exploratory inguinotomy\\\",\\n\\\"time\\\": \\\"12 weeks after initial presentation\\\",\\n\\\"outcome\\\": \\\"Patient recovered well and returned to normal activity four weeks postoperatively with a relief of symptoms\\\",\\n\\\"details\\\": \\\"The sack was removed and the defect repaired\\\"\\n}\\n],\\n\\\"symptoms\\\": [\\n{\\n\\\"name of symptom\\\": \\\"Right lower quadrant pain, nausea, vomiting, intermittent right inguinal bulge, radiating pain into the right scrotum\\\",\\n\\\"intensity of symptom\\\": \\\"None\\\",\\n\\\"location\\\": \\\"Right lower quadrant, right inguinal region, right scrotum\\\",\\n\\\"time\\\": \\\"After jumping off the back of a pickup truck and in the days following\\\",\\n\\\"temporalisation\\\": \\\"Intermittent, spontaneously resolving\\\",\\n\\\"behaviours affecting the symptom\\\": \\\"Rest seemed to resolve the pain and nausea initially\\\",\\n\\\"details\\\": \\\"No scrotal swelling or skin changes were reported\\\"\\n}\\n],\\n\\\"medical examinations\\\": [\\n{\\n\\\"name\\\": \\\"Abdominal/genital exam\\\",\\n\\\"result\\\": \\\"Unimpressive\\\",\\n\\\"details\\\": \\\"Performed by multiple surgeons and a radiologist\\\"\\n},\\n{\\n\\\"name\\\": \\\"Inguinal and scrotal sonography\\\",\\n\\\"result\\\": \\\"No evidence of inguinal hernia and other unimpressive findings\\\",\\n\\\"details\\\": \\\"Mild increased fullness to the right inguinal region, significant tenderness limited comprehensive examination\\\"\\n}\\n],\\n\\\"diagnosis tests\\\": [\\n{\\n\\\"test\\\": \\\"CT imaging with IV/enteric contrast and Valsalva\\\",\\n\\\"severity\\\": \\\"None\\\",\\n\\\"result\\\": \\\"Negative\\\",\\n\\\"condition\\\": \\\"Initially suspected hernia\\\",\\n\\\"time\\\": \\\"During the first visit to the local emergency room\\\",\\n\\\"details\\\": \\\"Ruled out hernia\\\"\\n},\\n{\\n\\\"test\\\": \\\"Repeat CT\\\",\\n\\\"severity\\\": \\\"None\\\",\\n\\\"result\\\": \\\"Unimpressive for herniation or any soft tissue bulge\\\",\\n\\\"condition\\\": \\\"None\\\",\\n\\\"time\\\": \\\"Prior to exploratory surgery\\\",\\n\\\"details\\\": \\\"Patient had difficulty achieving adequate changes at imaging\\\"\\n}\\n],\\n\\\"treatments\\\": [\\n{\\n\\\"name\\\": \\\"Conservative management\\\",\\n\\\"related condition\\\": \\\"Musculoskeletal injury to the lower abdomen\\\",\\n\\\"dosage\\\": \\\"None\\\",\\n\\\"time\\\": \\\"After initial diagnosis at the local emergency room\\\",\\n\\\"frequency\\\": \\\"None\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"reason for taking\\\": \\\"To manage the musculoskeletal injury\\\",\\n\\\"reaction to treatment\\\": \\\"Advised to follow up with primary care if no improvement was noted\\\",\\n\\\"details\\\": \\\"None\\\"\\n}\\n],\\n\\\"discharge\\\": {\\n\\\"reason\\\": \\\"Successful postoperative recovery\\\",\\n\\\"referral\\\": \\\"None\\\",\\n\\\"follow up\\\": \\\"None\\\",\\n\\\"discharge summary\\\": \\\"Patient recovered well and returned to normal activity four weeks postoperatively with a relief of symptoms\\\"\\n}\\n}\",\n          \"{\\n\\\"visit motivation\\\": \\\"Complaint of left side chest pain that lasted for an hour with concomitant hypotension\\\",\\n\\\"admission\\\": [\\n{\\n\\\"reason\\\": \\\"Inferior wall STEMI and suspected TAAD\\\",\\n\\\"date\\\": \\\"None\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"care center details\\\": \\\"Emergency department\\\"\\n}\\n],\\n\\\"patient information\\\": {\\n\\\"age\\\": \\\"58 years old\\\",\\n\\\"sex\\\": \\\"Male\\\",\\n\\\"ethnicity\\\": \\\"None\\\",\\n\\\"weight\\\": \\\"None\\\",\\n\\\"height\\\": \\\"None\\\",\\n\\\"family medical history\\\": \\\"None\\\",\\n\\\"recent travels\\\": \\\"None\\\",\\n\\\"socio economic context\\\": \\\"None\\\",\\n\\\"occupation\\\": \\\"None\\\"\\n},\\n\\\"patient medical history\\\": {\\n\\\"physiological context\\\": \\\"Hypertension without regular medical control\\\",\\n\\\"psychological context\\\": \\\"None\\\",\\n\\\"vaccination history\\\": \\\"None\\\",\\n\\\"allergies\\\": \\\"None\\\",\\n\\\"exercise frequency\\\": \\\"None\\\",\\n\\\"nutrition\\\": \\\"None\\\",\\n\\\"sexual history\\\": \\\"None\\\",\\n\\\"alcohol consumption\\\": \\\"None\\\",\\n\\\"drug usage\\\": \\\"None\\\",\\n\\\"smoking status\\\": \\\"None\\\"\\n},\\n\\\"surgeries\\\": [\\n{\\n\\\"reason\\\": \\\"None\\\",\\n\\\"Type\\\": \\\"None\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"outcome\\\": \\\"None\\\",\\n\\\"details\\\": \\\"None\\\"\\n}\\n],\\n\\\"symptoms\\\": [\\n{\\n\\\"name of symptom\\\": \\\"Chest pain\\\",\\n\\\"intensity of symptom\\\": \\\"None\\\",\\n\\\"location\\\": \\\"Left side\\\",\\n\\\"time\\\": \\\"Lasted for an hour\\\",\\n\\\"temporalisation\\\": \\\"None\\\",\\n\\\"behaviours affecting the symptom\\\": \\\"None\\\",\\n\\\"details\\\": \\\"No cold sweating, radiating pain, or claudication\\\"\\n}\\n],\\n\\\"medical examinations\\\": [\\n{\\n\\\"name\\\": \\\"12-lead electrocardiogram\\\",\\n\\\"result\\\": \\\"Suggested inferior wall and right ventricle STEMI\\\",\\n\\\"details\\\": \\\"ST elevation in leads III, and aVF, lead I with reciprocal ST depression, and right side V4R elevation\\\"\\n},\\n{\\n\\\"name\\\": \\\"Bedside echocardiography\\\",\\n\\\"result\\\": \\\"Dissection flap located over the ascending aorta with moderate aortic valve regurgitation\\\",\\n\\\"details\\\": \\\"None\\\"\\n}\\n],\\n\\\"diagnosis tests\\\": [\\n{\\n\\\"test\\\": \\\"Primary PCI\\\",\\n\\\"severity\\\": \\\"None\\\",\\n\\\"result\\\": \\\"Abnormally large pressure differential between peripheral radial artery and central ascending aorta\\\",\\n\\\"condition\\\": \\\"Suspected TAAD\\\",\\n\\\"time\\\": \\\"Emergent\\\",\\n\\\"details\\\": \\\"Pressure damping site found at the junction of aorta arch and innominate artery\\\"\\n},\\n{\\n\\\"test\\\": \\\"Injection of contrast medium through diagnostic catheter\\\",\\n\\\"severity\\\": \\\"None\\\",\\n\\\"result\\\": \\\"Stenosis near the injection site and irregularly narrowing of the ascending aorta\\\",\\n\\\"condition\\\": \\\"TAAD\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"details\\\": \\\"Extensive dissection involving innominate artery, left carotid artery, and bilateral iliac arteries\\\"\\n},\\n{\\n\\\"test\\\": \\\"Computer tomography of the aorta\\\",\\n\\\"severity\\\": \\\"None\\\",\\n\\\"result\\\": \\\"Verified TAAD with extensive dissection\\\",\\n\\\"condition\\\": \\\"TAAD\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"details\\\": \\\"Evidence of a false lumen compromising the innominate artery that had caused the pressure damping\\\"\\n}\\n],\\n\\\"treatments\\\": [\\n{\\n\\\"name\\\": \\\"Antiplatelet medications\\\",\\n\\\"related condition\\\": \\\"Inferior wall STEMI\\\",\\n\\\"dosage\\\": \\\"None\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"frequency\\\": \\\"None\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"reason for taking\\\": \\\"To manage STEMI\\\",\\n\\\"reaction to treatment\\\": \\\"None\\\",\\n\\\"details\\\": \\\"None\\\"\\n},\\n{\\n\\\"name\\\": \\\"Inotropic agent\\\",\\n\\\"related condition\\\": \\\"Inferior wall STEMI\\\",\\n\\\"dosage\\\": \\\"None\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"frequency\\\": \\\"None\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"reason for taking\\\": \\\"To manage STEMI\\\",\\n\\\"reaction to treatment\\\": \\\"None\\\",\\n\\\"details\\\": \\\"None\\\"\\n}\\n],\\n\\\"discharge\\\": {\\n\\\"reason\\\": \\\"None\\\",\\n\\\"referral\\\": \\\"Consultation with cardiovascular surgeon\\\",\\n\\\"follow up\\\": \\\"None\\\",\\n\\\"discharge summary\\\": \\\"None\\\"\\n}\\n}\",\n          \"{\\n\\\"visit motivation\\\": \\\"Unesthetic appearance of the gums and hypersensitivity in relation to his upper right canine\\\",\\n\\\"admission\\\": [\\n{\\n\\\"reason\\\": \\\"None\\\",\\n\\\"date\\\": \\\"None\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"care center details\\\": \\\"None\\\"\\n}\\n],\\n\\\"patient information\\\": {\\n\\\"age\\\": \\\"32\\\",\\n\\\"sex\\\": \\\"Male\\\",\\n\\\"ethnicity\\\": \\\"None\\\",\\n\\\"weight\\\": \\\"None\\\",\\n\\\"height\\\": \\\"None\\\",\\n\\\"family medical history\\\": \\\"None\\\",\\n\\\"recent travels\\\": \\\"None\\\",\\n\\\"socio economic context\\\": \\\"None\\\",\\n\\\"occupation\\\": \\\"None\\\"\\n},\\n\\\"patient medical history\\\": {\\n\\\"physiological context\\\": \\\"No significant medical history\\\",\\n\\\"psychological context\\\": \\\"None\\\",\\n\\\"vaccination history\\\": \\\"None\\\",\\n\\\"allergies\\\": \\\"None\\\",\\n\\\"exercise frequency\\\": \\\"None\\\",\\n\\\"nutrition\\\": \\\"None\\\",\\n\\\"sexual history\\\": \\\"None\\\",\\n\\\"alcohol consumption\\\": \\\"None\\\",\\n\\\"drug usage\\\": \\\"None\\\",\\n\\\"smoking status\\\": \\\"No habits were reported\\\"\\n},\\n\\\"surgeries\\\": [\\n{\\n\\\"reason\\\": \\\"Localized gingival inflammation and Class I gingival recession in relation to maxillary right canine\\\",\\n\\\"Type\\\": \\\"Root coverage using an epithelial embossed graft technique\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"outcome\\\": \\\"None\\\",\\n\\\"details\\\": \\\"Oral prophylaxis was done 2 weeks before surgery.\\nUnder local anesthesia, a sulcular incision was made in the right canine region, also involving mesial aspect of the first premolar and distal aspect of the lateral incisor.\\nEnvelop flap was raised without making vertical incisions.\\nThorough root planing was done.\\nThe connective tissue graft was procured from the contralateral side of the palate.\\\"\\n}\\n],\\n\\\"symptoms\\\": [\\n{\\n\\\"name of symptom\\\": \\\"Hypersensitivity\\\",\\n\\\"intensity of symptom\\\": \\\"None\\\",\\n\\\"location\\\": \\\"Upper right canine\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"temporalisation\\\": \\\"None\\\",\\n\\\"behaviours affecting the symptom\\\": \\\"None\\\",\\n\\\"details\\\": \\\"Patient reported hypersensitivity in relation to his upper right canine.\\\"\\n},\\n{\\n\\\"name of symptom\\\": \\\"Unesthetic appearance of the gums\\\",\\n\\\"intensity of symptom\\\": \\\"None\\\",\\n\\\"location\\\": \\\"Gums in relation to upper right canine\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"temporalisation\\\": \\\"None\\\",\\n\\\"behaviours affecting the symptom\\\": \\\"None\\\",\\n\\\"details\\\": \\\"Patient reported unesthetic appearance of the gums.\\\"\\n}\\n],\\n\\\"medical examinations\\\": [\\n{\\n\\\"name\\\": \\\"Periodontal examination\\\",\\n\\\"result\\\": \\\"Localized gingival inflammation in relation to maxillary right canine, probing pocket depth of 2 mm, clinical attachment loss of 5 mm with deep/wide Class I gingival recession, keratinized tissue thickness of 2 mm\\\",\\n\\\"details\\\": \\\"The keratinized tissue thickness was measured at the center of an imaginary line from mucogingival junction to marginal gingiva, using an endodontic file with stopper after anesthetizing the region.\\\"\\n},\\n{\\n\\\"name\\\": \\\"Intraoral radiograph\\\",\\n\\\"result\\\": \\\"No bone loss\\\",\\n\\\"details\\\": \\\"Intraoral radiograph in relation to the tooth concerned showed no bone loss.\\\"\\n}\\n],\\n\\\"diagnosis tests\\\": [\\n{\\n\\\"test\\\": \\\"None\\\",\\n\\\"severity\\\": \\\"None\\\",\\n\\\"result\\\": \\\"None\\\",\\n\\\"condition\\\": \\\"None\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"details\\\": \\\"None\\\"\\n}\\n],\\n\\\"treatments\\\": [\\n{\\n\\\"name\\\": \\\"Root coverage using an epithelial embossed graft technique\\\",\\n\\\"related condition\\\": \\\"Localized gingival inflammation and Class I gingival recession in relation to maxillary right canine\\\",\\n\\\"dosage\\\": \\\"None\\\",\\n\\\"time\\\": \\\"None\\\",\\n\\\"frequency\\\": \\\"None\\\",\\n\\\"duration\\\": \\\"None\\\",\\n\\\"reason for taking\\\": \\\"To cover the root and improve the esthetic appearance of the gums and reduce hypersensitivity\\\",\\n\\\"reaction to treatment\\\": \\\"None\\\",\\n\\\"details\\\": \\\"Treatment plan was explained to the patient, and a duly signed written consent was obtained.\\\"\\n}\\n],\\n\\\"discharge\\\": {\\n\\\"reason\\\": \\\"None\\\",\\n\\\"referral\\\": \\\"None\\\",\\n\\\"follow up\\\": \\\"None\\\",\\n\\\"discharge summary\\\": \\\"None\\\"\\n}\\n}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"full_note\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 24341,\n        \"samples\": [\n          \"A 35-year-old G4P2 attended for reproductive surgery consultation to discuss a variety of problems she began to experience subsequent to undergoing the Essure\\u00ae procedure for permanent sterilization. HS was performed in October 2012 under general anesthesia; pre-procedure pelvic ultrasound was unremarkable. Before HS, the patient was in good general health and all of her pregnancies were established without medical assistance. Cervical cytology was routinely normal, the patient did not smoke and she never had a miscarriage. Soon after the Essure\\u00ae devices had been placed, the patient reported gradually increasing pelvic pain, headache, dizziness, lower extremity paresthesia and fatigue. In the first six months following the Essure\\u00ae procedure, the patient registered a 20 pound weight gain. The patient\\u2019s concerns persisted over a three-year interval, although her gynecologist was disinclined to attribute any of the problems to Essure\\u00ae.\\\\nThree months after HS, the patient presented for hysterosalpingogram as recommended. While the study did confirm bilateral tubal occlusion, it also revealed an abnormal (bifid) uterine cavity. 3-D ultrasound or other imaging was not performed to clarify or refine the diagnosis of the uterine anomaly and the patient received no further counseling.\\\\nThe patient later requested surgical removal of the Essure\\u00ae implants and the possibility of device migration required evaluation (). A repeat HSG was obtained in 2015. This study revealed minimal device migration and no contrast dye spill from either Fallopian tube, a deeply bifid uterine cavity was again the most conspicuous finding ().\\\\nAt our center the patient was counseled about the atypical nature of her Essure\\u00ae placement given the anatomical abnormality of the uterus. After obtaining informed consent, the patient underwent diagnostic hysteroscopy which verified an abnormal bifid uterus (). The ostia on the right was normal as was the entire right uterine segment. However, the Essure\\u00ae device on the left partially extended into the endometrial compartment (). The exterior uterus was consistent with ESHRE Class IIb anomaly (uterine septum) (). There was no evidence of tissue perforation by either contraceptive device. Laparoscopic dissection of the left cornu and partial tubal resection bilaterally achieved complete removal of the Essure\\u00ae implants. Removal of terminal markers was confirmed. Electrocautery was maintained at 40 W power throughout the case, blood loss was estimated to be less than 50 mL. The patient was discharged three hours after surgery and her postoperative convalescence has been uneventful.\",\n          \"A 72-year-old man presented with left hip pain and intermittent low grade fever, as well as occasional yellowish drainage from a sinus tract at the surgical incision of a cementless THA performed 4 years before at another hospital. Patient's past medical history was also significant for a 2-vessel coronary artery bypass graft (CABG), performed one year prior to the current presentation. Prior use of steroids, a previous state of immunosuppression, or recent travel was not reported. The patient reported multiple prior hospital admissions due to drainage, allegedly attributed to a superficial infection and suppressed multiple times with multiple courses of per os and/or intravenous antibiotics including vancomycin, clindamycin, ciprofloxacin and cotrimoxazole, only to recur a few months after each episode and antibiotics regimen. Anteroposterior (AP) pelvis, AP and lateral hip radiographs as well as laboratory findings were consistent with PJI, as well as heterotopic ossification adjacent to the left hip joint (Fig. ). Preoperative cultures collected with wound swabs showed Staphylococcus hominis and Staphylococcus capitis isolates of debatable clinical significance; cultures of synovial fluid aspiration were negative. With the assumptive diagnosis of PJI and septic loosening of the implants a joint decision was obtained for a staged THA revision.\\\\nThe patient was scheduled for the first stage THA revision 4 weeks after cessation of any antibiotics. Through a posterior hip approach, the femoral component was removed via a Paprosky-style extended proximal femoral osteotomy . Next, the acetabular cup and supporting screw were removed (Fig. ). Eight tissue samples were obtained from the bone, joint capsule and femoral canal for cultures, and the implants were sent for sonication. We routinely use sonication to identify bacteria in the biofilm on explanted implants, as this method has been found to be significantly more sensitive than tissue biopsy, while maintaining almost identical specificity , . A custom-made polymethyl-methacrylate (PMMA) hip spacer was fashioned and placed in the femoral lumen. We used gentamicin-loaded Palacos R+G\\u00ae bone cement (Zimmer, Inc. Warsaw, IN). When using an antibiotic loaded bone cement, we routinely admixture a second antibiotic (preferably vancomycin or other based on preoperative cultures and antibiogram, if available) to increase the local concentration of antibiotics and to obtain a synergistic effect, as adding a second antibiotic seems to increase the elution of both antibiotics , . The osteotomy was repaired with cerclage wires (Fig. ). The sinus tract was resected. The patient was given 600mg of teicoplanin iv intraoperatively and was subsequently started on a standing daily dose of the same regimen.\\\\nPostoperative recovery was uneventful and the patient was afebrile without any wound healing problems. Partial weight bearing with a walker was started on postoperative day two, and progressed as tolerated. Intraoperative tissue cultures were negative. Sonication of the implant at 15 days showed Pseudomonas oryzihabitans bacterial isolate (Fig. ). Based on antibiotic susceptibilities, intravenous teicoplanin 600 mg and piperacillin/tazobactam 4.5 g qid was administered for 3 weeks, followed by ciprofloxacin 750 mg bid and clindamicin 600 mg qid for another four weeks, aiming for a second stage revision surgery. However, because of cardiovascular comorbidities, the patient was informed for the high risk associated with a second operation and did not consent for further surgery.\\\\nAt the last follow-up, 24 months after the first stage THA revision, the patient is well, without any clinical, laboratory or imaging evidence of infection; his wound healed completely, he could ambulate with crutches for short distances with mild pain, and inflammatory markers had reduced to normal values. Radiographs of the left hip joint showed a stable PMMA spacer, without any evidence of osteolysis or loosening, and with extensive periarticular heterotopic bone formation that obviously provided for the stability of the joint (Fig. ). The patient denied further surgery and remains at close follow-up for the risk of recurrent Pseudomonas oryzihabitans infection.\",\n          \"A 32-year-old woman was admitted to the gastroenterology department for upper abdominal pain. Gastroenteritis was continually managed using omeprazole. The treatment relieved her symptoms just a little. The symptoms of upper abdominal pain appeared intermittently for about 8 months. Repeated visits to the gastroenterology department and other departments in the local hospital were made. Omeprazole treatment for gastroenteritis was continued. However, the symptoms were still not improving. Finally, the patient went to the local gastrointestinal surgery department. The abdomen computed tomography examination was performed, which revealed that thrombosis had occurred in the portal vein, superior mesenteric vein and splenic vein (Fig. ). The thrombus did not improve even after repeated visits in gastrointestinal surgery and vascular surgery. The patient was referred to the Rheumatology Department in the hospital for the aggravation of abdominal pain, involving the whole abdomen.\\\\nThe patient had two abnormal abortions in past medical history. Abnormal physical examinations included total abdominal tenderness, rebound pain and muscle tension. The patient declined for abdominal palpation. Laboratory investigations showed raised APL (anti-\\u03b22GPI 143R U/mL, ACL IgM 70 U/mL, ACL IgG 20 U/mL). Renal biochemistry, hepatobiliary biochemistry, serum lipid profile, muscular enzymes and thyroid function were normal. Computed tomography of the abdomen confirmed multiple thrombi in superior mesenteric vein and other vessels, dilatation of the small intestine and spleen infarction (Fig. ).\\\\nThe patient was diagnosed with antiphospholipid syndrome based on clinical manifestations, past medical history and auxiliary examination results. The patient did not meet the catastrophic antiphospholipid syndrome (CAPS) diagnostic criteria. The patient claimed a previous pregnancy loss and presented with characteristics of high-risk APL (Table ). Moreover, the patient was affected by multiple abdominal vessels and viscus. Therefore, these findings demonstrated that the patient based on the 2019 EULAR recommendations for the management of antiphospholipid syndrome in adults, was at high risk. The patient was administered with intravenous immunoglobulin (gamma globulin 40 mg daily) and glucocorticoid (methylprednisolone 40 mg daily) to limit further disease progression. Low molecular weight heparin (LMWH, enoxaparin 40 mg twice a day) therapeutic dose was used for anticoagulant therapy. Abdominal pain was significantly improved after systemic treatment. The patient was discharged and put on warfarin given orally 3 mg daily, methylprednisolone 40 mg daily, and hydroxychloroquine 0.2 g twice daily to be taken with food.\\\\nAfter months of discharge, the patient was later hospitalized with recurrent abdominal pain. The patient complained about nausea, vomiting, abdominal distension, no defecation, and no exhaust during the last treatment in the Rheumatology Department. The abdominal computed tomography indicated incomplete ileus (Fig. ). Gastrointestinal decompression and conservative medical treatment were performed first. However, the therapeutic effect was not satisfactory. Therefore, the patient was transferred to the department of gastrointestinal surgery for surgical treatment. As for the reasons for the patient's admission, we consider the following two aspects: First, the patient had multiple mesenteric thromboses. Although anticoagulant therapy was applied, it could only prevent new thrombosis, the existing thrombosis could not be dissolved. Also, the collateral circulation was not completely established, leading to insufficient blood supply to the intestinal tract and non-mechanical obstruction. Second, although the patient regularly took warfarin anticoagulant therapy after discharge, the drug is greatly affected by diet and inconvenient monitoring, so the INR value outside the hospital was poorly controlled.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"}},"metadata":{},"execution_count":8}]},{"cell_type":"markdown","source":["#**MIMIC DATA**\n"],"metadata":{"id":"E-shcgGWA_Wd"}},{"cell_type":"code","source":["mimic_data_prescription=pd.read_csv(\"/content/prescriptions (1).csv.crdownload\")\n","mimic_data_prescription.head()"],"metadata":{"id":"wLYechgdBDOC","colab":{"base_uri":"https://localhost:8080/","height":400},"executionInfo":{"status":"ok","timestamp":1748790580784,"user_tz":240,"elapsed":12436,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"da822287-66ae-4fbb-b5d0-79b4df0880f6"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["   subject_id   hadm_id  pharmacy_id       poe_id  poe_seq  \\\n","0    10000032  22595853     11700683  10000032-34     34.0   \n","1    10000032  22595853     14779570  10000032-22     22.0   \n","2    10000032  22595853     19796602  10000032-50     50.0   \n","3    10000032  22595853     20256254  10000032-32     32.0   \n","4    10000032  22595853     28781051  10000032-27     27.0   \n","\n","             starttime             stoptime drug_type  \\\n","0  2180-05-07 01:00:00  2180-05-07 22:00:00      MAIN   \n","1  2180-05-07 00:00:00  2180-05-07 22:00:00      MAIN   \n","2  2180-05-08 08:00:00  2180-05-07 22:00:00      MAIN   \n","3  2180-05-07 01:00:00  2180-05-07 22:00:00      MAIN   \n","4  2180-05-07 00:00:00  2180-05-07 22:00:00      MAIN   \n","\n","                          drug formulary_drug_cd     gsn           ndc  \\\n","0                Acetaminophen           APAP500  004490  9.041989e+08   \n","1  Sodium Chloride 0.9%  Flush         NACLFLUSH     NaN  0.000000e+00   \n","2                   Furosemide            FURO40  008209  5.107901e+10   \n","3                  Raltegravir           RALT400  063231  6.022761e+06   \n","4                      Heparin            HEPA5I  006549  6.332303e+10   \n","\n","               prod_strength form_rx dose_val_rx dose_unit_rx form_val_disp  \\\n","0               500mg Tablet     NaN         500           mg             1   \n","1              10 mL Syringe     NaN           3           mL           0.3   \n","2                40mg Tablet     NaN          40           mg             1   \n","3              400 mg Tablet     NaN         400           mg             1   \n","4  5000 Units / mL- 1mL Vial     NaN        5000         UNIT             1   \n","\n","  form_unit_disp  doses_per_24_hrs  route  \n","0            TAB               NaN  PO/NG  \n","1            SYR               3.0     IV  \n","2            TAB               1.0  PO/NG  \n","3            TAB               2.0     PO  \n","4             mL               3.0     SC  "],"text/html":["\n","  <div id=\"df-f7cb8727-1cf2-4b56-91f1-f516f5408962\" class=\"colab-df-container\">\n","    <div>\n","<style scoped>\n","    .dataframe tbody tr th:only-of-type {\n","        vertical-align: middle;\n","    }\n","\n","    .dataframe tbody tr th {\n","        vertical-align: top;\n","    }\n","\n","    .dataframe thead th {\n","        text-align: right;\n","    }\n","</style>\n","<table border=\"1\" class=\"dataframe\">\n","  <thead>\n","    <tr style=\"text-align: right;\">\n","      <th></th>\n","      <th>subject_id</th>\n","      <th>hadm_id</th>\n","      <th>pharmacy_id</th>\n","      <th>poe_id</th>\n","      <th>poe_seq</th>\n","      <th>starttime</th>\n","      <th>stoptime</th>\n","      <th>drug_type</th>\n","      <th>drug</th>\n","      <th>formulary_drug_cd</th>\n","      <th>gsn</th>\n","      <th>ndc</th>\n","      <th>prod_strength</th>\n","      <th>form_rx</th>\n","      <th>dose_val_rx</th>\n","      <th>dose_unit_rx</th>\n","      <th>form_val_disp</th>\n","      <th>form_unit_disp</th>\n","      <th>doses_per_24_hrs</th>\n","      <th>route</th>\n","    </tr>\n","  </thead>\n","  <tbody>\n","    <tr>\n","      <th>0</th>\n","      <td>10000032</td>\n","      <td>22595853</td>\n","      <td>11700683</td>\n","      <td>10000032-34</td>\n","      <td>34.0</td>\n","      <td>2180-05-07 01:00:00</td>\n","      <td>2180-05-07 22:00:00</td>\n","      <td>MAIN</td>\n","      <td>Acetaminophen</td>\n","      <td>APAP500</td>\n","      <td>004490</td>\n","      <td>9.041989e+08</td>\n","      <td>500mg Tablet</td>\n","      <td>NaN</td>\n","      <td>500</td>\n","      <td>mg</td>\n","      <td>1</td>\n","      <td>TAB</td>\n","      <td>NaN</td>\n","      <td>PO/NG</td>\n","    </tr>\n","    <tr>\n","      <th>1</th>\n","      <td>10000032</td>\n","      <td>22595853</td>\n","      <td>14779570</td>\n","      <td>10000032-22</td>\n","      <td>22.0</td>\n","      <td>2180-05-07 00:00:00</td>\n","      <td>2180-05-07 22:00:00</td>\n","      <td>MAIN</td>\n","      <td>Sodium Chloride 0.9%  Flush</td>\n","      <td>NACLFLUSH</td>\n","      <td>NaN</td>\n","      <td>0.000000e+00</td>\n","      <td>10 mL Syringe</td>\n","      <td>NaN</td>\n","      <td>3</td>\n","      <td>mL</td>\n","      <td>0.3</td>\n","      <td>SYR</td>\n","      <td>3.0</td>\n","      <td>IV</td>\n","    </tr>\n","    <tr>\n","      <th>2</th>\n","      <td>10000032</td>\n","      <td>22595853</td>\n","      <td>19796602</td>\n","      <td>10000032-50</td>\n","      <td>50.0</td>\n","      <td>2180-05-08 08:00:00</td>\n","      <td>2180-05-07 22:00:00</td>\n","      <td>MAIN</td>\n","      <td>Furosemide</td>\n","      <td>FURO40</td>\n","      <td>008209</td>\n","      <td>5.107901e+10</td>\n","      <td>40mg Tablet</td>\n","      <td>NaN</td>\n","      <td>40</td>\n","      <td>mg</td>\n","      <td>1</td>\n","      <td>TAB</td>\n","      <td>1.0</td>\n","      <td>PO/NG</td>\n","    </tr>\n","    <tr>\n","      <th>3</th>\n","      <td>10000032</td>\n","      <td>22595853</td>\n","      <td>20256254</td>\n","      <td>10000032-32</td>\n","      <td>32.0</td>\n","      <td>2180-05-07 01:00:00</td>\n","      <td>2180-05-07 22:00:00</td>\n","      <td>MAIN</td>\n","      <td>Raltegravir</td>\n","      <td>RALT400</td>\n","      <td>063231</td>\n","      <td>6.022761e+06</td>\n","      <td>400 mg Tablet</td>\n","      <td>NaN</td>\n","      <td>400</td>\n","      <td>mg</td>\n","      <td>1</td>\n","      <td>TAB</td>\n","      <td>2.0</td>\n","      <td>PO</td>\n","    </tr>\n","    <tr>\n","      <th>4</th>\n","      <td>10000032</td>\n","      <td>22595853</td>\n","      <td>28781051</td>\n","      <td>10000032-27</td>\n","      <td>27.0</td>\n","      <td>2180-05-07 00:00:00</td>\n","      <td>2180-05-07 22:00:00</td>\n","      <td>MAIN</td>\n","      <td>Heparin</td>\n","      <td>HEPA5I</td>\n","      <td>006549</td>\n","      <td>6.332303e+10</td>\n","      <td>5000 Units / mL- 1mL Vial</td>\n","      <td>NaN</td>\n","      <td>5000</td>\n","      <td>UNIT</td>\n","      <td>1</td>\n","      <td>mL</td>\n","      <td>3.0</td>\n","      <td>SC</td>\n","    </tr>\n","  </tbody>\n","</table>\n","</div>\n","    <div class=\"colab-df-buttons\">\n","\n","  <div class=\"colab-df-container\">\n","    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-f7cb8727-1cf2-4b56-91f1-f516f5408962')\"\n","            title=\"Convert this dataframe to an interactive table.\"\n","            style=\"display:none;\">\n","\n","  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n","    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n","  </svg>\n","    </button>\n","\n","  <style>\n","    .colab-df-container {\n","      display:flex;\n","      gap: 12px;\n","    }\n","\n","    .colab-df-convert {\n","      background-color: #E8F0FE;\n","      border: none;\n","      border-radius: 50%;\n","      cursor: pointer;\n","      display: none;\n","      fill: #1967D2;\n","      height: 32px;\n","      padding: 0 0 0 0;\n","      width: 32px;\n","    }\n","\n","    .colab-df-convert:hover {\n","      background-color: #E2EBFA;\n","      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n","      fill: #174EA6;\n","    }\n","\n","    .colab-df-buttons div {\n","      margin-bottom: 4px;\n","    }\n","\n","    [theme=dark] .colab-df-convert {\n","      background-color: #3B4455;\n","      fill: #D2E3FC;\n","    }\n","\n","    [theme=dark] .colab-df-convert:hover {\n","      background-color: #434B5C;\n","      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n","      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n","      fill: #FFFFFF;\n","    }\n","  </style>\n","\n","    <script>\n","      const buttonEl =\n","        document.querySelector('#df-f7cb8727-1cf2-4b56-91f1-f516f5408962 button.colab-df-convert');\n","      buttonEl.style.display =\n","        google.colab.kernel.accessAllowed ? 'block' : 'none';\n","\n","      async function convertToInteractive(key) {\n","        const element = document.querySelector('#df-f7cb8727-1cf2-4b56-91f1-f516f5408962');\n","        const dataTable =\n","          await google.colab.kernel.invokeFunction('convertToInteractive',\n","                                                    [key], {});\n","        if (!dataTable) return;\n","\n","        const docLinkHtml = 'Like what you see? Visit the ' +\n","          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n","          + ' to learn more about interactive tables.';\n","        element.innerHTML = '';\n","        dataTable['output_type'] = 'display_data';\n","        await google.colab.output.renderOutput(dataTable, element);\n","        const docLink = document.createElement('div');\n","        docLink.innerHTML = docLinkHtml;\n","        element.appendChild(docLink);\n","      }\n","    </script>\n","  </div>\n","\n","\n","    <div id=\"df-f9df9ad3-1821-4a17-ade6-a8c5153c3b5a\">\n","      <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-f9df9ad3-1821-4a17-ade6-a8c5153c3b5a')\"\n","                title=\"Suggest charts\"\n","                style=\"display:none;\">\n","\n","<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n","     width=\"24px\">\n","    <g>\n","        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n","    </g>\n","</svg>\n","      </button>\n","\n","<style>\n","  .colab-df-quickchart {\n","      --bg-color: #E8F0FE;\n","      --fill-color: #1967D2;\n","      --hover-bg-color: #E2EBFA;\n","      --hover-fill-color: #174EA6;\n","      --disabled-fill-color: #AAA;\n","      --disabled-bg-color: #DDD;\n","  }\n","\n","  [theme=dark] .colab-df-quickchart {\n","      --bg-color: #3B4455;\n","      --fill-color: #D2E3FC;\n","      --hover-bg-color: #434B5C;\n","      --hover-fill-color: #FFFFFF;\n","      --disabled-bg-color: #3B4455;\n","      --disabled-fill-color: #666;\n","  }\n","\n","  .colab-df-quickchart {\n","    background-color: var(--bg-color);\n","    border: none;\n","    border-radius: 50%;\n","    cursor: pointer;\n","    display: none;\n","    fill: var(--fill-color);\n","    height: 32px;\n","    padding: 0;\n","    width: 32px;\n","  }\n","\n","  .colab-df-quickchart:hover {\n","    background-color: var(--hover-bg-color);\n","    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n","    fill: var(--button-hover-fill-color);\n","  }\n","\n","  .colab-df-quickchart-complete:disabled,\n","  .colab-df-quickchart-complete:disabled:hover {\n","    background-color: var(--disabled-bg-color);\n","    fill: var(--disabled-fill-color);\n","    box-shadow: none;\n","  }\n","\n","  .colab-df-spinner {\n","    border: 2px solid var(--fill-color);\n","    border-color: transparent;\n","    border-bottom-color: var(--fill-color);\n","    animation:\n","      spin 1s steps(1) infinite;\n","  }\n","\n","  @keyframes spin {\n","    0% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","      border-left-color: var(--fill-color);\n","    }\n","    20% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    30% {\n","      border-color: transparent;\n","      border-left-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","      border-right-color: var(--fill-color);\n","    }\n","    40% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-top-color: var(--fill-color);\n","    }\n","    60% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","    }\n","    80% {\n","      border-color: transparent;\n","      border-right-color: var(--fill-color);\n","      border-bottom-color: var(--fill-color);\n","    }\n","    90% {\n","      border-color: transparent;\n","      border-bottom-color: var(--fill-color);\n","    }\n","  }\n","</style>\n","\n","      <script>\n","        async function quickchart(key) {\n","          const quickchartButtonEl =\n","            document.querySelector('#' + key + ' button');\n","          quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n","          quickchartButtonEl.classList.add('colab-df-spinner');\n","          try {\n","            const charts = await google.colab.kernel.invokeFunction(\n","                'suggestCharts', [key], {});\n","          } catch (error) {\n","            console.error('Error during call to suggestCharts:', error);\n","          }\n","          quickchartButtonEl.classList.remove('colab-df-spinner');\n","          quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n","        }\n","        (() => {\n","          let quickchartButtonEl =\n","            document.querySelector('#df-f9df9ad3-1821-4a17-ade6-a8c5153c3b5a button');\n","          quickchartButtonEl.style.display =\n","            google.colab.kernel.accessAllowed ? 'block' : 'none';\n","        })();\n","      </script>\n","    </div>\n","\n","    </div>\n","  </div>\n"],"application/vnd.google.colaboratory.intrinsic+json":{"type":"dataframe","variable_name":"mimic_data_prescription"}},"metadata":{},"execution_count":29}]},{"cell_type":"code","source":["mimic_data_prescription.to_csv(\"mimic_prescription.csv\")"],"metadata":{"id":"Ipl7G6oLBPRX"},"execution_count":null,"outputs":[]},{"cell_type":"markdown","source":["# **FINAL COLUMNS**"],"metadata":{"id":"XiDjeYLUohoy"}},{"cell_type":"code","source":["df_final_fda.columns\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"CFuVNK3uog-e","executionInfo":{"status":"ok","timestamp":1748789764025,"user_tz":240,"elapsed":182,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"fc4699bb-82e4-4428-bad7-aea0a4d501fc"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["Index(['submissions', 'application_number', 'sponsor_name',\n","       'openfda.application_number', 'openfda.brand_name',\n","       'openfda.generic_name', 'openfda.manufacturer_name',\n","       'openfda.product_ndc', 'openfda.product_type', 'openfda.route',\n","       'openfda.substance_name', 'openfda.rxcui', 'openfda.spl_id',\n","       'openfda.spl_set_id', 'openfda.package_ndc', 'openfda.unii',\n","       'openfda.nui', 'openfda.pharm_class_pe', 'openfda.pharm_class_epc',\n","       'openfda.pharm_class_cs', 'openfda.pharm_class_moa', 'product_number',\n","       'reference_drug', 'brand_name', 'reference_standard', 'dosage_form',\n","       'route', 'marketing_status', 'te_code', 'name', 'strength'],\n","      dtype='object')"]},"metadata":{},"execution_count":9}]},{"cell_type":"code","source":["clinical_notes.columns\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"KKEueEZOpBCT","executionInfo":{"status":"ok","timestamp":1748789764159,"user_tz":240,"elapsed":157,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"d5f53455-f00b-4b93-e739-250c88d9c49c"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["Index(['note', 'conversation', 'idx', 'summary', 'full_note'], dtype='object')"]},"metadata":{},"execution_count":10}]},{"cell_type":"code","source":["kaggle_drug.columns"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"F1sO09JspDIe","executionInfo":{"status":"ok","timestamp":1748789764251,"user_tz":240,"elapsed":85,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"9a5e4b25-ebb3-4e43-f68b-573c6bea6e99"},"execution_count":null,"outputs":[{"output_type":"execute_result","data":{"text/plain":["Index(['Drug 1', 'Drug 2', 'Interaction Description'], dtype='object')"]},"metadata":{},"execution_count":11}]},{"cell_type":"markdown","source":["# **EDA on FDA**"],"metadata":{"id":"-GxU1aY3U1uF"}},{"cell_type":"code","source":["#Flatten and count\n","flat_pharm_names = [name for sublist in df_final_fda[\"openfda.pharm_class_pe\"].dropna() for name in sublist]\n","\n","pharm_class_pe = Counter(flat_pharm_names)\n","\n","##Count df\n","pharm_class_pe_df = pd.DataFrame(pharm_class_pe.items(), columns=[\"pharm_class\", \"count\"]).sort_values(by=\"count\", ascending=False)\n","\n","print(\"Top 10 Pharmacologic Classes (Physiologic Effect):\\n\", pharm_class_pe_df.head(10))\n","\n","\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"EXxDyoDVVnyu","executionInfo":{"status":"ok","timestamp":1748789764473,"user_tz":240,"elapsed":83,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"0f9ce9db-7be4-4549-cc56-d074e754a04a"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["Top 10 Pharmacologic Classes (Physiologic Effect):\n","                                           pharm_class  count\n","0                             Increased Diuresis [PE]    838\n","9   Decreased Central Nervous System Disorganized ...    759\n","2             Central Nervous System Stimulation [PE]    173\n","10                                  Vasodilation [PE]    141\n","20                Decreased Platelet Aggregation [PE]    107\n","11           Increased Diuresis at Loop of Henle [PE]    103\n","26     Decreased Respiratory Secretion Viscosity [PE]     90\n","8               Decreased Cholesterol Absorption [PE]     80\n","22                Decreased Immunologic Activity [PE]     78\n","21                        Microtubule Inhibition [PE]     74\n"]}]},{"cell_type":"code","source":["##Visualize\n","plt.figure(figsize=(10, 5))\n","pharm_class_pe_df.head(10).plot.bar(x=\"pharm_class\", y=\"count\", legend=False, title=\"Top 10 Pharmacologic Classes (PE)\", color=\"mediumpurple\")\n","plt.ylabel(\"Count\")\n","plt.xticks(rotation=45, ha=\"right\")\n","plt.tight_layout()\n","plt.show()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":504},"id":"zfVcdE_aV8VG","executionInfo":{"status":"ok","timestamp":1748789765590,"user_tz":240,"elapsed":1101,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"b388c369-c93d-46a5-e67b-60779891777c"},"execution_count":null,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x500 with 0 Axes>"]},"metadata":{}},{"output_type":"display_data","data":{"text/plain":["<Figure size 640x480 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}]},{"cell_type":"code","source":["##Count values for binary flags\n","ref_drug_counts = df_final_fda[\"reference_drug\"].value_counts(dropna=False)\n","ref_std_counts = df_final_fda[\"reference_standard\"].value_counts(dropna=False)\n","marketing_status_counts = df_final_fda[\"marketing_status\"].value_counts(dropna=False)\n","\n","print(\"Reference Drug Flag Counts:\\n\", ref_drug_counts)\n","print(\"\\nReference Standard Flag Counts:\\n\", ref_std_counts)\n","print(\"\\nMarketing Status Distribution:\\n\", marketing_status_counts)\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"hLDz_BuuW8Hw","executionInfo":{"status":"ok","timestamp":1748789765738,"user_tz":240,"elapsed":133,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"c41d7aaf-17d6-44e8-a0fc-cd7c679d8a9c"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["Reference Drug Flag Counts:\n"," reference_drug\n","No     48403\n","Yes     9157\n","NaN      361\n","TBD      103\n","Name: count, dtype: int64\n","\n","Reference Standard Flag Counts:\n"," reference_standard\n","No                        50818\n","Yes                        5257\n","NaN                        1948\n","ESOMEPRAZOLE MAGNESIUM        1\n","Name: count, dtype: int64\n","\n","Marketing Status Distribution:\n"," marketing_status\n","Prescription                 28902\n","Discontinued                 26203\n","None (Tentative Approval)     1606\n","Over-the-counter               953\n","NaN                            360\n","Name: count, dtype: int64\n"]}]},{"cell_type":"code","source":["##remove unexpected non-binary string\n","df_final_fda[\"reference_standard\"] =  df_final_fda[\"reference_standard\"].replace(\"ESOMEPRAZOLE MAGNESIUM\", pd.NA)\n"],"metadata":{"id":"tMogPsl1Y9Vu"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["##Replace missing/NaN values\n","df_final_fda[\"marketing_status_clean\"] = df_final_fda[\"marketing_status\"].fillna(\"Unknown\")\n","\n","##Count\n","marketing_counts = df_final_fda[\"marketing_status_clean\"].value_counts()\n","\n","##Viusalise\n","plt.figure(figsize=(10, 5))\n","marketing_counts.plot(kind=\"bar\", color=\"coral\")\n","plt.title(\"Marketing Status Distribution\")\n","plt.xlabel(\"Marketing Status\")\n","plt.ylabel(\"Number of Drugs\")\n","plt.xticks(rotation=45, ha=\"right\")\n","plt.tight_layout()\n","plt.show()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":507},"id":"2ttCDXflpgOQ","executionInfo":{"status":"ok","timestamp":1748789767747,"user_tz":240,"elapsed":1926,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"4cf68cdf-aee7-4119-8ee9-2c16df8a579f"},"execution_count":null,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x500 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}]},{"cell_type":"markdown","source":["# **EDA on clinical_notes**"],"metadata":{"id":"WBVg3H-IqX-B"}},{"cell_type":"code","source":["##Length\n","print(\"Total rows:\", len(clinical_notes))\n","print(\"Unique idx values:\", len(set(clinical_notes['idx'])))\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"Fx0TWJx0q1iH","executionInfo":{"status":"ok","timestamp":1748789767958,"user_tz":240,"elapsed":98,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"b2c5f5b2-3b8b-4412-f1ef-f9497508dcb7"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["Total rows: 30000\n","Unique idx values: 30000\n"]}]},{"cell_type":"code","source":["#Notes df\n","df_notes = pd.DataFrame(clinical_notes)\n","\n","##length\n","df_notes[\"note_length\"] = df_notes[\"note\"].str.len()\n","df_notes[\"summary_length\"] = df_notes[\"summary\"].str.len()\n","df_notes[\"full_note_length\"] = df_notes[\"full_note\"].str.len()\n","\n","print(df_notes[[\"note_length\", \"summary_length\", \"full_note_length\"]].describe())\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"VArjqkM1rETS","executionInfo":{"status":"ok","timestamp":1748789768136,"user_tz":240,"elapsed":97,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"fa8378de-1ab1-4957-a957-d81d44d4ec50"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["        note_length  summary_length  full_note_length\n","count  30000.000000    30000.000000      30000.000000\n","mean    2050.386533     3476.303200       3441.443667\n","std       91.738198      641.547313       1473.074268\n","min     1689.000000      864.000000        746.000000\n","25%     1988.000000     3050.000000       2456.000000\n","50%     2048.000000     3417.000000       3034.000000\n","75%     2111.000000     3840.000000       3953.000000\n","max     2445.000000     7904.000000      30995.000000\n"]}]},{"cell_type":"code","source":["##Visualize\n","plt.figure(figsize=(10, 5))\n","df_notes[\"full_note_length\"].hist(bins=50, alpha=0.6, label=\"Full Note\")\n","df_notes[\"note_length\"].hist(bins=50, alpha=0.6, label=\"Note\")\n","df_notes[\"summary_length\"].hist(bins=50, alpha=0.6, label=\"Summary\")\n","plt.legend()\n","plt.title(\"Length Distribution (Characters)\")\n","plt.xlabel(\"Text Length\")\n","plt.ylabel(\"Frequency\")\n","plt.tight_layout()\n","plt.show()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":507},"id":"wCvSN2j7rJ0d","executionInfo":{"status":"ok","timestamp":1748789768285,"user_tz":240,"elapsed":173,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"865400ad-628d-499e-d3a7-a01517240357"},"execution_count":null,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 1000x500 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}]},{"cell_type":"code","source":["##key word analysis\n","#brianstorm\n","keywords = [\"prescribed\", \"prescription\", \"tablet\", \"capsule\", \"medication\", \"drug\", \"mg\", \"dose\", \"take\", \"administer\"]\n","\n","#Combine into regex pattern (case-insensitive)\n","pattern = r\"\\b(\" + \"|\".join(keywords) + r\")\\b\"\n","\n","#Apply to full_note (or note) column\n","df_notes[\"has_drug\"] = df_notes[\"full_note\"].str.contains(pattern, case=False, na=False)\n","\n","#Count how many notes mention drugs\n","drug_mention_count = df_notes[\"has_drug\"].sum()\n","print(f\"🧾 Notes mentioning drugs/prescriptions: {drug_mention_count} / {len(df_notes)}\")\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"2sFAUZJksqK7","executionInfo":{"status":"ok","timestamp":1748789771732,"user_tz":240,"elapsed":3439,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"926ae671-98e6-4f50-9e39-a720e78f512e"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stderr","text":["<ipython-input-20-aa9b5b1051fa>:9: UserWarning: This pattern is interpreted as a regular expression, and has match groups. To actually get the groups, use str.extract.\n","  df_notes[\"has_drug\"] = df_notes[\"full_note\"].str.contains(pattern, case=False, na=False)\n"]},{"output_type":"stream","name":"stdout","text":["🧾 Notes mentioning drugs/prescriptions: 14719 / 30000\n"]}]},{"cell_type":"markdown","source":["# **Kaggle EDA**"],"metadata":{"id":"CZ5-TzYus3AD"}},{"cell_type":"code","source":["print(\"Total interactions:\", len(kaggle_drug))\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"8pK7TQ1Rsxxs","executionInfo":{"status":"ok","timestamp":1748789771807,"user_tz":240,"elapsed":58,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"930a97cd-9f9f-47bd-ee17-46c61528cfd3"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["Total interactions: 191541\n"]}]},{"cell_type":"code","source":["##Count drugs\n","drug_counts = Counter(kaggle_drug['Drug 1']) + Counter(kaggle_drug['Drug 2'])\n","\n","# Top 10\n","top_drugs = pd.DataFrame(drug_counts.items(), columns=['drug', 'interaction_count']).sort_values(by='interaction_count', ascending=False)\n","print(top_drugs.head(10))\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"-FTSuvpKxGcR","executionInfo":{"status":"ok","timestamp":1748789771972,"user_tz":240,"elapsed":151,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"deb8d006-027f-49b9-fba7-bfcf4d044233"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["               drug  interaction_count\n","22    Phenobarbital                920\n","21        Primidone                896\n","17        Phenytoin                895\n","19     Fosphenytoin                877\n","20    Carbamazepine                868\n","1017    Venlafaxine                860\n","761     Fluvoxamine                845\n","23    Pentobarbital                845\n","478      Amiodarone                844\n","1016     Nefazodone                815\n"]}]},{"cell_type":"code","source":["##visualize\n","top_drugs.head(10).plot.bar(x='drug', y='interaction_count', color='skyblue', title=\"Top 10 Most Interacting Drugs\")\n","plt.xticks(rotation=45, ha=\"right\")\n","plt.ylabel(\"Interaction Count\")\n","plt.tight_layout()\n","plt.show()\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/","height":487},"id":"4C1Qbu4ExSYU","executionInfo":{"status":"ok","timestamp":1748789772170,"user_tz":240,"elapsed":183,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"12d4a072-c1b9-4df1-b46e-fce25b2179fc"},"execution_count":null,"outputs":[{"output_type":"display_data","data":{"text/plain":["<Figure size 640x480 with 1 Axes>"],"image/png":"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\n"},"metadata":{}}]},{"cell_type":"code","source":["##Common word analysis\n","kaggle_drug[\"interaction_lower\"] = kaggle_drug[\"Interaction Description\"].str.lower()\n","\n","#Most common interaction\n","interaction_words = kaggle_drug[\"interaction_lower\"].str.cat(sep=' ').split()\n","interaction_word_counts = Counter(interaction_words)\n","print(\"Top 20 common words in interaction descriptions:\")\n","print(interaction_word_counts.most_common(20))\n"],"metadata":{"colab":{"base_uri":"https://localhost:8080/"},"id":"aFbdE0fMxYqh","executionInfo":{"status":"ok","timestamp":1748789772897,"user_tz":240,"elapsed":623,"user":{"displayName":"Kelsey Ryan","userId":"01618277718695335433"}},"outputId":"2612f6f3-cb36-4efa-e0d9-fc2d1b849860"},"execution_count":null,"outputs":[{"output_type":"stream","name":"stdout","text":["Top 20 common words in interaction descriptions:\n","[('of', 192471), ('the', 192356), ('can', 144286), ('when', 143338), ('with', 143338), ('be', 143311), ('combined', 134466), ('is', 95443), ('increased', 91027), ('risk', 61397), ('or', 61370), ('severity', 61370), ('adverse', 60909), ('effects', 60722), ('decreased', 52082), ('may', 47228), ('activities', 45339), ('metabolism', 39313), ('increase', 38937), ('serum', 36850)]\n"]}]},{"cell_type":"markdown","source":["#**MIMIC EDA**"],"metadata":{"id":"h-0lM6mdAzGV"}}]}
